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CHAPTER 1 INTRODUCTION
1.1

Nucleic Acids
Nucleic acids include deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) [1].

DNA molecules contain information for the synthesis of a functional biological product, for
instance RNA or protein, and they are responsible for storage and transmission of genetic
information from one generation to the next. RNA carries information translated from DNA
and transcripts that information into proteins [1]. The three major kinds of RNAs are
messenger RNAs (mRNAs), transfer RNAs (tRNAs), and ribosomal RNAs (rRNAs). The
mRNAs encode the amino acid sequence of one or more polypeptides specified by a
gene or set of genes. The tRNAs read the information encoded in the mRNA and transfer
the appropriate amino acid to a growing polypeptide chain during protein synthesis. The
rRNAs are the skeleton constituents of the ribosome. After transcription from DNA, RNA
strands may undergo posttranscriptional modifications to achieve full function or regulate
protein production [1]. Posttranscriptional modifications have been found in many types of
RNA across archaea, bacteria, and eukarya [2-4].
DNA and RNA are polymers of nucleotides, and nucleotides consist of nucleosides
and phosphate groups. The major chemical difference between DNA and RNA
nucleosides is their 2′-hydrogen versus 2′-hydroxyl substituents of the ribose sugar. This
seemingly minor chemical change however greatly impacts the structures, stability, and
functions of DNA and RNA nucleic acids [1]. DNA usually adopts the B-form structure (the
Watson-Crick structure), which is the most stable form for a random-sequence DNA
molecule under physiological conditions. B-form DNA is a double-stranded right-handed
helix in which the 2′-deoxyribose sugars exhibit C2′-endo sugar puckering. RNA is usually
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single-stranded, but it may fold back on itself or anneal with other RNAs to form a
double-stranded structure. The predominant structure of double-stranded RNA is A-form,
which is a right-handed double helix in which the ribose sugars exhibit C3′-endo sugar
puckering [1,5]. Nucleobases take on anti orientations in both A and B form structures to
form base pairs via hydrogen-bonding interactions. But in Z-form DNA or RNA strands,
nucleobases (e.g., guanine) may adopt a syn orientation [6,7]. In summary, nucleobase
orientation, sugar puckering, and hydrogen-bonding interactions are three of the
important factors that determine the structure of nucleic acids.
1.1.1 Canonical DNA and RNA Nucleosides
Figure 1.1 shows the structures of the canonical DNA and RNA nucleosides. Each
nucleoside contains a purine or pyrimidine base as well as a sugar moiety. The major
chemical difference between DNA and RNA nucleosides is their 2′-hydrogen versus
2′-hydroxyl substituents of the ribose sugar. DNA nucleosides include 2′-deoxyadenosine
(dAdo), 2′-deoxyguanosine (dGuo), 2′-deoxycytidine (dCyd), and thymidine (dThd). RNA
nucleosides include adenosine (Ado), guanosine (Guo), cytidine (Cyd), and uridine (Urd).
Nucleobases of adenine (Ade), guanine (Gua), and cytosine (Cyt) are common in both
DNA and RNA nucleosides. Thymine (Thy) and uracil (Ura) only differ by a methyl group
at the 5 position of the nucleobase. Thy is one of the building block pyrimidines in DNA
and only rarely occurs in RNA, whereas Ura is one of the building block pyrimidines in
RNA and is rarely found in DNA [1]. 2′-Deoxyuridine (dUrd) and 5-methyluridine (Thd) are
two important modified nucleosides that enable the influence of methylation on the
pyrimidine nucleobase to be elucidated via comparisons with the canonical nucleosides.
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1.1.2 2-O-Methylated Nucleosides
Each of the canonical RNA nucleobases, adenine, cytosine, guanine, and uracil,
can undergo modification at several sites; however, modification of the ribosyl moiety has
only been found to occur naturally at the 2′-position [2,3]. Modifications at the
2′ position of ribose may influence the overall structure and behavior of RNA. Although
the modifications of RNA nucleosides involve a large diversity of chemical groups,
methylation is involved in about two thirds of the modified nucleosides [8-10]. As a result,
2′-O-methylated nucleosides are being investigated in a variety of biological systems [3].
The 2′-O-methylated nucleosides are present in all major RNAs, and have also
been discovered in small non-coding RNAs, such as spliceosomal RNAs (snRNAs)
[3,8-10]. In rRNAs, the majority of these methylation sites are highly conserved among all
living organisms [11]. According to previous studies, methylation on the ribose may
increase the stability of DNA:RNA and RNA:RNA duplexes [12-16]. In particular, in a
study of thermophilic archaea by McCloskey and coworkers [17], they found that the level
of

2′-O-methyladenosine

(Adom)

in

16S

rRNA

as

well

as

the

levels

of

2′-O-methylguanosine (Guom) and 2′-O-methylcytidine (Cydm) in 23S rRNA significantly
increased when cultured at an elevated temperature. Their results established that
2′-O-methylation of nucleosides is influenced notably by temperature, and may lead to
increased stability of the rRNA of thermophilic archaea. In addition, 2′-O-methylated
nucleosides also participate in RNA function, especially in the recognition of
tRNA [11,18-24]. For example, one single Guom modification controls the activation or
inhibition of Toll-like receptor 7, which is one of the mediators of tRNA [25]. Furthermore,
it has been discovered that the 5′ end guanosine cap of the messenger RNA (mRNA) of
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higher eukaryotes is 2′-O-methylated, and many viruses mimic this modification on their
mRNA to avoid the self and non-self discrimination of mRNA from the host [26-28]. Cydm
has been found in the anticodon loop of phenylalanine tRNA in yeast, and
2′-O-methyuridine (Urdm) is involved in glutamine tRNA of Tetrahymena and alanine
tRNA of Bombyx mori [29-32]. 2′-O-Methylthymidine (Thdm) has been found in lysine and
glutamic acid tRNAs from Drosophila and mammals [29,31,33].
Methylation of the ribosyl moiety at the 2′-postion leads to changes in the
electronic and hydrogen-bonding characteristics [1]. Compared to DNA nucleosides, the
presence of 2′-hydroxyl substituents in RNA nucleosides increases the number of
favorable rotational orientations of the 2′- and 3′-hydroxyl substituents and the potential
for canonical and noncanonical hydrogen-bonding interactions [1]. The 2′-O-methyl
substituent exhibits hydrogen-bonding characteristics that are intermediate between that
of DNA and RNA, as it can act as a hydrogen-bond acceptor but not a hydrogen-bond
donor, which limits the nature of the hydrogen-bonding interactions possible between the
2′- and 3′-hydroxyl substituents, and noncanonical hydrogen bonding in some low-energy
conformers of the RNA nucleosides [34-38]. Thus, the structures of 2′-O-methylated
nucleosides are worthy of study in their own right, but are also being compared to the
canonical DNA and RNA nucleosides to elucidate the influence of 2′-O-methylation on
their structures.
The structures of 2′-O-methylated nucleosides have been studied using a variety
of techniques in both their nucleoside and nucleotide forms in the condensed
phases [16,29,39-45]. These studies indicate that 2′-O-methylated nucleosides prefer
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3′-endo sugar puckering, and increase the structural and thermal stability of DNA and
RNA strands [12-16,29,43,46-48].
1.1.3 Glycosidic Bond Stability
The glycosidic bond is the covalent bond that connects the nucleobase and sugar
moieties of a nucleoside. In the canonical nucleosides, the glycosidic bond links the N9
and C1′ (purine) or N1 and C1′ (pyrimidine) atoms of the nucleobase and sugar, and is
also referred to as an N-glycosidic bond (Figure 1.1). Glycosidic bond cleavage is an
important step in DNA repair by the base-excision repair pathway [1,49]. Thus, glycosidic
bond stability is of interest, especially the relative stability change when modification
occurs [50-54]. The glycosidic bond stabilities of protonated canonical nucleosides have
been investigated and compared by previous Rodgers group members, Ranran Wu via
threshold collision-induced dissociation (TCID) in a guided ion beam tandem mass
spectrometer (GIBMS) and Yanlong Zhu by energy-resolved collision-induced
dissociation (ER-CID) in a quadrupole ion trap mass spectrometer (QIT MS)
[34-38,53-62]. The relative glycosidic bond stabilities of the 2′-O-methylated nucleosides
are measured by ER-CID in a QIT MS and compared to the previous results in this
dissertation.
1.1.4 Nucleobase Orientation and Sugar Puckering Designations
Nucleobase orientation and sugar puckering are two major structural features of
nucleic acids. The nucleobase orientation relative to the glycosidic bond is defined by the
dihedral angle ∠C4N9C1′O4′ in purine or ∠C2N1C1′O4′ in pyrimidine nucleosides. If the
dihedral angle falls between 90° and 270°, the nucleobase is designated as anti;
otherwise (if the dihedral angle equals –90° to 90°) the nucleobase is designated as syn.
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Figure 1.2 demonstrates anti and syn orientations of Adom and Cydm as examples for
the purine and pyrimidine nucleosides, respectively. As mentioned previously, the
nucleobases take anti orientations in both A and B form nucleic acid structures to form
base pairs, but guanine adopts a syn orientation in Z-form DNA or within certain RNA
strands [6,7].
Sugar puckering is designated based on the relative positions of the atoms in the
ribose. There are two common designations for the sugar puckering. The first designation
focuses on the atom that is most puckered out of the plane of the sugar ring. Endo
(puckering toward the 5-substituent) or exo (puckering away from the 5-substituent) are
used to represent the relationship of the puckered atom and the sugar ring. As mentioned
above, B-form DNA or RNA adopt C2′-endo sugar puckering, whereas A-form DNA or
RNA adopt C3′-endo sugar puckering [1,5]. This designation is widely used to describe
DNA and RNA strands. The second designation classifies the sugar puckering based on
the pseudorotation angle, P, of the sugar moiety [63,64]. If only one atom is puckered out
of the plane, i.e., the other four atoms all lie perfectly in a plane, the sugar puckering is
designated as envelope (E). All other modes of puckering are denoted as twist (T). Figure
1.3 illustrates the pseudorotation angle diagram, where the angle (P) is calculated using
Equation 1.1,
tan P =

( 4+ 1) ‒ ( 3+ 0)
2 2 (sin36° + sin72°)

(1.1)

where the angles, 𝑣0 , 𝑣1 , 𝑣2 , 𝑣3 and 𝑣4 , represent the ∠C4′O4′C1′C2′, ∠O4′C1′C2′C3′,
∠C1′C2′C3′C4′, ∠C2′C3′C4′O4′ and ∠C3′C4′O4′C1′ sugar dihedral angles, respectively.
If 𝑣2 is positive (upper section of the diagram), P can be used directly to find the
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corresponding sugar puckering in Figure 1.3. If 𝑣2 is negative (lower section of the
diagram), the phase of P must be shifted by 180°. Figure 1.3 also provides three
examples of C2′-endo (2T3, 2E, and 2T1) sugar puckering. In this case, both designations
indicate that the C2′ atom is the ring atom that deviates most from the plane of the ring,
but the 2T3 or 2T1 designations also communicate that the C3′ or C1′ atom is also slightly
exo puckered out of the plane of the sugar ring.
1.1.5 Application of Mass Spectrometry in the Study of Nucleosides
Mass spectrometry has become increasingly popular in the characterization of
ribonucleosides [65-67]. Qualitative and quantitative analyses via liquid chromatography
coupled with mass spectrometry (LC-MS) have contributed significantly to RNA
modification analysis [17,18,68,69]. On the generic level, modifications control the
activities of the biological system [20]. During standard LC-MS analysis, RNAs are usually
digested into nucleosides for easier and more consistent results. Mass spectrometry
necessarily examines ions rather than neutral molecules, and protonated nucleosides are
typically generated during the LC-MS detection [17,18,69]. When digested into
nucleosides, the phosphate group is cleaved off from the nucleotide and the 3′-hydroxyl
group is free for potential hydrogen-bonding interactions [1]. Electrospray ionization (ESI)
is a soft ionization technique that typically maintains the solution-phase structures of
molecules [66]. Thus, the structures of protonated nucleosides in the gas phase are
commonly proposed from solution-phase results such as NMR and X-ray crystallography.
However, these assumptions have not been validated by detailed structural investigation
in the gas phase. Protonated nucleosides may adopt different sugar conformations in the
gas phase due to the lack of solvent and the presence of excess charge. Further, the
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presence of the excess proton and the absence of solvent stabilizing hydrogen-bonding
interactions may alter the intramolecular hydrogen-bonding interactions and even the
tautomeric state of the nucleobase. Elucidating the gas-phase structures can facilitate
further mass spectral study of nucleosides and nucleic acids, and provide chemical
insight into the folding and unimolecular decomposition of oligonucleotides and nucleic
acids. The gas-phase structures of the protonated and sodium cationized forms of the
canonical DNA and RNA nucleosides [34-38,58-62,70-73], and deprotonated and
protonated forms of the canonical DNA and RNA mononucleotides have been thoroughly
investigated using IRMPD action spectroscopy [74-84] and ion mobility mass
spectrometry approaches in conjunction with electronic structure methods [84,85].
1.1.6 Systems Investigated
In this dissertation, protonated 2′-O-methylated nucleosides, [Nuom+H] +, were
investigated, including [Adom+H]+, [Guom+H]+, [Cydm+H]+, [Urdm+H]+, and [Thdm+H]+.
These nucleoside ions are examined by infrared multiple photon dissociation (IRMPD)
action spectroscopy [86-88] in the IR fingerprint and hydrogen-stretching regions [89,90].
Experiments are supported by theoretical electronic structure calculations to determine
the stable low-energy conformers present and their relative stabilities. Further study of
the energy-resolved collision-induced dissociation (ER-CID) behavior of these protonated
nucleosides and their canonical DNA and RNA nucleoside analogues elucidates their
relative glycosidic bond stabilities.
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1.2

Amino Acid-Linked Cisplatin Analogues

1.2.1 Cisplatin
Almost half a century has passed since cisplatin (Figure 1.4) was first discovered
as an anticancer drug [91,92]. Cisplatin has been employed to treat a variety of cancers,
including testicular, ovarian, head, neck, bladder, and lung cancers [93,94]. The
pharmacological mechanism of cisplatin is believed to be associated with its ability to
coordinate to genomic DNA, and in particular, guanine (Gua) residues [95]. Cisplatin
favors binding to the N7 position of purine bases, with a preference for guanine over
adenine [92,95,96]. Recent studies have demonstrated that cisplatin accumulates faster
and is more highly retained on RNA compared to DNA [97]. The reactivity of cisplatin
toward RNA may cause general damage to RNA structure and potentially impact the
established DNA-based mechanism [98,99]. In a previous report, cisplatin was
successfully utilized as a chemical probe to detect solvent accessible sites in ribosomal
RNA (rRNA) [100]. Despite its success, cisplatin suffers from resistance and low cell
accumulation due to reactivity with thiol-containing molecules that may be present at
relatively higher levels in cancerous cells [101,102]. Cisplatin may also cause severe side
effects, such as neurotoxicity, nephrotoxicity, nausea, vomiting, and emetogenesis
[103-105]. The development of RNA-targeting Pt compounds is one of the approaches
being pursued in an attempt to overcome DNA repair-related resistance and reduce
dose-related side effects.
1.2.2 Amino Acid-Linked Platinum Complexes
The chlorido ligands of cisplatin are labile, a prominent factor in determining the
rate of DNA adduct formation. The ammonia molecules are carrier ligands, which play a
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role in producing structurally distinct DNA adducts [105-107]. In this thesis work, amino
acids (AA) are used to replace the ammonia groups in cisplatin (Figure 1.4) in order to
alter the reactivity, and potentially the selectivity of binding, to DNA or RNA strands [108].
The backbone amino and carboxylate groups of each amino acid may coordinate to the
Pt metal center. The diverse side chains among canonical and noncanonical amino acids
also expand the pool of potential binding sites/modes to the Pt metal center [1].
Because of potential differences between cisplatin and its amino acid-linked
analogues in the condensed and gas phases, the best choice of theoretical methods to
describe their structures and stabilities must be validated via comparison with
spectroscopic results. Due to its structural simplicity and lack of side chain, Glyplatin
(glycine-linked cisplatin, [(GlyH)PtCl2], Figure 1.4) provides an opportunity for a wide
variety of hybrid theoretical approaches to be evaluated at a reasonable computational
cost.
In the screening of a solution-phase mixture of 17 amino acid-linked cisplatin
derivatives, lysine-linked cisplatin (Lysplatin, (Lys)PtCl2, Figure

1.4) exhibited

outstanding reactivity, and a coordination preference for all d(AG) and d(GG) sites on an
82mer DNA, which differed from that of cisplatin in which d(GG) sites were favored [109].
Arginine-linked cisplatin (Argplatin, (Arg)PtCl2, Figure 1.4) exhibited modest reactivity,
and has been synthesized and investigated further in follow-up experiments. After
adjusting the method of synthesis and crystallization, Argplatin exhibited reactivity and
cytotoxicity parallel to that of Lysplatin [110]. When reacted with ribosomal RNA (rRNA),
Lysplatin also exhibited binding preference at r(AG) and r(GA) sites, whereas cisplatin
mainly bound to r(GG) sites [108]. Argplatin exhibited very different binding preferences
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for r(AG) and r(GA) sites compared to those of Lysplatin and Ornplatin (ornithine-linked
cisplatin, (Orn)PtCl2, Figure 1.4) [108]. In particular, Lysplatin and Ornplatin target the
helix 24 hairpin loop region of the 16S rRNA isolated from E. coli, whereas Argplatin
showed a preference for a three-nucleotide bulge region with less reactivity at the sites
where Ornplatin or Lysplatin bound. The probing results provided valuable structural
information about rRNA and showed that the reactivity of Pt(II) complexes can be altered
with modifications to the size and charge distribution within the complex. At the
nucleoside level, (Orn)PtCl2 shows a four-fold higher reactivity with Ado than with Guo
[104]. X-ray crystallography results indicate that Argplatin, Ornplatin, and Lysplatin all
bind to Pt via the backbone nitrogen and oxygen atoms, yet the reactivity of Argplatin
clearly differs from that of Ornplatin and Lysplatin [108-111]. The bulky guanidino side
chain of arginine may be responsible for the observed difference in reactivity due to its
potentially different interactions with the nucleotides. These descriptions suggest that
structural differences between these amino acid-linked platinum complexes may have
existed but been neglected in previous studies.
Other analogues of Ornplatin and Lysplatin, namely diaminocarboxylate (Dac,
HO2C(NH2)CH(CH2)nNH2) linked platinum complexes, such as 2,3-diaminopropionate
(Dap, n=1), 2,4-diaminobutyrate (Dab, n=2), ornithine (Orn, n=3), and lysine (Lys, n=4)
were examined and compared [112-114]. The (Dap)PtCl2, (Dab)PtCl2, (Orn)PtCl2, and
(Lys)PtCl2 complexes all showed reactivity toward DNA or RNA, and in some cases even
exhibited antitumor activity [108,109,115,116]. Cytotoxicity studies of (Dap)PtCl 2 and
(Dab)PtCl2 with HeLa cancer cells indicated that toxic side effects associated with these
two compounds were greatly reduced, while their biological activity was retained. The cell
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survival percentage of (Dap)PtCl2 and (Dab)PtCl2 were comparable to that of
carboplatin [117], a second generation analogue of cisplatin [116]. Moreover, (Dab)PtCl 2
was more biologically active than (Dap)PtCl2 in HL-60 and A431 cell lines [116]. In a study
of (Dap)PtCl2, (Dab)PtCl2, and their ethyl ester derivatives (Dap–H+Et)PtCl2 and
(Dab–H+Et)PtCl2, higher antitumor activity was observed for their ester derivatives [115].
The increased antitumor activity of the ester derivatives was explained based on the
negative charge on [(Dap–H)PtCl2]– and [(Dab–H)PtCl2]– complexes in solution, which
could inhibit their penetration of cell membranes relative to that of the ethyl esters. Dap
and Dab bind to Pt via NNs (backbone and sidechain nitrogens) or NO (backbone
nitrogen and oxygen) modes under different reaction conditions [112,113]. However, the
NNs binding mode for Ornplatin or Lysplatin was not observed in the condensed-phase IR
experiments, as evidenced by the lack of strong C=O stretch in the IR fingerprint
region [113].
More questions about the structures of Ornplatin and Lysplatin arise rather than
have been answered if we picture the backbone NO binding structures together with their
outstanding reactivity. For instance, the study of Lysplatin with HeLa cells indicated that it
suffers from low uptake by cells, which again may relate to inefficient penetration.
However, this is inconsistent with the assumption that the side chain of Lys is protonated,
which may suggest that instead the NO structure of Lysplatin should actually facilitate
penetration [118]. These experimental observations can be easily explained if Lys also
binds to Pt via an NNs binding mode. If we consider only NO binding conformers of
Lysplatin, in which the overall positive charge of the complex should facilitate cell
penetration, the low uptake of Lysplatin cannot be readily explained [109].
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1.2.3 Quasimolecular

Forms

of

Amino

Acid-Linked

Platinum

Complexes

Investigated and Their Nomenclature
To reduce the bias of condensed-phase measurements, tandem mass
spectrometry and spectroscopic approaches complemented by theoretical work is
applied here to investigate amino acid-linked platinum complexes, including Glyplatin,
Argplatin, Lysplatin, and Ornplatin. IRMPD action spectroscopy is an effective approach
for the study of the structures of gas-phase ions [86-88]. Glyplatin was investigated as
[(Gly‒H)PtCl2]‒ due to its inherent negative charge. Using a combination of IRMPD and
theoretical techniques, the structure of Glyplatin is elucidated via comparison of the
measured IRMPD and computed IR spectra for the stable structures computed. The
fidelity with which each hybrid theoretical approach is able to reproduce the measured
IRMPD spectrum is evaluated to determine the most accurate and efficient approaches
for theoretically characterizing the structures and IR spectra of more complex Pt(II) based
cisplatin analogues.
Argplatin, Lysplatin, and Ornplatin were all investigated in their deprotonated and
sodium cationized forms, [(AA‒H)PtCl2]‒ and [(AA)PtCl2+Na]+, to elucidate their
structures and evaluate the stability of the mode of AA-Pt binding in different chemical
and ionization environments. Complementary electronic structure calculations are
performed to facilitate the interpretation of IRMPD spectra using the hybrid theoretical
approach determined in our study of Glyplatin. Structures of different amino acid-linked
platinum complexes are also compared to each other and to previous results in the
condensed phase to gain additional insight into the structures and reactivities of these
systems.
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Amino acids, especially Arg, Lys, and Orn, may chelate to the Pt metal center via
different binding modes. The nomenclature used to discribe the structures of these amino
acid-linked platinum complexes follow these rules: conformers are designated by their Pt
chelating mode, followed by Na chelating mode for the [(AA)PtCl 2+Na]+ complexes. If the
binding mode involves a deprotonated site, it is indicated with a negative sign. Backbone
and sidechain nitrogens are denoted as N and Ns (see Figure 1.4), and the two chlorido
ligands are denoted based on the atom trans to the chlorido ligand (e.g., Cl b, Cls, ClO). Arg
has multiple nitrogen atoms, which are designated as N, N s, N, and N (Figure 1.4). For
example, NO‒_ClbClO conformers indicate structures in which Lys binds to Pt via the
backbone nitrogen and oxygen atoms, and the carboxylate group is deprotonated; the
sodium cation binds between the two chlorido ligands (one that is trans to the backbone N,
and the other is trans to the backbone O). In the case of NsO_ClsClO conformers, the
carboxylate group is protonated and is thus a neutral carboxylic acid group, thus the N sO
binding mode is neutral; the sodium cation binds between the two chlorido ligands (one
that is trans to the sidechain N, and the other is trans to the backbone O).
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2′-O-Methyladenosine (Adom)
X = OCH3
2′-Deoxyadenosine (dAdo)
X=H
Adenosine (Ado)
X = OH

2′-O-Methylguanosine (Guom)
X = OCH3
2′-Deoxyguanosine (dGuo)
X=H
Guanosine (Guo)
X = OH

2′-O-Methylcytidine (Cydm) 2′-O-Methyluridine (Urdm) 5,2′-O-Dimethyluridine (Thdm)
X = OCH3
X = OCH3
X = OCH3
2′-Deoxycytidine (dCyd)
2′-Deoxyuridine (dUrd)
Thymidine (dThd)
X=H
X=H
X=H
Cytidine (Cyd)
Uridine (Urd)
5-Methyluridine (Thd)
X = OH
X = OH
X = OH
Figure 1.1 Chemical structures of 2′-O-methylated nucleosides, the canonical DNA
and RNA nucleosides, and the 2-deoxy and 5-methylated nucleosides of uridine. The
numbering of the nucleobase and sugar moieties is shown and the abbreviated
names for each are given in parenthesis.
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anti orientation
∠C4N9C1′O4′ = 90° to 270°

syn orientation
∠C4N9C1′O4′ = -90° to 90°

Adom

anti orientation
∠C2N1C1′O4′ = 90° to 270°

syn orientation
∠C2N1C1′O4′ = -90° to 90°

Cydm
Figure 1.2 Designations of nucleobase orientation (anti or syn) of the
2′-O-methylated purine and pyrimidine nucleosides, Adom and Cydm, based on their
∠C4N9C1′O4′ and ∠C2N1C1′O4′ dihedral angles, respectively.
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C3'-endo

C2'-endo

Major Minor

2

T

Major
endo

3

exo

C2′-endo (2T3)

2

E

Major Minor
endo
exo

C2′-endo (2E)

2

T

endo

1

exo

C2′-endo (2T1)

Figure 1.3 Pseudorotation phase angle (P) diagram. The most commonly adopted
sugar puckering configurations are highlighted. Examples of C2′-endo (2T3, 2E,
and 2T1) sugar puckering (shaded red region) are shown to demonstrate the
nomenclature, which is determined by the location of P in the diagram. Subscripts
and superscripts designate the major (before) and minor (after) puckered atoms and
the direction of puckering toward (endo) or away (exo) from the 5-substituent.
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Cisplatin

Amino Acid-Linked Cisplatin
Glycine
(C2H5NO2)
Arginine
(C6H14N4O2)
Lysine
(C6H14N2O2)

Ornithine
(C5H12N2O2)
Figure 1.4 Chemical structures of cisplatin and a schematic designation of amino
acid-linked platinum complexes in which the amino acid binds in a cis bidentate
fashion to the Pt metal center. The amino acids studied in this dissertation include
glycine, arginine, lysine, and ornithine. The structure of these four amino acids are
shown, with potential binding sites to Pt labeled, with nitrogen binding sites
designated as N, Ns, Ne, and Nh.
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CHAPTER 2 EXPERIMENTAL SETUP AND THEORETICAL METHODS
2.1

Introduction
This chapter focuses on the experimental and theoretical approaches employed

for characterization of the protonated forms of the 2′-O-methylated nucleosides and the
amino acid-linked platinum complexes discussed in Chapter 1. Two types of tandem
mass spectrometry were performed, which include infrared multiple photon dissociation
(IRMPD) action spectroscopy and energy-resolved collision-induced dissociation
(ER-CID) experiments. Theoretical calculations were performed to facilitate the structural
elucidation of the 2′-O-methylated nucleosides and the amino acid-linked platinum
complexes. Details of the modified parameters used in the candidate structure generation
of the amino acid-linked platinum complexes are also described in the theoretical section.
2.2

Materials
All the 2′-O-methylated nucleosides were purchased commercially. The

2′-O-methyladenosine (Adom), 2′-O-methylguanosine (Guom), 2′-O-methylcytidine
(Cydm), and 2′-O-methyluridine (Urdm) were purchased from Alfa Aesar (Haverhill, MA,
USA), and 5,2′-O-methyluridine (Thdm) was purchased from Berry & Associates (Dexter,
MI, USA). The canonical DNA and RNA nucleosides, and the 2′-deoxy and 5-methylated
nucleosides of uridine were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Cisplatin and amino acid-linked platinum complexes were synthesized by our
collaborators, Xun Bao and Bett Kimutai based on procedures previously described
[104,111]. Formic acid used in the IRMPD experiments were purchased from
Sigma-Aldrich (Saint-Quentin-Fallavier, France). Acetic acid was purchased from
Mallinckrodt Chemicals (St. Louis, MO, USA). Ammonium acetate was purchased from
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Fluka (St. Louis, MO, USA). Sodium chloride (NaCl) was purchased from Sigma-Aldrich
(Zwijndrecht, The Netherlands) for the IRMPD experiments in the fingerprint region and
from Sigma-Aldrich (St. Louis, MO, USA) for the IRMPD experiments in the
hydrogen-stretching region and ER-CID experiments of platinum complexes. The HPLC
grade

water

and

methanol

were

purchased

from

the

Sigma-Aldrich

(Saint-Quentin-Fallavier, France/ Zwijndrecht, The Netherlands/ St. Louis, MO, USA
based on the experimental location).
2.3

Tandem Mass Spectrometry
Tandem mass spectrometry generally includes ionization, mass selection,

activation, mass analysis, and detection (Figure 2.1). The information elucidated from the
experiments depends on the nature of the analyte, the method of ionization, types of
mass analyzers used, and types of activation employed, etc. Each of these factors are
discussed individually.
2.3.1 Sample Preparation for Mass Spectrometry
The nature of the sample determines the preparation steps in the experiments. For
mass spectrometry experiments performed in this thesis, all samples were dissolved in a
MeOH:H2O (1:1 v/v) mixture. The biological samples examined in the experiments, such
as nucleosides and platinum complexes, are soluble in water, and the aqueous condition
also mimics the biological environment in the cell. Methanol was added to assist the
desolvation process which occurs in the electrospray ionization (ESI) process. Acids
(formic acid, acetic acid) were added to facilitate protonation of the nucleosides. Buffer
solution (ammonium acetate) can also serve as proton donor, and it was used in the
ER-CID experiments of protonated pyrimidine nucleosides instead of acetic acid used for
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the protonated purine nucleosides to avoid the interference from the impurity (similar
mass as Urd and dThd) in the acetic acid in our laboratory. No acids were added to the
platinum complexes due to the precipitation previously observed for the solution of
Ornplatin with 0.1% formic acid. Different solution conditions were also used based on the
type of experiments performed. Sodium chloride (NaCl) was added to platinum
complexes in order to provide a positive charge for better ionization in the sodium
cationized platinum complexes experiments, and the ratio between the concentrations of
platinum complexes and NaCl was 1:1. The solution preparation of the platinum
complexes was performed in the dark to prevent the photo degradation reported for
cisplatin [119]. The eppendorf tubes and the ESI source were covered with aluminum foil
to minimize exposure to ambient light. Detailed solution conditions are summarized in
Table 2.1.
2.3.2 Electrospray Ionization Source
Electrospray ionization (ESI) is a soft ionization technique that typically maintains
the solution-phase structures of molecules [66]. ESI was employed in all the experiments
performed in this work. Depends on the nature of the analyte and chemical property that
needs to be measured, positive or negative ions are generated using an ESI source. For
example, all nucleosides were measured in positive ion mode because nucleobases are
good proton acceptor. For cisplatin, deprotonation of the ammonia group generates the
negatively charged cisplatin species, and protonation is almost impossible because both
nitrogen atoms are saturated. The deprotonation of the carboxylate group in the amino
acid-linked platinum complexes is easier to achieve than the neutral amino group
considering the binding sites of the amino acid (Gly, Arg, Lys, Orn) to Pt (see Figure 1.4).
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In order to maintain a neutral species of the platinum complexes, sodium cationized
platinum complexes were measured in the positive ion mode. With the advantage of
charge manipulation in the gas phase and the comparison of the structures in different
ionization modes, the binding modes of amino acids to Pt metal center and how it is
influenced by the local environment were able to be revealed (see Chapter 5 for details).
High voltage was applied in the ionization process to facilitate ion generation and guide
the ions, and nebulizer gas as well as drying gas/curtain gas were applied in most cases
to help desolvation process. In addition, different ESI source designs also influence the
limit of detection of the ions. Table 2.1 indicates that the concentration of the sample may
vary from μM to mM range based on the source design as well as the type of mass
analyzer.
2.3.3 Mass Analyzers
Mass analysis is performed by different types of mass analyzers. The mass
spectrometers usually name after the types of their mass analyzers. For instance, two
types of mass spectrometers were used in the measurements, Fourier transform ion
cyclotron resonance mass spectrometers (FT-ICR MS) and quadrupole ion trap mass
spectrometers (QIT MS). The mass analyzer for FT-ICR MS is the ICR cell, and the mass
analyzer for QIT MS is the quadrupole ion trap. FT-ICR MS provides high mass resolution
and high mass accuracy [120-122]. Mass selection in the ICR cell also allows isolation of
a single isotopic peak that minimizes complexity in data analysis resulting from the
multiple isotopes of platinum and chlorine in the amino acid-linked platinum complexes
examined in this work. QIT MS has high scanning speed across a wide mass range,
which saves significant amount of time in the IRMPD action spectroscopy and ER-CID
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studies. Tandem mass analysis (MS2 or even MSn type of experiments) can be achieved
either in the ICR cell on FT-ICR MS or in the quadrupole ion trap on QIT MS. Detailed
instrument type chosen for each experiment is summarized in Table 2.1.
2.3.4 Activation Methods
The activation methods employed in this thesis include infrared multiple photon
dissociation (IRMPD) and collision-induced dissociation (CID). IRMPD and CID are both
nuclear activation techniques that increase the internal energy of the ions to induce
unimolecular dissociation; however, the excitation of the precursor ions is achieved by
different mechanisms in these two types of activation.
The mechanism of IRMPD must necessarily involve intramolecular vibrational
redistribution (IVR). IR absorption requires the photon energy to be resonant with a
rotational-vibrational mode transition of the precursor ion. Upon photon absorption, the
internal energy of the ion increases, and the photon energy is redistributed throughout the
ion by IVR. The resonant vibrational mode relaxes back to its ground vibrational level and
is ready to absorb the next photon. After tens to hundreds of absorptions, the internal
energy of the ion reaches or exceeds the dissociation threshold, and the ion dissociates.
The observed fragmentation pathways generally involve the weakest bonds of the ion
[90,123].
Collision-induced dissociation (CID) is an activation technique that induces
dissociation of the precursor ion by collisions. The precursor ion is accelerated to
increase its kinetic energy and collides with inert gas, and the kinetic energy of the ion is
converted to its internal energy. When the internal energy of the ion reaches or exceeds
the dissociation threshold after single or multiple collisions, dissociation usually occurs at
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the weakest bonds of the ion. In the QIT MS, collisions occur in the quadrupole ion trap.
The inert gas in the quadrupole ion trap is helium (He), which not only served as the
collision gas but also enabled efficient trapping and cooling of the ions. Sustained
off-resonance irradiation collision-induced dissociation (SORI-CID) is another type of CID
which occurs only in the ICR cell. The precursor ion is excited based on its frequency in
the Fourier transform process, and the on-resonance irradiation will provide too much
kinetic energy to the precursor ion during the excitation step. Instead, SORI-CID applies
an off-resonance excitation to the precursor ions inside the ICR cell. The excitation
frequency is usually slightly lower than the frequency of the precursor ion, because a
lower frequency which corresponds to a higher m/z can also reduce the signal of the
isotopes. Argon (Ar) gas is typically used as collision gas in FT-ICR MS. Instead of a
constant gas pressure, SORI-CID introduces a pulse of Ar gas into the ICR cell, slowly
pumps away the excessive gas, then introduces the second pulse of Ar gas. The average
of mass spectra collected under different gas pressure provides a reasonable
fragmentation spectrum of the precursor ion.
Similar fragmentation pathways for the same precursor ions may be observed in
the IRMPD and CID experiments. Both types of activation methods can also induce
sequential dissociation. If the IRMPD fragments lose the functional group of which the
vibrational mode is resonant with the photon, the fragments cannot undergo further
sequential dissociation. If the fragments still contain the chromophore that is resonant
with the photon, sequential dissociation may also occur. On the other hand, after the first
dissociation in CID, fragment ions with enough kinetic energy may also undergo
sequential dissociation.
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2.4

Infrared Multiple Photon Dissociation (IRMPD) Action Spectroscopy
IRMPD action spectroscopy is a powerful technique that can be used to elucidate

the IR spectrum of an analyte using the extent of fragmentation of the precursor ion as a
function of vibrational frequency in the gas phase rather than using the absorbance of the
analyte as in condensed-phase IR spectroscopy [86-88,124-126].
The IR spectra observed for analytes via IRMPD action spectroscopy and
condensed-phase IR spectroscopy are similar as both are based on the resonant
characterization of IR active modes of the analyte. However, without the interference of
solvent (especially water), the IR features of ions are often more discernible in the IR
fingerprint and hydrogen-stretching regions than that is typically achieved in
condensed-phase IR measurements [89,90].
IRMPD yield is calculated based on the extent of fragmentation of the precursor
ion, using the ratio of the total fragment ion intensity to the total ion intensity as described
by Equation 2.1,
IRMPD yield = ∑i Ifi ⁄( ∑i Ifi +Ip )

(2.1)

where Ifi and Ip are the ion intensities of the fragment and precursor ions, respectively.
Intensities at each frequency (or wavelength) are usually power corrected for the
frequency dependent variations in the laser output. The corrected IRMPD yield is plotted
as a function of the tunable IR laser frequency (or wavelength) to generate the IRMPD
action spectrum.
A simplified schematic of the instrumental setup for the IRMPD experiments
performed in this dissertation is shown in Figure 2.2. The ICR cell and quadrupole ion
trap represent the mass analyzers of FT-ICR MS and QIT MS, which are also the reaction
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chambers of the IRMPD experiments. In general, ions are generated using an ESI source,
guided by rf ion guides, mass isolated, accumulated, and irradiated by the tunable IR
laser in the ICR cell or quadrupole ion trap (see Section 2.3). A widely tunable free
electron laser (FEL) was applied to acquire the IRMPD spectra in the IR fingerprint region.
The FEL at the FELIX facility (free electron laser for infrared experiments) provides pulse
energies of up to 40 mJ per 5 μs pulse, at a 510 Hz repetition rate, and a bandwidth of
0.5% of the laser frequency [127]. The IR laser frequency is calibrated using a grating
spectrometer for the FEL. Intensities at each wavelength were power corrected for the
frequency dependent variations in the laser output. A parallel FEL setup at the CLIO
facility was used for the measurements of the protonated 2′-O-methylated nucleosides
[124-126]. An Nd:YAG-pumped (Innolas Spitlight 600 or Continuum Lasers) optical
parametric oscillator laser system (OPO, LaserVision, Bellevue, WA) was used in all
cases to acquire the IRMPD spectra in hydrogen-stretching region. The OPO laser
typically provides 6 ns pulses at a 10 Hz repetition rate with energies of up to 20 mJ, and
a bandwidth of 3 cm-1. The IR laser frequency is calibrated using a wavemeter
(HighFinesse GmbH, Germany) for the OPO laser at the FELIX facility.
2.5

ER-CID Experiments and Survival Yield Analysis
Energy-resolved CID (ER-CID) experiments vary the rf excitation amplitude to

describe the relationship of the increasing kinetic energy of the precursor ion and the
degree of fragmentation. During ER-CID experiments, the extent of fragmentation of the
precursor ion was plotted as a function of rf excitation amplitude, and relative stabilities of
the canonical and modified protonated nucleosides were revealed.
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The ER-CID experiments for the protonated forms of 2′-O-methylated nucleosides
and their analogous DNA and RNA nucleosides were performed on the QIT MS in our
laboratory (Figure 2.3). The experimental protocol described in detail in previous work
was employed for the experiments performed here [58-62]. Ions were generated via an
ESI source and transferred to the quadrupole ion trap via ion guides, then the ions of
interest were mass isolated, accumulated, and had collisions with the helium (He) gas in
the quadrupole ion trap. The rf excitation amplitude is increased from 0 V to the rf
excitation amplitude required to produce complete dissociation of the precursor ion at a
step size of 0.01 V. Series of CID spectra are generated, and the survival yield was
calculated for each MS/MS spectrum. The survival yield was plotted as a function of the rf
excitation amplitude to produce the survival yield curve. Each experiment was performed
in triplicate in order to access reproducibility.
The intensities of the precursor and fragment ions were extracted from the CID
mass spectrum for each rf excitation amplitude examined using DataAnalysis 4.0 (Bruker
Daltonics, Bremen, Germany), and the survival yield was computed as the ratio of the
precursor ion intensity to the total ion intensity using Equation 2.2,
Survival yield = Ip ⁄( ∑i Ifi +Ip )

(2.2)

where Ifi and Ip are defined as in Equation 2.1. The rf excitation amplitude required to
produce 50% dissociation (CID50%) was extracted from the data by fitting the survival yield
curve using a four-parameter logistic dynamic algorithm, as shown in Equation 2.3,
Survival yield = min + (max-min) 1+

rfEA
CID50%

CIDslope

(2.3)
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In this equation, max and min are the maximum and minimum values (1 and 0,
respectively) of the survival yield, rfEA is the rf excitation amplitude applied to induce
fragmentation, and CIDslope is the slope of the declining region of the survival yield curve.
For the protonated nucleosides, glycosidic bond cleavage with the proton retained
by the nucleobase was generally the only dissociation pathway observed, and thus the
relative stability can be equated with the glycosidic bond stability. The CID 50% values of
the protonated forms of the 2′-O-methylated nucleosides and their analogous DNA and
RNA nucleosides were compared to elucidate their relative glycosidic bond stabilities.
Data analyses are performed using SigmaPlot 10.0 (Systat Software, Inc., San Jose, CA,
USA) and custom software developed in our laboratory.
2.6

ER-SORI-CID Experiments and Fragmentation Pathway Analysis
Energy-resolved SORI-CID (ER-SORI-CID) experiments were performed in a

fashion that parallels to the ER-CID experiments described in Section 2.5 except that the
collisions occurred in a different fashion described in Section 2.3.4. ER-SORI-CID
experiments vary the degree of the excitation power applied on the precursor ion to
describe the relationship of the increasing kinetic energy of the precursor ion and the
degree of fragmentation.
The FT-ICR MS in our laboratory (Figure 2.4) was employed in the ER-SORI-CID
experiments performed on deprotonated and sodium cationized cisplatin and Ornplatin
complexes because the high mass accuracy and mass resolution on the FT-ICR MS
reduces the complexity of fragmentation pathway analyses. Mass isolation in the ICR cell
also enabled sole fragmentation of the monoisotopic mass of the platinum complex,
which increases confidence of the interpretation of the fragmentation data, especially for
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the small neutral loss pathways (e.g. H2O vs NH3 loss). Ions were generated via an ESI
source, transferred by a dual ion funnel through a heated capillary. The quadrupole
operated as an ion guide and transferred the ions into the hexapole ion guides. The ions
were accumulated for a few seconds in the hexapole ion guide, then transferred into the
ICR cell by a transfer optics (a second hexapole ion guide). Ions of interest were mass
isolated and underwent collisions with the pulsed Ar gas in the ICR cell. The percentage
of SORI excitation power was increased from 0% to the percentage of SORI excitation
power required to produce complete dissociation of the precursor ion at a step size of
0.1%. Series of SORI-CID spectra were collected, and the survival yield of the precursor
ion as well as the yield of each fragment ion were calculated for each SORI-CID
spectrum.
The survival yield of the precursor ion was also calculated using Equation 2.2.
The yield for each fragment observed in the experiments was plotted using the
complement of this equation, replacing the intensity of precursor ion with the intensity of
each fragment ion. The yields were plotted as a function of the percentage of SORI
excitation power to produce the SORI-CID appearance curves. The intensities of the
precursor and fragment ions were extracted and normalized versus the total ion intensity.
Data analyses were performed using DataAnalysis 4.0 (Bruker Daltonics, Bremen,
Germany) and SigmaPlot 10.0 (Systat Software, Inc., San Jose, CA, USA).
2.7

Experimental Details

2.7.1 Quadrupole Ion Trap Mass Spectrometers
Three different quadrupole ion trap mass spectrometers (QIT MS) were used to
acquire the IRMPD action spectra and ER-CID data described in this thesis, and they are
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the QIT MS in our laboratory at Wayne State University (WSU), the QIT MS at the FELIX
facility, and the QIT MS at the University of Lyon.
The

IRMPD

spectra

of

Argplatin,

Lysplatin,

and

Ornplatin

in

the

hydrogen-stretching region as well as the ER-CID experiments for the protonated forms
of the 2-O-methylated nucleosides and their analogous DNA and RNA nucleosides
(Table 2.1) were collected on a modified 3D QIT MS (amaZon ETD, Bruker Daltonics,
Figure 2.3) in our laboratory. In general, samples were prepared as a 10 M solution in
1:1 (v/v) MeOH:H2O mixture. 10 M NaCl was added to the platinum complexes in the
positive ion mode experiments for platinum complexes. No acids were added for platinum
complexes, but 1% acetic acid (purine) or 5mM ammonium acetate (pyrimidine) were
added into the nucleosides to facilitate ionization. The injection syringe used in the
experiments of the platinum complexes were covered with aluminum foil. The ions of
interest were generated via the Apollo ESI source at a flow rate of 2‒3 μL/min. During
ionization, the droplets were desolvated by the nebulizer gas and drying gas, which were
both nitrogen (N2) gas. The temperature of the drying gas was held at ~200 °C. Ions were
extracted into the capillary by ~4 kV applied to the entrance of the capillary. Ions
emanating from the glass capillary were guided by a dual ion funnel, transferred into a
hexapole ion guide, and guided into the quadrupole ion trap. Ions of interest were mass
selected, accumulated, and reacted with photons or helium gas in the quadrupole ion trap.
Helium buffer gas (~2 mTorr, default helium pressure for enhanced resolution mode) was
introduced into the ion trap for efficient trapping and cooling of the ions, but also served as
the collision gas for the CID experiments. The qz value was set to 0.25, which
corresponds to a low-mass cutoff of 27% of the precursor ion m/z. In the ER-CID
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experiments, ions of interested were mass isolated with a 20 ms isolation delay and the
fragmentation time of the precursor ions with the background He gas was set to 60 ms for
all protonated nucleosides. In the IRMPD measurements of platinum complexes, ions of
interest were mass isolated with a 50 ms isolation delay to achieve equilibrium, then
accumulated and irradiated by the OPO laser for 2‒4 s in the quadrupole ion trap.
The IRMPD action spectra for Argplatin, Lysplatin, and Ornplatin in the IR
fingerprint region were collected using a modified 3D QIT MS (amaZon Speed ETD,
Bruker Daltonics) at the FELIX facility very similar to the instrument in our laboratory at
WSU. The experimental setup has been described in detail elsewhere [128,129]. The
solutions of platinum complexes were prepared in a similar fashion as mentioned for the
IRMPD measurements in the hydrogen-stretching region (Table 2.1). The ions were
generated by an ESI source with the assistance of N2 served as nebulizer gas and drying
gas then extracted into the entrance of the capillary. Ions emanating from the glass
capillary were guided by a dual ion funnel, transferred into a hexapole ion guide, and
guided into the quadrupole ion trap. Ions of the corresponding platinum complexes were
mass selected, accumulated, and reacted with the FELIX FEL for two pulses with 0‒8 dB
attenuation in the quadrupole ion trap.
The IRMPD spectra of the protonated 2-O-methylated nucleosides in the
hydrogen-stretching region were collected on a modified QIT MS equipped with an ESI
source (LCQ classic, Thermo Finnigan) at the University of Lyon (Villeurbanne, France)
[130-132]. Ions were generated via the ESI source from solutions containing 250 M
analyte and 1:1 (v/v) MeOH:H2O mixture, and 0.1% formic acid was used to facilitate
ionization process. The desolvated ions were guided by octopole ion guides and
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transmitted into the quadrupole ion trap. The pronated 2-O-methylated nucleosides were
mass isolated, accumulated, and irradiated by the OPO laser for 0.4‒0.9 s in the
quadrupole ion trap. The IRMPD yields for the protonated 2-O-methylated nucleosides
were high, especially the IRMPD yield for [Guom+H]+ was near saturation at some data
points. Hence, the experimental spectra in the hydrogen-stretching region for the
protonated 2-O-methylated nucleosides were plotted as IRMPD yield in the experimental
spectra (Figure 3.1‒3.5) but as [1-log (IRMPD Yield)] to correct the power in the
comparisons between the measured IRMPD and predicted IR spectra (Figure
3.23‒3.31).
2.7.2 Fourier Transform Ion Cyclotron Resonance Mass Spectrometers
Three FT-ICR MS were used to perform the IRMPD action spectroscopy and
energy-resolved CID experiments described in this thesis, including the 4.7 T FT-ICR MS
at the FELIX facility, the 7 T FT-ICR MS in our laboratory at Wayne State University, and
the 7T FT-ICR MS at the CLIO user facility.
The IRMPD spectrum of deprotonated Glyplatin, [(GlyH)PtCl2], was acquired
using the custom-built 4.7 T FT-ICR MS at the FELIX Facility in the Radboud University
(Nijmegen, the Netherlands). Details of the instrument setup have been documented
elsewhere [86-88]. Ions were generated using a Micromass “Z-spray” ESI source from
solutions containing 1‒7 mM Glyplatin in a MeOH:H2O (1:1 v/v) mixture. No acids were
added. The light was turned off until the source was covered by a cardboard box. The
solution was sprayed at a flow rate ~2 μL/min, and the voltage on the ESI needle was held
at ‒2.5 kV. Ions emanating from the spray were guided and accumulated in an rf
hexapole ion trap for 5.5‒12.5 s to provide an intense ion signal and ensure efficient

33
thermalization of the ions. Ions were pulse extracted through a quadrupole bender and
injected into the ICR cell by an rf octupole ion guide. Glyplatin ions, [(Gly-H)PtCl 2]-, were
mass selected and isolated using stored waveform inverse Fourier transform (SWIFT)
techniques in the ICR cell and ready to be irradiated with the tunable FEL or OPO laser for
4‒11 s. Due to the lack of strong hydrogen-stretching vibrations in [(Gly–H)PtCl 2]–, ions
were irradiated for 11 s by the OPO laser, then for 50 ms with the output of a 30 W
continuous wave CO2 laser directly after each OPO pulse to facilitate dissociation of the
resonantly excited ions [133].
Several experiments related to the platinum complexes (Table 2.1) were
performed on a Bruker 7 T hybrid FT-ICR MS (solariX, Bruker Daltonics) in our laboratory
at WSU. A schematic diagram of this instrument is shown in Figure 2.4. The platinum
complexes were dissolved in MeOH:H2O (1:1 v/v) mixture at a concentration of 5‒10 M.
NaCl was added as 1:1 ratio to the platinum complexes in the positive ion mode
experiments (Table 2.1). Samples were prepared with the lights off, and the injection
syringe was covered with aluminum foil. Ions of interest were generated via an ESI source
at a flow rate of 1‒3 μL/min. The drying gas temperature was held at ~180 °C; however, in
the ER-SORI-CID experiment of [(OrnH)PtCl2], the temperature was dropped to 37 °C
to obtain cool enough precursor ions. Nitrogen (N2) was used as the drying gas at 4.0‒4.5
L/min and nebulizer gas at ~1.4 bar. Ions were extracted by ~‒4.5 kV in positive ion mode
(or ~4.2 kV in negative ion mode) on the capillary, then ions emanating the glass capillary
were bent by the voltage (~200 V) on the deflector plate, passed through dual ion funnels,
and were guided by dual octopole ion guides. In the IRMPD experiments of
[(OrnH)PtCl2] and [(LysH)PtCl2], the quadrupole is used solely as a mass filter,
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fragmentation in the hexapole ion guide is not employed. Ions were accumulated in the
collision cell for a few seconds and extracted as an ion packet into the ICR cell. Mass
isolation was achieved in the ICR cell, and the peak corresponding to the isotopic mass is
selected for [(OrnH)PtCl2] or [(LysH)PtCl2] and irradiated by the OPO laser for 20 s.
The IRMPD spectra were first collected with a continuous scan mode of the OPO laser,
and only one mass spectrum was collected for each point due to the long irradiation time.
The regions that exhibit fragmentation were recollected. A specific laser frequency with a
stepsize of 4 cm-1 was used, and four mass spectra are averaged (the intensities are
added up due to the mechanism of signal detection in FT-ICR MS). In the SORI-ER-CID
experiments for the deprotonated and sodium cationized quasimolecular ions of cisplatin
and Ornplatin (Table 2.1), the rf frequency excitation offset for the precursor ions was set
to 500 Hz (500 Hz lower in frequency than the frequency of the precursor ion). The
percentage of SORI excitation power was increased from 0% to the percentage of SORI
excitation power required to produce complete dissociation of the precursor ion at a step
size of 0.1%.. Ar gas was pulsed into the ICR cell from a reservoir held at a gas pressure
of 25 mbar, and the length of the SORI excitation pulse was set to 0.40.5 s. 1002200
averaged scans were collected for each data point to achieve a good signal to noise ratio.
IRMPD action spectroscopy experiments for the protonated 2′-O-methylated
nucleosides in the IR fingerprint region were performed using a Bruker 7T hybrid FT-ICR
MS (Apex Qe, Bruker Daltonics) at the CLIO user facility at the Université Paris-Sud
(Orsay, France). Detailed instrumental setups have been described elsewhere [124-126].
This instrument is one generation older than the FT-ICR MS in our laboratory, which is
described in the previous paragraph. The ions of the protonated 2′-O-methylated
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nucleosides were prepared as ~1 mM solution in MeOH:H2O (1:1 v/v) mixture with 0.1%
formic acid (FA). Ions were generated using an ESI source, then extracted by high
voltage on the glass capillary. Then ions emanating the glass capillary were bent by the
potential on the deflector plate, passed through dual ion funnels, and were guided by dual
octopole ion guides. The ions of the protonated 2′-O-methylated nucleosides were mass
selected by the quadrupole mass filter, accumulated in the hexapole ion trap for a few
seconds, and transmitted into the ICR cell. The selected ions were irradiated by the CLIO
FEL for 0.22‒0.39 s with 0‒5 dB attenuation in the ICR cell to induce dissociation.
2.8

Theoretical Approaches
Candidate structures were generated at the molecular mechanics (MM) level of

theory using either the AMBER or MM+ force field in HyperChem [134] software through a
simulated

annealing

process

[135].

Select

low-energy

structures

along

with

manually-built structures were submitted to quantum mechanical (QM) calculations for
geometry optimization and more accurate determination of their relative energies. All QM
calculations were performed using the Gaussian 09 suite of programs [136]. Many QM
theoretical approaches were evaluated for Glyplatin, the simplest platinum complex, to
determine an efficient protocol capable of predicting the IRMPD spectra of platinum
complexes. Predicted IR spectra for the low-energy conformers of each species were
extracted for further comparisons.
2.8.1 Generation of Candidate Structures using Molecular Dynamics
The most favorable protonation sites of each of the canonical DNA and RNA
nucleosides were previously determined [34-38]. As 2′-O-methylation occurs on the sugar
moiety, whereas the most favorable sites of protonation are associated with the
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nucleobases, the same sites of protonation were examined for the 2′-O-methylated
nucleosides. These sites include the N1, N3, and N7 positions of Adom, the N3, O6, and
N7 positions of Guom, the N3 and O2 positions of Cydm, and the O2, O4 positions as well
as the 2,4-dihydroxy tautomers of Urdm and Thdm. Simulated annealing procedures [135]
were performed using HyperChem [137] software with the AMBER 3 force field to
generated candidate structures for more accurate QM calculations. The initial structure
for each protonated form of each 2′-O-methylated nucleoside was built by modifying the
most stable conformers determined for the analogous protonated forms of the canonical
RNA nucleosides found in previous work by simply replacing the 2′-hydroxyl hydrogen
atom by a methyl group [34-38]. Each initial structure was subjected to 0.3 ps of thermal
heating elevating the temperature from 0 to 1000 K, the temperature was held at 1000 K
for 0.2 ps to allow sampling of conformational space, after which the system was cooled
down to 0 K over a period of 0.3 ps. Molecular mechanics calculations were performed on
the annealing structures every 1 fs of each cycle, and a snapshot of the structure at the
end of each cycle was captured and used as the initial structure for the subsequent cycle.
This process was repeated for 300 cycles for each protonated form of each nucleoside,
providing 600900 structures for each protonated 2′-O-methylated nucleoside. The thirty
lowest-energy structures based on the MM calculations were chosen for further
calculations. Additional structures were also built to ensure comprehensive sampling of
the structure pool, with these additional conformers chosen based on results found for the
analogous protonated forms of the canonical or modified RNA nucleosides [34-38].
The candidate structures for each deprotonated or sodium cationized platinum
complex were constructed, including [(Arg‒H)PtCl2]‒, [(Arg)PtCl2+Na]+, [(Lys‒H)PtCl2]‒,
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[(Lys)PtCl2+Na]+, [(Orn‒H)PtCl2]‒, and [(Orn)PtCl2+Na]+. Structures involving bidentate
interaction of the amino acid (Arg, Lys, or Orn) were manually built for all platinum
complexes based on previous studies [109-111,113,114] to comprehensively examine all
plausible bidentate interactions between the amino acid (AA) and Pt (see Figure 1.4).
The chlorido ligands were bound to the Pt center in a cis- configuration. Various modes of
binding of the sodium cation were also examined. Starting structures with unique AA and
sodium cation binding modes were first optimized at the B3LYP/mDZP/def2-TZVP level
of theory based on the results of Glyplatin (see the discussion about level of theory in
Section 2.8.4). Optimized structures and partial charges were extracted as the initial
structures in the simulated annealing process [135,138] to relax the side chain of the AA
and explore the conformational space of that structure.
Due to the lack of parameters for Pt in the AMBER force field, the MM+ force field,
which is derived from the MM2 force field, was employed in the simulated annealing
process [135,138]. Parameters for Pt have been developed and validated to work with the
MM+ force field [139,140]. Extra parameters such as the bond length and bond angles
involving PtO bond were derived from the QM calculations of the initial structures
mentioned above. Other missing parameters for PtO related parameters used the
existing PtN parameters in the literatures [139,140]. As the candidate structure
candidate generation process, the approximation of some PtO related parameters will
not alter the results of the candidate structures significantly. The simulated annealing
procedures employed here were already described for the protonated 2′-O-methylated
nucleosides. The only difference is that energy restrictions for angles and dihedral angles
were applied to the initial structures in order to maintain an approximately square planar
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shape of the Pt coordination sphere. Thirty of the 300 candidate structures generated for
each unique binding mode were selected based on their relative energies calculated at
the MM level of theory. Overall, at least 2100 candidate structures were generated for the
deprotonated species, and at least 5100 candidate structures were generated for the
sodium cationized species. One tenth of these candidate structures along with many
manually generated structures were subjected to further calculations.
2.8.2 Structural Optimization and Single-Point Energy Calculations
Geometry optimizations were performed on the selected candidate structures of
protonated 2′-O-methylated nucleosides and platinum complexes using quantum
mechanics (QM) level of theory with Gaussian 09 suite of programs [136]. The
B3LYP/6-311+G(d,p) level of theory was employed for geometry optimizations of the
protonated 2′-O-methylated nucleosides to provide results directly comparable to those
from previous investigations of the protonated forms of the canonical and modified DNA
and RNA nucleosides [34-38]. The single-point energies of protonated 2′-O-methylated
nucleosides were further calculated using B3LYP/6-311+G(2d,2p) level of theory at 298 K,
and the relative Gibbs energies among different candidate of each species were
extracted and compared. In the previous studies of the protonated forms of canonical and
modified DNA and RNA nucleosides, energetics based on both B3LYP and MP2
(Second-Order Moller-Plesset Perturbation) theories were examined. The results
suggest that B3LYP predicts the energetics of these systems slightly better than MP2
theory for the protonated pyrimidine nucleosides, but not necessary for the protonated
purine nucleosides. Therefore, energetic calculations performed here were limited to
B3LYP with a 6-311+G(2d,2p) basis set for protonated 2′-O-methylated purine
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nucleosides; whereas B3LYP and MP2(full) calculations with a 6-311+G(2d,2p) basis set
were performed for protonated 2′-O-methylated pyrimidine nucleosides [34-38]. To help
explain the possible presence of higher-energy conformers of [Adom+H]+ and [Guom+H]+
in the experiments, the effects of solvation on the relative stabilities of ground and the
relevant excited conformers of the these species were also examined using the same
theoretical approaches [136], but in a polarizable continuum model corresponding to
water [141]. This model is sometimes referred as the implicit water model because a
series of potentials rather than actual water molecules is added in the calculation of the
molecule to mimic the presence of water as the solvent around the molecule.
Optimizations of the candidate structures for Argplatin, Lysplatin, and Ornplatin.
were performed using the B3LYP/mDZP/def2-TZVP hybrid approach based on the
results for Glyplatin (see Section 2.8.4). Single-point energies of the optimized structures
were also calculated at 298 K and extracted at B3LYP/mDZP/def2-TZVP level of theory.
Implicit water model was further applied on select conformers of Lysplatin to rationalize
the difference observed in the experiment and theoretical calculations. Relative Gibbs
energies

of

these

select

low-energy

conformers

were

calculated

at

the

B3LYP/mDZP/def2-TZVP level of theory using default polarizable continuum model
corresponding to water with the integral equation formalism variant (IEFPCM) in
Gaussian 09 suite of programs [136].
2.8.3 Frequency Analyses and Scaling Factors
The predicted IR spectrum for each optimized structure was extracted from the
calculation. Scaling factors were used to correct for the differences between experimental
and theoretical spectra to eliminate known systematic errors that are caused by the
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neglect of anharmonicity, the incomplete incorporation of electron correlation, and the
use of finite basis sets [142-144]. Sophisticated anharmonic calculations may provide
more accurate predictions of the resonant vibrational frequencies without an empirical
scaling factor, but the computational cost of these calculations is significantly higher than
the harmonic calculations. With limited resource investigated, the results of anharmonic
calculations may be even worse than those based on harmonic calculations. On the other
hand, the calculated IR spectra are based on a single photon excitation model, whereas
the experiments involve multiple photon absorption such that the intensity of the IR band
is not always well reproduced by the predicted IR spectrum. Thus, the band positions in
the experimental IRMPD spectrum were primarily used for structural determination,
whereas relative intensities were used but given less weighting.
The harmonic vibrational frequency analyses were extracted from the optimization
calculations. Different scaling factors were applied in the IR fingerprint region and
hydrogen-stretching region. The B3LYP/6-311+G(d,p) level of theory was employed for
protonated 2′-O-methylated nucleosides. Vibrational frequencies were scaled by a factor
of 0.973‒0.980 in the fingerprint region and 0.957‒0.959 in the hydrogen-stretching
region. The B3LYP/mDZP/def2-TZVP hybrid approach was performed for Argplatin,
Lysplatin, and Ornplatin. Based on the results for Glyplatin (see Section 2.8.4), the
computed frequencies of all amino acid-linked platinum complexes were scaled by a
factor of 0.970 and 0.957–0.960 in the IR fingerprint region and hydrogen-stretching
region, respectively. In order to reproduce the observed experimental broadening, the
computed IR spectra were convoluted with a Gaussian line shape of 20 cm -1 fwhm (full
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width at half maximum) in the fingerprint region and 10 cm -1 fwhm in the
hydrogen-stretching region to best reproduce the experimental data.
2.8.4 Theoretical Approaches for Glyplatin
A variety of hybrid theoretical approaches were first evaluated for the
characterization of Glyplatin based on the density functional employed, treatment of the
Pt center, and basis set used to describe the remainder of the system. Basis sets that are
not incorporated in the Gaussian software were acquired from the EMSL basis set
exchange library [145,146]. A total of seven different density functionals including: B3LYP,
B3PW91, mPW1PW91, M06, PBE0, LC-ωPBE, and CAM-B3LYP were chosen for
examination based on previous studies of cisplatin. In particular, previous studies have
suggested that several of these density functional theory (DFT) methods exhibit better
performance than B3LYP [134,147-150], and thus these conclusions are re-examined
here for Glyplatin. The challenge associated with describing the Pt metal center is due to
the large number of electrons it possesses. Five valence basis sets along with their
corresponding effective core potentials (ECPs) including: LANL2DZ, LANL2TZ,
LANL2TZ(f), SDD, and def2-TZVP were examined and are compared to three all-electron
basis sets including the recently developed all-electron double zeta polarization basis set
(DZP) and its augmented derivatives (ADZP and mDZP) [151,152]. Nineteen different
basis sets were examined for the non-metal atoms including: eight Pople, six Dunning,
and five Ahlrichs basis sets. Details regarding the choice of basis sets employed are
summarized in Table 2.2. As illustrated in the table, the sizes of the basis sets were
carefully increased in each series to examine the effects of the flexibility (ζ), polarization
functions, and diffuse functions on the computed IR spectra. To provide a consistent
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treatment of Pt and the other atoms comprising Glyplatin, four Ahlrichs basis sets
(def2-TZVP, def2-QZVP, def2-TZVPPD, and def2-QZVPPD) and two all-electron basis
sets (DZP and ADZP) were also used to describe all atoms. Henceforth, the hybrid
theoretical approaches examined will be abbreviated as follows: DFT method/Pt
treatment/non-metal atom basis set. Finally, anharmonic calculations were also
performed using second-order vibrational perturbation theory (VPT2) implemented in
Gaussian 09 [136,153]. Due to the difficulty of combining the all-electron basis set (mDZP)
into the anharmonic calculation, the B3LYP/LANL2TZ(f)/def2-TZVP approach was
examined in these comparisons. The deperturbed and generalized VPT2 approaches
(DVPT2 and GVPT2) as well as the degeneracy-corrected PT2 approach (DCPT2) were
examined. Because vibrational spectroscopic analysis is not available for DCPT2 in the
version of Gaussian 09 available, the frequencies were taken from vibrational energies
and combined with the corresponding anharmonic intensities based on the GVPT2
method to generate the convoluted DCPT2 spectrum.
The harmonic DFT approaches were evaluated for best reproduction of the
experimental IRMPD spectrum of Glyplatin. Results in the fingerprint region (measured
with the FELIX FEL) were aligned to the C=O stretch at 1669 cm -1, and results in the
hydrogen-stretching region (measured with the OPO) were aligned to the NH 2
asymmetric stretch at 3360 cm-1. Scaling factors that vary from 0.9283 to 0.9881 in the IR
fingerprint region and 0.9321 to 0.9823 in the hydrogen-stretching region were applied to
best reproduce the experimental spectrum. To provide a quantitative assessment of the
theoretical results, the mean absolute error (MAE, in cm -1) between the measured and
computed frequencies of the seven major features observed in the IRMPD spectrum was
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calculated for each theoretical approach [149,154]. MAE is calculated using Equation
2.4,
Mean Absolute Error (MAE) = ∑i=1 νtheory ‒νexperiment ⁄𝑛

(2.4)

where νtheory are the predicted frequencies, νexperiment are the experimental frequencies,
and 𝑛 is the number of active IR normal modes available to the system in the range of
vibrational frequencies examined, in the case of Glyplatin, 𝑛 = 7.
2.9

Workflows of IRMPD and ER-CID Experiments
The experimental workflow for IRMPD experiments is illustrated in Figure 2.5.

Ions of interest are generated, mass selected, and undergo photodissociation. Mass
spectra are acquired as a function of IR frequency. Structure of ion is elucidated via
IRMPD action spectroscopy assisted with theoretical calculations. Comparison between
the experimental IRMPD and calculated IR spectra enable determination of stable
low-energy conformers populated in the experiments.
The experimental workflow for ER-CID experiments is illustrated in Figure 2.6.
Ions of interest are generated, mass selected, and subject to collisions. Mass spectra are
acquired as a function of rf excitation amplitude. Survival yield is calculated and plotted as
a function of rf excitation amplitude to generate the survival yield curve. The CID 50% value
of each precursor ion is determined using four parameter logistic dynamic fitting of the
survival yield curve. Relative glycosidic bond stabilities of protonated nucleosides are
elucidated via energy-resolved CID experiments.
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Table 2.1 Species Examined in this Thesis and the Instrumental Setup Employed.
Species Examined
Solution Conditionsa
Instrument
Experiment Type
+
[Adom+H]
1 mM +0.1% FA
FT-ICR MS
IRMPD (FEL)b
250 μM+0.1% FA
QIT MS
IRMPD (OPO)c
10 μM+1% AA
QIT MS
ER-CIDd
+
[Guom+H]
1 mM +0.1% FA
FT-ICR MS
IRMPD (FEL)b
250 μM+0.1% FA
QIT MS
IRMPD (OPO)c
10 μM+1% AA
QIT MS
ER-CIDd
[Cydm+H]+
1 mM +0.1% FA
FT-ICR MS
IRMPD (FEL)b
250 μM+0.1% FA
QIT MS
IRMPD (OPO)c
10 μM+5mM AmAc
QIT MS
ER-CIDd
+
[Urdm+H]
1 mM +0.1% FA
FT-ICR MS
IRMPD (FEL)b
250 μM+0.1% FA
QIT MS
IRMPD (OPO)c
10 μM+5mM AmAc
QIT MS
ER-CIDd
+
[Thdm+H]
1 mM +0.1% FA
FT-ICR MS
IRMPD (FEL)b
250 μM+0.1% FA
QIT MS
IRMPD (OPO)c
10 μM+5mM AmAc
QIT MS
ER-CIDd
[(Gly–H)PtCl2]–
1 mM
FT-ICR MS
IRMPD (FEL)e
7 mM
FT-ICR MS
IRMPD (OPO)e
–
[(Arg–H)PtCl2]
10 μM
QIT MS
IRMPD (FEL)e
10 μM
QIT MS
IRMPD (OPO)d
[(Arg)PtCl2+Na]+
10 μM+10 μM NaCl
QIT MS
IRMPD (FEL)e
10 μM+10 μM NaCl
QIT MS
IRMPD (OPO)d
[(Lys–H)PtCl2]–
10 μM
QIT MS
IRMPD (FEL)e
5 μM
FT-ICR MS
IRMPD (OPO)d
[(Lys)PtCl2+Na]+
10 μM+10 μM NaCl
QIT MS
IRMPD (FEL)e
10 μM+10 μM NaCl
QIT MS
IRMPD (OPO)d
[(Orn–H)PtCl2]–
10 μM
QIT MS
IRMPD (FEL)e
5 μM
FT-ICR MS
IRMPD (OPO)d
5 μM
FT-ICR MS
SORI-ER-CIDd
[(Orn)PtCl2+Na]+
10 μM+10 μM NaCl
QIT MS
IRMPD (FEL)e
10 μM+10 μM NaCl
QIT MS
IRMPD (OPO)d
5 μM+5 μM NaCl
FT-ICR MS
SORI-ER-CIDd
–
[(NH3)(NH2)PtCl2]
10 μM
FT-ICR MS
SORI-ER-CIDd
[(NH3)2PtCl2+Na]+
10 μM+10 μM NaCl
FT-ICR MS
SORI-ER-CIDd
a FA – formic acid; AA – acetic acid; AmAc – ammonium acetate.
b Experiments were performed at CLIO user facility.
c Experiments were performed at University of Lyon.
d Experiments were performed at Wayne State University (WSU).
e Experiments were performed at FELIX user facility.
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Table 2.2 Basis Sets Used For Non-Metal Atoms of [(Gly–H)PtCl2]–.
Type
Pople
Dunning
Ahlrichs
Double Zeta
6-31G
cc-pVDZ
def2-SVP
6-31G(d)
aug-cc-pVDZ
6-31+G(d)
6-31+G(d,p)
Triple Zeta
6-311+G(d,p)
cc-pVTZ
def2-TZVP
6-311++G(d,p)
aug-cc-pVTZ
def2-TZVPPD
6-311+G(2d,2p)
6-311+G(3df,3dp)
Quadruple Zeta
cc-pVQZ
def2-QZVP
aug-cc-pVQZ
def2-QZVPPD
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Ionization

Mass Selection

Activation

Mass Analysis

Detection
Figure 2.1 A generic schematic for tandem mass spectrometry. The analyte is first
ionized, and the ions of interest are mass selected. Then the selected ions are
activated and undergo unimolecular dissociation. The precursor and fragmented ions
are mass analyzed by mass analyzer, and then detected by detector.
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Quadrupole

ICR cell

HV
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OPO

Analyte
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rf Ion Guide(s)

Quadrupole
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Figure 2.2 IRMPD action spectroscopy studies are performed on FT-ICR MS or QIT
MS coupled to an FEL or OPO laser. In general, ions of interest are generated via
ESI source, transferred by rf ion guides, mass selected, and accumulated in the ICR
cell or quadrupole ion-trap to induce IR photodissociation. Mass selection is
performed by the linear quadrupole mass filter or the ICR cell in FT-ICR MS, and is
performed by the quadrupole ion trap in QIT MS.
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Electrospray
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Transfer

Detection
Ion Trap Multiplier

CI Source

Figure 2.3 A schematic diagram of the Bruker amaZon ETD QIT MS in our
laboratory. Ions are generated via an ESI source and transferred into a dual ion
funnel though a heated capillary. An rf hexapole ion guide is used to transfer the ions
into the ion trap. Ions of interested are mass selected, accumulated, and subjected to
IRMPD or CID in the 3D quadrupole ion trap.
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Figure 2.4 A schematic diagram of the 7 T Bruker solariX Hybrid FT-ICR MS in our
laboratory. Ions are generated using an ESI source, and transferred into a dual ion
funnel though a heated capillary. The dual octopole ion guide transfers the ions into
quadrupole ion guide, guided by the rf ion guides and accumulated in an rf hexapole
ion guide, transferred into the ICR cell. Mass isolation may occur before (in the
quadrupole mass filter) or after ion accumulation (in the ICR cell). In the ICR cell, the
selected ions are subjected to IRMPD or SORI-CID.
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Figure 2.5 Workflow for infrared multiple photo dissociation (IRMPD) action
spectroscopy. Ions of interest are generated, mass selected, and undergo
photodissociation. Mass spectra are acquired as a function of IR frequency. Structure
of ion is elucidated via IRMPD action spectroscopy assisted with theoretical
calculations. Comparison between the experimental IRMPD and calculated IR
spectra enable determination of stable low-energy conformers populated in the
experiments.
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Figure 2.6 Workflow for energy-resolved collision-induced dissociation (ER-CID).
Ions of interest are generated, mass selected, and subject to collisions. Mass spectra
are acquired as a function of rf excitation amplitude. Survival yield was calculated and
plotted as a function of rf excitation amplitude to generate the survival yield curve.
The CID50% value of each precursor ion is determined using four parameter logistic
dynamic fitting of the survival yield curve. Relative glycosidic bond stabilities of
protonated nucleosides are elucidated via energy-resolved CID experiments.
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CHAPTER 3 STRUCTURAL CHARACTERIZATION OF PROTONATED
2-O-METHYLATED NUCLEOSIDES VIA TANDEM MASS SPECTROMETRY
Portions of this chapter were reprinted with permission from the followed research
publication. C. C. He, L. A. Hamlow, Z. J. Devereaux, Y. Zhu, Y.-w. Nei, L. Fan, C. P.
McNary, P. Maitre, V. Steinmetz, B. Schindler, I. Compagnon, P. B. Armentrout, and M. T.
Rodgers, J. Phys. Chem. B 2018, 122, 9147-9160.
3.1

Introduction
The motivation for studying the 2′-O-methylated nucleosides was described in

Chapter 1. IRMPD action spectroscopy experiments were performed on the protonated
forms of the 2′-O-methylated nucleosides, including: protonated 2′-methyladenosine,
[Adom+H]+, protonated 2′-methylguanosine, [Guom+H]+, protonated 2′-methylcytodine,
[Cydm+H]+,

protonated

2′-methyluridine,

[Urdm+H]+,

and

protonated

5,2′-O-dimethyluridine, [Thdm+H]+ to determine the structures of these species populated
in the experiments. ER-CID experiments were performed on these protonated
2′-O-methylated nucleosides to elucidate their relative glycosidic bond stabilities.
Theoretical calculations were performed to facilitate structural elucidation based on
comparisons to the IRMPD action spectra measured. Experimental details were
described in Chapter 2.
3.2

Experimental Results

3.2.1 IRMPD Pathways of [Nuom+H]+
IRMPD produces one major fragmentation pathway in IR fingerprint and
hydrogen-stretching regions for all five protonated 2′-O-methylated nucleosides, which
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includes [Adom+H]+, [Guom+H]+, [Cydm+H]+, [Urdm+H]+, and [Thdm+H]+. This major
pathway results in glycosidic bond cleavage with the excess proton retained by the
nucleobase, resulting in elimination of the neutral O2′-methylated sugar moiety as
summarized in Reaction 3.1,
[Nuom+H]+ + n h  [Nua+H]+ + (NuomNua)

(3.1)

where Nuom = Adom, Guom, Cydm, Urdm or Thdm. and Nua is the corresponding
nucleobases, i.e. adenine (Ade), guanine (Gua), cytosine (Cyt), uracil (Ura), or thymine
(Thy). For [Adom+H]+, [Guom+H]+, and [Cydm+H]+, glycosidic bond cleavage is the only
fragmentation pathway observed in the experiments. These results exactly parallel those
found for the protonated canonical DNA and RNA nucleosides [34-36]. Several minor
dissociation pathways are also observed for [Urdm+H] + and [Thdm+H]+. The results for
[Urdm+H]+ and [Thdm+H]+ are comparable to those found in the IRMPD experiments of
their corresponding protonated DNA and RNA nucleoside analogues, [dUrd+H] +,
[Urd+H]+, [dThd+H]+, [Thd+H]+ [37,38]. Minor pathways involving water loss are observed
in the photodissociation of [dUrd+H]+ and [dThd+H]+. Instead of water loss, the loss of
methanol (M) is observed as a very minor fragmentation pathway for both [Urdm+H] + and
[Thdm+H]+ as summarized in Reaction 3.2,
[Pymm+H]+ + n h  [PymmM+H]+ + M

(3.2)

where Pymm = Urdm or Thdm. In addition, glycosidic bond cleavage resulting in neutral
loss of the nucleobase from [Urdm+H]+ is also observed as described in Reaction 3.3.
[Urdm+H]+ + n h  [UrdmUra+H]+ + Ura

(3.3)

To reduce the noise in the IRMPD spectrum, the very minor dissociation pathway
involving loss of methanol was not included in the IRMPD yield calculated for [Urdm+H] +
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in the IR fingerprint region; only the dominant neutral loss of sugar was included in the
computed IRMPD yield in the hydrogen-stretching region.
3.2.2 IRMPD Spectra of [Nuom+H]+
The IRMPD spectrum measured here for [Adom+H]+ is compared with those
measured for the corresponding protonated canonical DNA and RNA analogues,
[dAdo+H]+ and [Ado+H]+ in Figure 3.1. As can be seen in the figure, the IRMPD spectra
of these protonated adenine nucleoside analogues are highly parallel. Except for the
broadening and splitting of the intense feature spanning the region from ~10701150
cm-1 and the minor splitting of the feature at ~1660 cm -1 in the spectrum of [Adom+H]+,
only modest shifts in the band positions are observed in both the fingerprint and
hydrogen-stretching regions, indicating a high degree of structural similarity among the
conformers populated for these protonated adenine nucleosides. In contrast, significant
differences in the IRMPD yields are observed. Spectral features observed at ~1100, 1130,
1210, 1650 and 3430 cm-1 in the spectrum of [Adom+H]+ are much more intense than the
corresponding features in the spectra of [dAdo+H] + and [Ado+H]+, whereas virtually all
other features become much less intense and may only be discernible from baseline with
amplification (see Figure 3.1). The differences in the IRMPD yields may arise from the
variation in the sugar moiety across these systems; however, discrimination resulting
from differences in the experimental setups and specific tuning condition employed for
experiments performed here (Chapter 2) versus those used for the canonical
nucleosides, which were measured at the FELIX facility, cannot be ruled out. It should be
noted that although the overall IRMPD yields for [dAdo+H]+ and [Ado+H]+ exhibit a
greater degree of similarity, the features that do exhibit the largest variation in yield in the

55
spectrum of [Adom+H]+ also exhibit sizeable yield differences in the spectra of the
canonical analogues, and thus suggest effects from both the sugar moieties and the
instrumental setups.
The IRMPD spectrum measured here for [Guom+H]+ is compared with those
measured for the corresponding canonical DNA and RNA analogues, [dGuo+H] + and
[Guo+H]+, in Figure 3.2. As found for the protonated adenine nucleosides, the IRMPD
spectra of the protonated guanine nucleosides are also highly parallel. Except for the
disappearance of the shoulder to the red of the intense feature observed at ~1100 cm -1 in
the spectrum of [Guom+H]+, only modest shifts in the band positions are again observed
in both the fingerprint and hydrogen-stretching regions. These spectral similarities are
clear indicators of a high degree of structural similarity among the conformers populated
for these protonated guanine nucleoside analogues. Significant differences in the IRMPD
yields of several features are again observed, with features at ~1110 and 3470 cm -1 in the
spectrum of [Guom+H]+ being much more intense than the corresponding features in the
spectra of [dGuo+H]+ and [Guo+H]+. Other spectral features exhibited by [Guom+H]+ are
much less intense than those in the spectra of the canonical analogues, particularly in the
range between ~1160 and 1550 cm -1 (Figure 3.2). Again, these differences may arise
from both the variation in the sugar moieties and the instrumental setups and the specific
tuning conditions employed in the experiments.
The IRMPD spectrum measured here for [Cydm+H]+ is compared with those
measured for the corresponding canonical DNA and RNA analogues, [dCyd+H] + and
[Cyd+H]+, in Figure 3.3. As can be seen in the figure, the IRMPD spectra of these
protonated cytosine nucleoside analogues also exhibit parallel IR features. One of the
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most obvious differences in the IRMPD spectrum of [Cydm+H]+ is that the band at ~1750
cm-1 almost disappears. The peak at ~1620 cm -1 is also much more intense than other
bands nearby; in contrast, the corresponding IR bands of [dCyd+H] + and [Cyd+H]+ have
comparable relative intensities. No IR feature is observed below 1000 cm -1 for [Cydm+H]+,
whereas two minor features are observed in the IRMPD spectra of [dCyd+H] + and
[Cyd+H]+ [36]. Splitting of the feature at ~3420 cm-1 in the spectrum of [Cydm+H]+
parallels that observed for [Cyd+H]+. The two IR bands near 3550 cm-1 are also fully
resolved in [Cydm+H]+, whereas they are not for the canonical DNA and RNA analogues
(Figure 3.3).
The IRMPD spectrum measured here for [Urdm+H]+ is compared with those
measured for the corresponding modified and canonical RNA analogues, [dUrd+H] + and
[Urd+H]+, in Figure 3.4. Only modest shifts in the band positions are observed in both the
fingerprint and hydrogen-stretching regions. The band at ~1750 cm-1 in the spectrum of
[Urdm+H]+ is red shifted compared to those of [dUrd+H]+ and [Urd+H]+. The unresolved
peak observed at ~1200 cm-1 for [dUrd+H]+ and [Urd+H]+ is buried beneath several small
IR bands nearby in the spectrum of [Urdm+H]+. The IR feature at ~1100 cm-1 is more
significant in [Urdm+H]+ than [dUrd+H]+ or [Urd+H]+. The peak observed at ~3420 cm-1 for
[Urdm+H]+ is more intense than that of [Urd+H]+, whereas this feature is sufficiently weak
for [dUrd+H]+ that it is difficult to differentiate from noise (Figure 3.4).
The IRMPD spectrum measured here for [Thdm+H] + is compared with those
measured for the corresponding canonical DNA and modified RNA analogues, [dThd+H] +
and [Thd+H]+, in Figure 3.5. The IRMPD spectra of the protonated thymine nucleoside
analogues are also highly parallel. The most obvious spectral difference is that the band
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at ~1120 cm-1 in [dThd+H]+ and [Thd+H]+ is almost hidden underneath the broad and
intense peak at ~1100 cm-1 in [Thdm+H]+. As a result of the broadening of this feature, the
peak at ~1180 cm-1 in the spectra of [dThd+H]+ and [Thd+H]+ now appears as a shoulder
of the peak at ~1100 cm-1 in the spectrum of [Thdm+H]+. The moderate IR band observed
at ~1380 cm-1 in the spectra of [dThd+H]+ and [Thd+H]+ is much less intense in the
spectrum of [Thdm+H]+ such that it is hardly discernible from the baseline. Peak splitting
in the spectrum of [Thdm+H]+ at ~3560 cm-1 becomes more obvious than that observed in
the spectra of [dThd+H]+ and [Thd+H]+. A very weak shoulder to the blue of these features
is observed at ~3600 cm-1 for [Thdm+H]+ and [Thd+H]+, but not [dThd+H]+ (Figure 3.5).
3.2.2 CID Fragmentation Pathways of [Nuom+H]+
As found in the IRMPD experiments, CID of the protonated 2′-O-methylated
nucleosides proceeds via a single major fragmentation pathway involving glycosidic bond
cleavage with the excess proton retained by the nucleobase, resulting in elimination of
the neutral O2′-methylated sugar moiety as summarized in Reaction 3.4,
[Nuom+H]+ + n He  [Nua+H]+ + (Nuom‒Nua)

(3.4)

where Nuom = Adom, Guom, Cydm, Urdm, or Thdm, and Nua = Ade, Gua, Cyt, Ura, or
Thy. These results again parallel those found for the protonated canonical DNA and RNA
nucleosides as can be seen in the comparisons of the CID mass spectra of the protonated
adenine, guanine, and cytosine nucleoside analogues measured at rf excitation
amplitudes that result in ~50% fragmentation in Figures 3.6‒3.8. The parallel
dissociation behavior observed in the IRMPD and CID experiments of the protonated
2-O-methylated nucleosides indicates that activation via multiple low-energy collisions or
multiple IR photon absorption results in the same unimolecular dissociation pathways for

58
these protonated nucleosides. For [Adom+H]+, [Guom+H]+, and [Cydm+H]+, glycosidic
bond cleavage (Reaction 3.4) is the only fragmentation pathway observed in the
experiments.
In addition to Reaction 3.4, methanol loss is also observed in the fragmentation of
[Urdm+H]+ and [Thdm+H]+. Glycosidic bond cleavage resulting in neutral loss of the
nucleobase from [Urdm+H]+ is again only observed for [Urdm+H]+. The dissociation
pathways are summarized in Reactions 3.5 and 3.6,
[Pymm+H]+ + n He  [PymmM+H]+ + M

(3.5)

[Urdm+H]+ + n He  [UrdmUra+H]+ + Ura

(3.6)

where Pymm is Urdm or Thdm, and M is methanol. Representative CID mass spectra for
the protonated uracil and thymine nucleoside analogues are shown in Figures 3.9 and 10
at rf excitation amplitudes that produce ~50% fragmentation. The neutral loss of the
nucleobase was only observed for [Urdm+H]+ not [Thdm+H]+ suggesting the
5-methylation of uracil increases the proton affinity of the nucleobase. The CID
fragmentation behavior of [Urdm+H]+ and [Thdm+H]+ differ significantly from their
canonical and modified DNA analogues. Glycosidic bond cleavage resulting in loss of the
neutral nucleobase is not observed for [Urd+H]+, and many water loss pathways are
observed for [dUrd+H]+ and [dThd+H]+. Notably, water loss has been replaced by
methanol loss in [Urdm+H]+ and [Thdm+H]+, which suggests that the water and methanol
losses arise from the ribose moieties. In the case of [dUrd+H] + and [dThd+H]+, multiple
pathways including water loss, even partial ribose loss in [dUrd+H] + (resulting in the
[Ura+W+H]+ fragment ion), and the nucleobase loss all contribute to the survival yield
curve. The water loss pathways are dominant over neutral ribose loss in [dUrd+H] +, but
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not in [dThd+H]+. Higher degree of parallel behavior for the protonated 2-O-methylated
uracil and thymine nucleosides compared to their RNA nucleosides analogues than their
DNA nucleoside analogues suggest that 2-OH, 2-OCH3 substituents stabilize the ribose
moieties. Further control experiments suggest that the ketene pathway observed
previously may have come from an impurity in the acetic acid used in those experiments
[61,62].
3.2.3 Survival Yield Analyses of [Nuom+H]+
The survival yield curves measured for the protonated 2-O-methylated
nucleosides are compared to those measured for their canonical DNA and RNA
analogues in Figures 3.11 and 3.12. Most notably, the declining region of the survival
yield curves for the protonated adenine nucleosides are all shifted to significantly higher rf
excitation amplitudes than observed for all of the other protonated nucleosides. Although
the survival yield curves for the purine and pyrimidine nucleosides are not directly
comparable due to differences in the sizes of these systems and fragmentation pathways
observed, the glycosidic bonds of the protonated adenine nucleosides are probably
stronger than those of all of the other protonated nucleosides based on the significantly
higher CID50% values determined. This observation is consistent with absolute activation
energies (AEs) measured for glycosidic bond cleavage of the protonated forms of the
canonical DNA and RNA nucleosides using threshold CID techniques [53-57]. CID 50%
values and estimates for the uncertainties in these values extracted from fitting the
survival yield data using Equation 2.3 (Chapter 2) are also shown in Figures 3.11 and
3.12. The CID50% values follow the order [dGuo+H]+ < [Guom+H]+ < [Guo+H]+ for the
protonated guanine nucleosides, which suggests that 2′-O-methylation slightly weakens
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the glycosidic bonds relative to the RNA form, but that it is still stronger than the DNA form.
In contrast, trends in the CID50% values of the protonated adenine, cytosine, uracil, and
thymine nucleoside analogues follow the order [dNuo+H]+ < [Nuo+H]+ < [Nuom+H]+,
suggesting that 2′-O-methylation strengthens the glycosidic bond relative to the
protonated DNA and RNA nucleoside analogues. Due to the dominant water losses
(Figure 3.9), the survival yield curve and CID50% value do not represent the glycosidic
bond stability of [dUrd+H]+, but instead are lower limits for its stability. In contrast, the
dominant CID pathways of [Urd+H]+ and [Urdm+H]+ do involve glycosidic bond cleavage.
Combined with previous accurate thermochemical measurements [53], the glycosidic
bond stability order: [dUrd+H]+ < [Urd+H]+ < [Urdm+H]+ is robust. Although water or
methanol losses were observed for the protonated thymine nucleosides, ribose loss still
dominates the CID behavior of [dThd+H]+, [Thd+H]+, and [Thdm+H]+ (Figure 3.10). The
CID50% value of [Thdm+H]+ slightly exceeds that of [Thd+H]+, and is significantly higher
than that of [dThd+H]+, suggesting the glycosidic bond stability follows the order
[dThd+H]+ < [Thd+H]+ < [Thdm+H]+. Clearly accurate thermodynamic measurements of
the absolute AEs for glycosidic bond cleavage of the protonated 2′-O-methylated
nucleosides are of interest and would help clarify the differences that this modification
produces to the stability of the protonated nucleosides.
3.3

Theoretical Results
The stable conformations of the protonated 2′-O-methylated nucleosides were

comprehensively sampled as described in Chapter

1. Each of the stable

B3LYP/6-311+G(d,p) conformers computed are classified on the basis of the site of
protonation,

nucleobase

orientation,

sugar

puckering,

and

relative

61
B3LYP/6-311+G(2d,2p) Gibbs energy at 298 K. Relative Gibbs energies calculated at the
MP2(full)/6-311+G(2d,2p) level of theory at 298 K are also included for the protonated
2-O-methylated pyrimidine nucleosides based on previous findings for the protonated
canonical pyrimidine nucleosides. The classifications employed for the nucleobase
orientation and sugar puckering are described in Chapter 2. The nomenclature employed
for each conformer is based on the site of protonation, followed by a letter that indicates
the order of relative stability among all conformers protonated at that site, where A is used
for the most stable conformer protonated at a given site, B for the next most stable, etc.
Only select structures are shown for each nucleoside. To avoid confusion, the conformer
names taken from the published work are retained, but only a subset of those computed
are discussed here, and thus the designations are not contiguous. The interested reader
is referred to references [155] and [156] for a more comprehensive discussion of the
theoretical results.
3.3.1 Stable Conformation of [Adom+H]+
Select stable B3LYP/6-311+G(d,p) N3, N1, and N7 protonated conformers
computed for [Adom+H]+ are shown in Figures 3.13 and 3.14. The stable conformers
calculated for [Adom+H]+ are highly parallel to those found for [dAdo+H] + and [Ado+H]+
[34]. In particular, the most stable structure computed for each site of protonation of Adom
is very similar to those found for dAdo and Ado. The lowest-energy N3 protonated
conformer of Adom is favored over the most stable N1 and N7 protonated conformers by
25.9 and 33.2 kJ/mol. These stability differences are within 1 and 5 kJ/mol of those found
for [dAdo+H]+ and [Ado+H]+, respectively. The preference for N3 protonation results in a
syn nucleobase orientation stabilized by a strong N3H +O5 hydrogen-bonding
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interaction and C2-endo puckering in the lowest-energy conformer. In contrast, the N1
and N7 protonated structures prefer an anti nucleobase orientation as no such
hydrogen-bonding interaction is possible. Changes in the sugar puckering, nucleobase
orientation, and the hydrogen-bonding interaction between the 2- and 3-substituents are
less destabilizing than changes in the site of protonation such that the stable conformers
computed exhibit a wide variety of sugar puckerings and both syn and anti nucleobase
orientations. The most common C2-endo and C3-endo puckering modes are favored
over all others, with C2-endo preferred over C3-endo for the N3 and N1 protonated
species, and C3-endo favored over C2-endo for the N7 protonated conformers.
3.3.2 Stable Conformations of [Guom+H]+
Select stable B3LYP/6-311+G(d,p) N7, O6, and N3 protonated conformers of
[Guom+H]+ are displayed in Figures 3.15 and 3.16. The stable conformers calculated for
[Guom+H]+ are highly parallel to those found for [dGuo+H] + and [Guo+H]+ [35]. The
ground N7 protonated conformer of Guom is favored over the most stable O6 and N3
conformers by 37.4 and 47.6 kJ/mol. These stability differences are within 5 and 7 kJ/mol
of those found for [dGuo+H]+ and [Guo+H]+, respectively. The N7 and O6 protonated
conformers exhibit a preference for an anti nucleobase orientation, whereas similar to
that found for Adom, the N3 protonated conformers are stabilized by a strong N3H +O5
hydrogen-bonding interaction, such that syn is preferred over anti for these conformers.
Changes in the sugar puckering, nucleobase orientation, and the hydrogen-bonding
interaction between the 2- and 3-substituents are less destabilizing than changes in the
site of protonation, such that the stable conformers computed exhibit a wide variety of
sugar puckerings and both syn and anti nucleobase orientations. The most common
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C2-endo and C3-endo puckering modes are favored over others, with C3-endo
preferred over C2-endo for the N7 protonated species, and C2-endo favored over
C3-endo for the O6 and N3 protonated conformers.
3.3.3 Stable Conformations of [Cydm+H]+
Select stable B3LYP/6-311+G(d,p) N3 and O2 protonated conformers computed
for [Cydm+H]+ are displayed in Figure 3.17. The computed results for [Cydm+H]+ are
consistent with previous findings for [dCyd+H]+ and [Cyd+H]+, where B3LYP calculations
favor the N3 protonation site, and MP2 calculations suggest a preference for O2
protonated conformers [36]. However, the energy difference predicted by MP2 for the
N3A and O2A conformers is much smaller than that predicted by B3LYP. Both N3 and O2
protonated conformers exhibit a preference for an anti nucleobase orientation, whereas
conformers with a syn nucleobase orientation is predicted to be less stable. There is an
obvious preference for C2-endo or C3-endo sugar puckering among all stable structures
computed for [Cydm+H]+, with C3-endo preferred over C2-endo for the N3 protonated
species by ~6 kJ/mol, and C2-endo slightly favored (by ~1 kJ/mol) over C3-endo for the
O2 protonated conformers. Several conformers adopt C3-exo or C4-exo sugar
puckerings such as conformers N3G and O2I. It is understandable that these two sugar
puckerings are observed as they are closest to C2-endo and C3-endo conformations, as
a slight change in the pseudorotation angle (Section 1.1.4) can result in such a distortion.
3.3.4 Stable Conformations of [Urdm+H]+
Select stable B3LYP/6-311+G(d,p) O2 and O4 protonated conformers as well as
2,4-dihydroxy tautomers computed for [Urdm+H]+ are shown in Figures 3.18–3.20. The
low-energy structures found are quite parallel to those found for [dUrd+H] + and [Urd+H]+
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previously [37]. B3LYP exhibits a preference for O4 protonation, whereas MP2 predicts
2,4-dihydroxy tautomers as being more stable. Interestingly, O2 protonated conformers
of [Urdm+H]+ are just slightly less energetically favorable by 1.8 kJ/mol for B3LYP and 4.2
kJ/mol for MP2, compared to the most stable conformers computed. The differences in
stability computed for the lowest-energy O2 protonated conformers of [dUrd+H] + and
[Urd+H]+ and the corresponding ground conformers are somewhat larger and greater
than 7 kJ/mol. The O4 protonated conformers exhibit a preference for an anti nucleobase
orientation, whereas the O2 protonated conformers are stabilized by a strong O2H +O5
hydrogen-bonding interaction such that syn is preferred over anti for these conformers.
B3LYP predicts that the 2,4-dihydroxy tautomers prefer an anti orientation, whereas MP2
predicts that the 2,4-dihydroxy tautomers prefer a syn orientation. Several O2 protonated
conformers and 2,4-dihydroxy tautomers exhibit a strong O2HO2 hydrogen-bonding
interaction, and these conformers are important in the results for [Urd+H] +. Such
O2HO2 hydrogen-bonding interactions in [Urdm+H]+ disrupt or at least destabilize the
O3HO2 hydrogen-bonding interaction in the sugar moiety. A variety of sugar
puckerings are found, with the most common C2-endo and C3-endo puckering modes
again favored over others. O4 protonated conformers exhibit a preference for C3-endo
over C2-endo sugar puckering by over 7 kJ/mol, whereas C2-endo is favored by less
than 2 kJ/mol over C3-endo for the 2,4-dihydroxy tautomers and by more than 10 kJ/mol
for O2 protonated conformers.
3.3.5 Stable Conformations of [Thdm+H]+
Select stable B3LYP/6-311+G(d,p) O2 and O4 protonated conformers as well as
2,4-dihydroxy tautomers computed for [Thdm+H]+ are shown in Figures 3.21 and 3.22.
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As found for the other protonated 2-O-methylated nucleosides, the stable conformers
calculated for [Thdm+H]+ are highly parallel to those found for [dThd+H]+ and [Thd+H]+
[38]. Although [Thdm+H]+ only differs from [Urdm+H]+ by the 5-methyl substituent, the
calculated protonation preference is altered from that of [Urdm+H]+. Both B3LYP and
MP2 predict that 2,4-dihydroxy tautomers are the most stable among the structures
computed. B3LYP suggests that the lowest-energy O2 and O4 protonated conformers
are similar in energy and within 2 kJ/mol of the ground 2,4-dihydroxy tautomer. In contrast,
MP2 finds larger energy differences among these conformers, especially for conformer
O4A, which is predicted to be10 kJ/mol higher in Gibbs energy than the TA conformer.
Similar to the results found for [Urdm+H]+, several O2 protonated conformers and
2,4-dihydroxy tautomers exhibit a strong O2HO2 hydrogen-bonding interaction. Unlike
the results found for [Thd+H]+, this type of conformers exhibiting a O2HO2
hydrogen-bonding interaction are less energetically favored for [Urdm+H] +, especially in
O2 protonated conformers, which is probably related to the disruption of the O3HO2
hydrogen-bonding interaction in the sugar moiety. The O2 protonated conformers and
2,4-dihydroxy tautomers exhibit a preference for a syn nucleobase orientation, whereas
the O4 protonated conformers prefer an anti orientation probably due to the lack of a
strong O2H+O5 hydrogen-bonding interaction. The most common C2-endo and
C3-endo puckering modes are favored over all others, with C2-endo favored over
C3′-endo for the O2 protonated conformers and 2,4-dihydroxy tautomers, and C3-endo
preferred over C2-endo for the O4 protonated species.
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3.4

Elucidation of Conformations of Protonated 2-O-Methylated Nucleosides

3.4.1 Conformations of [Adom+H]+ Populated by ESI
The computed IR spectra for the stable conformations of [Adom+H]+ were
compared with the experimentally measured IRMPD spectrum to elucidate the structures
populated in the experiments. The predicted IR signatures vary with the site of
protonation, and both N3 and N1 protonated structures provide IR features that match the
experimental spectrum well. The calculated IR spectra predicted for the N3A and N1A
conformers are compared with the IRMPD spectrum of [Adom+H] + in Figure 3.23. Both
conformers provide a very good match, and combined provide an excellent match, to the
measured IRMPD spectrum. This is particularly apparent in the broadening of the feature
observed at ~1660 cm-1, and suggests that both conformers contribute, possibly nearly
equally given the splitting and peak shape of this feature, to the experimental population.
Similar spectral comparisons of other low-energy N3 and N1 protonated conformers
exhibiting a variety of nucleobase orientations and sugar puckerings are compared in
reference [155]. Spectral misalignments indicated that none of these conformers were
significantly populated in the experiments. Obvious spectral misalignments are also
found for all N7 protonated conformers, eliminating them as significant contributors to the
experimental population as well. Again, several example comparisons are shown in
reference [155].
Although N1A is predicted to be 25.9 kJ/mol less stable (298 K Gibbs energy) than
N3A, the broadening and splitting of the band observed at ~1660 cm -1 suggests that both
of these conformers contribute to that spectral feature. This IR feature arises from C6–N6
stretching and is sensitive to the site of protonation of the nucleobase. In general, N3

67
protonated conformers exhibit this IR feature at ~1650 cm -1, whereas N1 protonated
conformers exhibit this feature at ~1670 cm -1. In order to understand the presence of N1A
in the experiments given its relatively high Gibbs energy versus that of N3A, these
conformers were also computed in a polarizable continuum model corresponding to water.
The order of relative stability of these two conformers was maintained in the polarizable
continuum (see Section 2.8.2), but their energy difference reduced from 25.9 to 9.3
kJ/mol. More accurate calculations, possibly involving a few explicit water molecules
might further shift the relative stabilities of these conformers in solution and thus explain
their apparent roughly equal populations in the experiments. Vibrational band
assignments of the features observed in the IRMPD spectrum of [Adom+H] + provided in
Table 3.1 are made on the basis of vibrational mode analyses of the N3A and N1A
conformers, which appear to contribute nearly equally to the experimental population
accessed by ESI.
3.4.2 Conformations of [Guom+H]+ Populated by ESI
The computed IR spectra for the stable conformations of [Guom+H] + were
compared with the experimentally measured IRMPD spectrum to elucidate the structures
populated in the experiments. The predicted IR signatures again vary with the site of
protonation, and only N7 protonated conformers are found to exhibit features that match
the experimental spectrum well. The calculated IR spectra predicted for the N7A, N7B,
and N7H conformers are compared with the measured IRMPD spectrum of [Guom+H] + in
Figure 3.24. Although the ground N7A conformer might be expected to be the dominant
contributor to the experiments, the spectral shift of the intense feature near 1100 cm -1
suggests that may not be the case, and that there may be other conformers that are also
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important. Conformer N7B predicted to be only 2.0 kJ/mol above N7A provides good
agreement with the experimental spectrum except that the minor feature observed at
~3610 cm-1 is predicted to appear at a slightly higher vibrational frequency. However, this
feature is associated with the C8H···O5′ noncanonical hydrogen bond, and the vibrational
frequency of such hydrogen-bonded modes are often overestimated in harmonic
calculations [157-160]. Therefore, the N7B conformer probably contributes to the
measured spectrum as well. A very minor peak is observed at ~3540 cm -1 that cannot be
explained by the IR signatures of either the N7A or N7B conformers. The N2H2
asymmetric stretch is predicted at this vibrational frequency for the N7H conformer, a syn,
C2′-endo structure predicted to be less stable than the ground N7A conformer by 23.3
kJ/mol. The low intensity of this IRMPD feature suggests a minor presence of the N7H
conformer in the experiments, which is consistent with its high relative Gibbs energy.
Interestingly, the N7H conformer probably contributes to the broad band at ~1100 cm -1
and provides better spectral alignment with the peak at ~3450 cm -1 as well, suggesting
that its population may not be quite so minor. In order to understand the presence of N7H
in the experiments given its relatively high Gibbs energy versus that of N7A, these
conformers were also computed in a polarizable continuum model corresponding to water.
The order of relative stability of these two conformers was also maintained in the
polarizable continuum, but their energy difference reduced from 23.3 to 10.9 kJ/mol.
Again, more accurate calculations might further shift the relative stabilities of these
conformers in solution and thus explain the presence of N7H in the experiments. Three
other N7 protonated conformers, N7D, N7I, and N7O (Figure 3.25), exhibit relatively
good agreement with the experimental IRMPD spectrum. N7D and N7B differ in the
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orientation of the 3-hydroxyl substituent, N7D is computed to be 8.5 kJ/mol higher in
Gibbs energy than N7B and thus is likely present in minor abundance in the experiments
as changes in the orientation of the 3-hydroxyl substituent should be readily achieved in
solution such that both conformers are likely accessed by the ESI process. Similarly, the
N7I and N7O conformers are 3-hydroxyl rotamers of the N7A and N7H conformers,
respectively, and their predicted IR spectra do not provide unique features that enable
them to be eliminated from the experimental population. However, the higher Gibbs
energy of the N7D compared to N7B, N7I compared to N7A, and N7O compared to N7H
suggest that they are less important contributors to the experiments than N7A, N7B, and
N7H. The predicted IR spectra of other N7 protonated conformers that exhibit different
combinations of nucleobase orientation and sugar puckering were also compared with
the experimental IRMPD spectrum in reference [155], but spectral mismatches eliminate
these conformers as important contributors to the experimental population. Comparison
of IR spectra predicted for stable O6 protonated conformers to the measured IRMPD
spectrum are also provided in reference [155]. All O6 protonated structures exhibit a
strong IR feature at ~1690 cm-1 associated with C5–C6 stretching, which is not observed
in the measured IRMPD spectrum. Further, the O6‒H stretch, which is predicted at ~3580
cm-1, is some 20 cm-1 below the frequency of the feature observed in this region. These
spectral differences indicate that O6 protonated structures are not present in measurable
abundance in the experiments (see reference [155]). The free C=O stretch of the N3
protonated conformers is predicted to occur at ~1820 cm -1, whereas the vibrational
frequency of the nearest spectral feature observed is at ~1770 cm -1 (see reference [155])
indicating that it is instead most likely associated with the C=O stretching mode of N7

70
protonated structures. This spectral mismatch clearly establishes the absence of N3
protonated conformers in the experimental population. Thus, only N7 protonated
conformers of [Guom+H]+ are accessed in the experiments, with the N7A, N7B, and N7H
conformers present in largest abundance, and N7D, N7I, and N7O conformers possibly
present in lower abundance. Based on the asymmetric N2H2 stretch at ~3570 cm-1 for
conformers N7A and N7B and at ~3540 cm-1 for N7H, the relative ratio of these three
conformers present in the experiments is roughly estimated at 10:5:1 for N7A:N7B:N7H.
Vibrational band assignments of the features observed in the IRMPD spectrum of
[Guom+H]+ provided in Table 3.2 are made on the basis of vibrational mode analyses of
the N7A and N7H conformers; frequencies of the vibrational modes of the other N7
protonated conformers populated do not exhibit any difference from those of these two
conformers.
3.4.3 Conformations of [Cydm+H]+ Populated by ESI
The computed IR spectra for the stable conformers of [Cydm+H]+ are compared
with the experimentally measured IRMPD spectrum to elucidate the structures populated
in the experiments. The N3A, O2A, and N3D conformers are found to match the
experimental spectrum very well (Figure 3.26). N3 conformers provide the signature
carbonyl stretch at ~1800 cm-1, as well as the two small features around 1620 cm-1 and
1580 cm-1, and both peaks are related to the C‒C or C‒N stretch of the cytosine
nucleobase. N3A and N3D also reproduce the band at ~1300 cm-1 quite well, and N3D
matches the band at ~1210 cm-1 reasonably well. In the hydrogen-stretching region, the
shoulder to the red of the strong band at ~3450 cm -1 arises from the N3‒H stretch of N3
protonated conformers. O2A provides the IR feature at ~1500 cm-1, which all N3
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conformers fail to reproduce. The broad experimental feature at ~1100 cm -1 is associated
with sugar breathing, and the shape of the computed IR bands in O2A reproduces this
feature better than the N3A and N3D conformers. The small band of N3A predicted next
to the strong feature of 3600 cm-1 represents the O3–H stretch in the strong O3HO2
hydrogen-bonding interaction. The vibrational frequencies of such hydrogen-bonded
modes are often overestimated in harmonic calculations [157-160]. The strong vibrational
band is related to the O2‒H stretch of the nucleobase calculated for O2 protonated
conformers, which is slightly blue shifted compared to the measured peak. Other
low-energy N3 and O2 protonated conformers with different sugar puckerings and
nucleobase orientations are compared in reference [156]. All of these latter structures
exhibit spectral misalignments compared to the experimental data such that none of them
are significantly populated amount in the experiments. Detailed vibrational mode
assignments based on the N3A and O2A conformers are listed in Table 3.3. In summary,
N3 and O2 protonated conformers of [Cydm+H]+ coexist in the gas phase, N3A, O2A and
N3D conformers are accessed in the experiments. However, N3D is not energetically
favored by either B3LYP or MP2, and thus is likely a minor contributor.
3.4.4 Conformations of [Urdm+H]+ Populated by ESI
The experimental spectrum of [Urdm+H]+ is compared with the IR spectra
predicted for the representative O4A, TA, and TB conformers in Figure 3.27. All three
conformers are significantly populated in the experiments. Figures 3.28 and 3.29 show
similar comparisons for other conformers that may be populated in the experiments.
However, these latter conformers are less energetically favorable, and do not provide any
unique features that can definitively demonstrate their presence in the experiments. The
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2,4-dihydroxy tautomers generally reproduce the IR bands at ~1650 cm -1 and ~1500 cm-1
very well. In the hydrogen-stretching region, 2,4-dihydroxy tautomers also provide the IR
features observed at ~3560 cm-1. The TB conformer matches this feature even better
than the TA conformer, even though the peak calculated at ~1580 cm-1 is slightly shifted
versus the measured feature. Both O4 and O2 protonated conformers may contribute to
the carbonyl stretch at ~1800 cm-1. The IR features in the fingerprint region are not
sensitive to the difference between these two protonation sites. The band at ~3400 cm -1
may arise from either O4 or O2 protonated conformers because that feature represents
the N3‒H stretch, which is lacking in the tautomers. However, O2A (Figure 3.20) exhibits
misalignment of the IR band in the hydrogen-stretching region, and that shifted computed
peak is associated with the O5′‒H stretch, which is influenced by a hydrogen bond with
the O2 hydroxyl substituent (see reference [156]). B3LYP and MP2 both predict O2A as
being higher in Gibbs energy compared to the O4A and TA conformers. Overall, O4
protonated conformers provide a better match to the experimental data than O2
protonated conformers, suggesting O4 protonation is more important in the experiments.
It is well worth pointing out that the TC and TE conformers (Figure 3.19) exhibit
O2–H···O2hydrogen-bonding interactions. This tautomer is populated significantly in the
canonical form, [Urd+H]+ [37]. However, current results indicate that this conformation
exhibits an obvious band shift at ~1450 and ~1550 cm -1, suggesting that this
conformation is not favored for [Urdm+H]+ (see reference [156]). The experimental
IRMPD spectrum clearly arises from contribution by multiple conformers with different
protonation preferences (Figures 3.26–3.28). The O4A, TA, and TB conformers are
significantly populated in the experiments. For the high-energy conformers, O4E is the
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O4-hydroxyl rotamer of O4A. O4C also adopts a similar conformation to that of O4A, but
the lack of hydrogen bond makes it less stable than O4A. The nucleobase of O4D is quite
parallel to O4A, however both B3LYP and MP2 find C2′-endo sugar puckering much less
stable. Detailed vibrational mode assignments based on the O4A and TA conformers are
listed in Table 3.4.
3.4.5 Conformations of [Thdm+H]+ Populated by ESI
The measured IRMPD and the IR spectra predicted for the TA, O2A, and TC
conformers of [Thdm+H]+ are compared in Figure 3.30. Conformer TA reproduces the IR
band at ~1500 cm-1 very well. The peak shape between 1050 and 1250 cm-1 also
represents the experimental spectrum nicely. All three conformers have Gibbs energies
within 5 kJ/mol of each other and are significantly populated in the experiments. The O2A
conformer provides the distinguishable carbonyl band at ~1800 cm -1 in the fingerprint
region and the N3‒H stretch at ~3400 cm-1 in the hydrogen-stretching region. The TC
conformer matches the strong IR band at ~3600 cm-1, which cannot be reproduced by
either the TA or O2A conformers. Other conformers that match the experimental
spectrum are shown in Figure 3.31. All of these latter conformers are computed to be
greater than 20 kJ/mol higher in Gibbs energy than the lowest-energy conformer
calculated, and none provides any unique IR features. Consistent with [Urdm+H] +,
conformers with an O2H···O2hydrogen bond cannot be significantly populated in the
experiments. All O4 protonated conformers exhibit obvious shifts in the carbonyl stretch
at ~1800 cm-1 and the IR band at ~3600 cm-1 that is associated with the O4‒H stretch
(see reference [156]). Unlike [Urdm+H]+, the 5-methyl substituent makes the difference
between O2 and O4 protonation more distinguishable in both regions. Overall, O2
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protonated conformers and 2,4-dihydroxy tautomers are highly favored structures in the
experiments. Conformers TA, O2A, and TC contribute to the experimental spectrum
significantly, whereas conformers TI, TL, O2N, and TBR (Figure 3.31) may also
contribute. Vibrational mode assignments based on the TA and O2A conformers are
listed in Table 3.5. The unique IR band contributed by the TC conformer is noted.
3.5

Structural Effects of the 2-Substituent on the Stable Conformations of the

Protonated Nucleosides
The N3A and N1A conformers of [Adom+H]+ populated in the experiments are
compared to the low-energy conformations previously reported for [dAdo+H] + and
[Ado+H]+ in Figure 3.32. Variation in the 2-substituent has very little impact on the
preferred conformation of these adenine nucleosides as the sites of protonation (N3 and
N1), nucleobase orientation (syn for N3 and anti for N1), and sugar puckering (C2′-endo)
are preserved for protonated dAdo, Ado, and Adom. The 2-substituent does however
influence hydrogen-bond stabilization as the 2-O-methyl and 2-hydroxyl substituents
enable a hydrogen-bonding interaction between the 2- and 3-substituents, whereas a
2-hydrogen

atom

does

not.

The

conformational

diversity

enabled

by

the

hydrogen-bonding interaction between the 2- and 3-substituents however differs, as Ado
can form either O2H···O3 or O2···HO3 hydrogen-bonding interactions, whereas Adom
can only form O2···HO3 hydrogen-bonding interactions. As a result, 2-O-methylation
reduces the number of very favorable low-energy hydrogen-bonding orientations possible,
and importantly inverts the preferred polarity of this interaction in [Adom+H] + versus that
of [Ado+H]+. The 2-O-methyl substituent leads to an enhancement in the IRMPD yield of
several features of [Adom+H]+ providing a stronger spectroscopic handle for elucidation
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of the conformers present in the experiments than the 2-hydrogen and 2-hydroxyl
substituents of the canonical analogues [34]. For [dAdo+H] +, five conformers exhibited
predicted IR spectra that suggested that they may be populated in the experiments, with
N3A (syn, C2-endo), N3B (syn, C3-endo), N3C (syn, C2-endo), and N1A (anti,
C2-endo) dominant in the population, and a minor presence of N3D (anti, C2-endo) [34].
For [Ado+H]+, only three conformers were appreciably populated by ESI, N3A (syn,
C2-endo, O2H···O3), N3C (syn, C3′-endo, O2H···O3), and N1A (anti, C2-endo,
O2H···O3′) [34]. For [Adom+H]+, only two conformers were populated by ESI, N3A (syn,
C2-endo, O2···HO3) and N1A (anti, C2-endo, O2···HO3). Overall, the conformations
of these protonated adenine nucleosides populated by ESI are all very similar regardless
of the identity of the 2-substituent. More importantly, 2-O-methylation inverts the
preferred polarity of the hydrogen-bonding interaction from O2H···O3 in [Ado+H]+ to
O2···HO3 in [Adom+H]+.
The ground N7A conformer of [Guom+H]+ is compared to the ground
conformations previously reported for [dGuo+H]+ and [Guo+H]+ in Figure 3.33. As found
for the adenine nucleosides, variation of the 2-substituent has very little impact on the
preferred conformation of these guanine nucleosides as the preferred site of
protonation (N7), nucleobase orientation (anti), and sugar puckering (C3-endo) are
preserved among dGuo, Guo, and Guom [35]. For [dGuo+H] +, only two conformers, N7A
(anti, C3-endo) and N7B (anti, C2-endo) were populated in the experiments [35]. The
diversity of conformations populated is enhanced by intramolecular hydrogen-bonding
interactions for [Guo+H]+ with N7A (anti, C3′-endo, O2′H···O3′), N7B (anti, C2′-endo,
O2′H···O3′), N7C (anti, C3′-endo, O2′···HO3′), and N7D (anti, C2′-endo, O2′···HO3′)
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present along with a minor population of N7E (anti, C2′-endo, O2′···HO3′) [35]. Only two
conformers of [Guom+H]+ are appreciably populated, N7A (anti, C3′-endo, O2′···HO3′)
and N7B (anti, C2-endo, O2···HO3), with minor populations of N7H (syn, C2′-endo),
and less stable 3′-hydroxyl rotamers of these conformers, N7D, N7I, and N7O. The
structures of these protonated guanine nucleosides populated by ESI are also very
similar regardless of the identity of the 2-substituent.
The dominant conformers N3A and O2A of [Cydm+H]+, and their similar
conformers found for [dCyd+H]+ and [Cyd+H]+ are shown in Figure 3.34 [36,71]. The
nucleobase always adopts an anti orientation, and the sugar puckering is either C2-endo
or C3-endo. However, N3 and O2 protonated conformers prefers C2-endo sugar
puckering in [dCyd+H]+ and [Cyd+H]+. In this thesis, conformer N3A for [Cydm+H]+
adopts C2-endo puckering, whereas conformer O2A adopts C3-endo puckering.
Theoretically, B3LYP always favors N3 protonation, whereas MP2 prefers O2 protonation.
However, in the case of [dCyd+H]+ and [Cyd+H]+, B3LYP and MP2 results only differ by a
few kJ/mol. In the case of [Cydm+H]+, the energy difference between N3A and O2A
predicted by B3LYP is ~7 kJ/mol, whereas MP2 finds them within 1 kJ/mol of one another,
which seems more realistic based on the experimental IRMPD spectrum.
According to previous work, [dUrd+H]+ and [Urd+H]+ have many conformers
populated by ESI [37], whereas [Urdm+H]+ has even more conformers present in the
experiments (Figure 3.27–3.29). Significantly populated conformers of [Urdm+H]+ are
compared to those of [dUrd+H]+ and [Urd+H]+ in Figure 3.35. The O4 protonated
conformers and 2,4-dihydroxy tautomers are dominant in [Urdm+H] +, [dUrd+H]+, and
[Urd+H]+. Among all conformers populated significantly, O4 conformers always adopt an
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anti orientation, but the energy differences between anti and syn oriented tautomers are
not large. However, in [dUrd+H]+ and [Urd+H]+, C2′-endo and C3′-endo sugar puckering
do not cause a dramatic change in energy. For [Urdm+H] +, there is a clear preference for
sugar puckering based on the site of protonation. The O4 protonated conformers favor
C3′-endo sugar puckering (O4A in Figure 3.18), and even though there is no hydrogen
bond between the 3-hydroxyl substituent and the 2-oxygen, the relative energy is still
slightly lower than a similar conformer that adopts C2′-endo sugar puckering (compare
O4C and O4D, Figure 3.18). This sugar puckering preference is similar to that found for
the N3 protonated conformers of [Cydm+H]+. Interestingly, many tautomers present in the
experiments adopt C2′-endo sugar puckering, whereas C3′-endo is not even found in the
structures significantly populated. The sugar puckering preference is consistent with O2
protonated conformers of [Cydm+H]+. Lastly, the unique structures that involve
O2H···O2 hydrogen-bonding interactions are only found for [Urd+H]+. Parallel
conformers that have interactions between the O2-hydroxyl group and the 2-oxygen are
found theoretically, but those structures are not populated in significant amount in the
experiments. In that regard, [Urdm+H]+ is more similar to [dUrd+H]+.
[Thdm+H]+, [dThd+H]+, and [Thd+H]+ all exhibit a preference for O2 protonated
conformers and 2,4-dihydroxy tautomers, and their low-energy conformers are compared
in Figure 3.36 [38,70]. The structures with O2H···O2 hydrogen-bonding interactions are
only found theoretically for [Thdm+H]+, and those structures are energetically competitive
with other stable low-energy structures. However, the comparison of the measured and
predicted IR spectra of [Thdm+H]+ suggest that this type of conformers cannot be
populated significantly in the experiments, whereas these conformers are very important
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for [Thd+H]+. Besides this type of conformers, the tautomers of [Thdm+H]+, [dThd+H]+,
and [Thd+H]+ adopt highly parallel structures. Both syn and anti orientations are found in
all three species, and C2′-endo is favored in combination with a syn orientation. The anti
oriented tautomers have a preference for C2′-endo for [dThd+H] + and [Thd+H]+, but
prefer C3′-endo sugar puckering for [Thdm+H]+ (conformer TC). For O2 protonated
conformers, it is consistent that syn, C2′-endo conformation is favored in all three species,
and their only difference is the orientation of the hydrogen-bonding interactions in
[Thd+H]+ and [Thdm+H]+.
3.6

Conclusions
The structural and energetic effects of O2-methylation of the protonated

nucleosides, [Adom+H]+, [Guom+H]+, [Cydm+H]+, [Urdm+H]+, and [Thdm+H]+, were
investigated experimentally by IRMPD action spectroscopy and ER-CID approaches and
theoretically via electronic structure calculations. The calculations find that the stable
low-energy conformations of the protonated 2-O-methylated nucleosides are highly
parallel to those found for the protonated forms of their canonical nucleoside analogues.
The 2-substituent does not alter the preferred site of protonation (N3 and N1 for Adom,
N7 for Guom, N3 and O2 for Cydm, O4 and T for Urdm, and O2 as well as T for Thdm),
nucleobase orientation (syn for N3 and anti for N1 for Adom, anti for Guom, anti for Cydm,
anti and syn for Urdm and Thdm). 2-O-Methylation does however influence
intramolecular hydrogen-bond stabilization inverting it from O2H···O3 in Nuo to
O3H···O2 in Nuom). The sugar puckering remains the same for purine nucleosides
(C2-endo for Adom and C3-endo for Guom), but is altered for the pyrimidine nucleosides:
C3-endo sugar puckering is observed with specific protonation site, which is the N3
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protonated conformer for [Cydm+H]+, an O4 protonated conformer for [Urdm+H]+, and a
2,4-dihydroxy tautomer for [Thdm+H]+. The glycosidic bond stability follows the order
[dNuo+H]+ < [Nuo+H]+ < [Nuom+H]+ for all of the protonated nucleosides except the
guanine nucleosides, which follow the order [dGuo+H]+ < [Guom+H]+ < [Guo+H]+.
Detailed transition state calculations and accurate guided ion beam tandem mass
spectrometry measurements are needed to further elucidate the reasons for these trends.
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Table 3.1 Vibrational Band Assignments of [Adom+H]+.a
Bands
N3A
N1A
-1
(cm )
1089
C5′H2 wagging/C1′‒O4′ stretching
Sugar ring C–H twisting
1103
‒
Sugar ring C‒H rocking
1132
O2′‒CH3/C2′‒C3′ stretching
‒
1210
Sugar C‒H rocking
C8‒H/O5′‒H scissoring
1320
Sugar ring twisting/scissoring
C4′‒H/O3′‒H scissoring
1445
C6‒N1 stretch/(O2′)CH3 scissoring
C6‒N1 stretching
1492
̶
C4‒C5 stretching
1584
N6H2 scissoring
N6H2/N1H scissoring
1654
C6–N6 stretching
‒
1665
̶
C6–N6 stretching
3431
N6H2 symmetric stretching
N6H2 symmetric stretch/N1H stretch
3554
N6H2 asymmetric stretching
N6H2 asymmetric stretching
3613
O3′‒H stretching
O3′‒H stretching
3675
O5′‒H stretching
O5′‒H stretching
a Vibrational band assignments are based on conformers N3A and N1A.

Table 3.2 Vibrational Band Assignments of [Guom+H]+.a
Bands (cm-1)
N7A

N7H

1110 Sugar ring stretching/scissoring
Sugar ring twisting/scissoring
1232 C5′–H twisting/N7–H scissoring
C5′H twisting/N7H and O5H waggingb
1311 C2′–H/N1–H scissoring
–
1365 C4′–H/C8–H/N7–H scissoring
N1–H scissoring/sugar ring twisting
1469 (O2′)CH3/C5′–H scissoring
C5′–H/(O2′)CH3 scissoring
1577 N2H2/N1–H scissoring
N2H2/N1–H scissoring
1605 C4–C5/C4–N3 stretching
C4–C5/C4–N3 stretching
1628 C2–N2 stretching
C2–N2 stretching
1772 C6=O6 stretching
C6=O6 stretching
3424 N1‒H stretching
N2H2 symmetric stretch/N1‒H stretch
3464 N2H2 symmetric stretch/N7‒H stretch N7‒H/O5′‒H stretching
3544 –
N2H2 asymmetric stretching
3572 N2H2 asymmetric stretching
–
3602 O3′–H stretching
–
3675 O5′–H stretching
O3′–H stretching
a Vibrational band assignments are based on conformers N7A and N7H.
b Minor contributions come from C8–H/O3–H/(O2′)CH wagging.
3
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Table 3.3 Vibrational Band Assignments of [Cydm+H]+.a
Bands (cm-1)
N3A

O2A

1102
Sugar ring stretching
Sugar ring stretching
1213
–
Sugar ring C–H bending
1277
Sugar ring C–H bending
–
1494
C4–N3 stretching
C2‒N3/C4‒N4 stretching
1562
C4‒C5/N1‒C6 stretching
C2‒O stretching
1612
NH2 scissoring
NH2 scissoring
1658
C–N stretching
C‒N stretching
1787
C2=O2 stretching
–
3417
N3–H stretching
–
3445
N4H2 symmetric stretching
N4H2 symmetric stretching
3548
N4H2 asymmetric stretching
–
3561
–
N4H2 asymmetric stretching
3585
O3′–H stretching
O2–H/O3′–H stretching
3676
O5′–H stretching
O5′–H stretching
a Vibrational band assignments are based on conformers N3A and O2A.

Table 3.4 Vibrational Band Assignments of [Urdm+H]+.a
Bands (cm-1)
O4A

TA

1100
Sugar ring stretching
Sugar ring stretching
1196
–
O–H rocking/scissoring
1256
Sugar C–H rocking
–
1304
–
Sugar ring C–H rocking
1367
–
Sugar ring C–H wagging/twisting
1427
Sugar ring C‒H/O‒H scissoring
(O2′)CH3 scissoring
1500
C4–N3 stretching
C4‒O4 stretching
1593
Uracil C–C/C–N stretching
C4–C5/N1–C2 stretching
1641
–
C5–C6/C2–N3 stretching
1773
C2=O2 stretching
–
3404
N3–H stretching
–
3567
–
O4–H/O2–H stretching
3621
O4–H/O3′–H stretching
O3′–H stretching
3676
O5′–H stretching
O5′–H stretching
a Vibrational band assignments are based on conformers O4A and TA.
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Table 3.5 Vibrational Band Assignments of [Thdm+H]+.a
Bands (cm-1)
TA

O2A

974
C–H wagging/sugar ring bending
C–H wagging/sugar ring bending
1129
Sugar ring stretching
Sugar ring stretching
1208
C5–CH3 stretching/O–H rocking
C5–CH3 stretching/O–H rocking
1375
Sugar C–H twisting
–
1490
C4–O4 stretching
–
1525
–
C1–N2 stretching
1582
C2–N3/C4–C5 stretching
C2–O2 stretching
1607
C5–C6 stretching
C5–C6 stretching
1779
–
C4–O4 stretching
3407
–
N3–H stretching
3562
O4–H stretching
–
3590b
–
–
3620
O3′–H stretching
O3′–H stretching
3675
O5′–H stretching
O5′–H stretching
a Vibrational band assignments are based on conformers TA and O2A.
b IR feature ~3590 cm-1 is contributed by O4‒H/O2‒H stretching of conformer TC.
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Figure 3.1 Comparison of the measured IRMPD spectrum of [Adom+H]+ to those of
its canonical DNA and RNA nucleoside analogues over the fingerprint and hydrogenstretching regions. IRMPD spectra previously reported for [dAdo+H]+ and [Ado+H]+
are taken from reference [34]. The spectra have been enhanced (via multiplication) to
better visualize minor features in several regions.
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Figure 3.2 Comparison of the measured IRMPD spectrum of [Guom+H]+ to those of
its canonical DNA and RNA nucleoside analogues over the fingerprint and hydrogenstretching regions. IRMPD spectra previously reported for [dGuo+H]+ and [Guo+H]+
are taken from reference [35]. The spectra have been enhanced (via multiplication) to
better visualize minor features in several regions.
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Figure 3.3 Comparison of the measured IRMPD spectrum of [Cydm+H]+ to those of
its canonical DNA and RNA nucleoside analogues over the fingerprint and hydrogenstretching regions. IRMPD spectra previously reported for [dCyd+H]+ and [Cyd+H]+
are taken from reference [36].
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Figure 3.4 Comparison of the measured IRMPD spectrum of [Urdm+H]+ to those of
its canonical DNA and RNA nucleoside analogues over the fingerprint and hydrogenstretching regions. IRMPD spectra previously reported for [dUrd+H]+ and [Urd+H]+
are taken from reference [37].
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Figure 3.5 Comparison of the measured IRMPD spectrum of [Thdm+H]+ to those of
its canonical DNA and RNA nucleoside analogues over the fingerprint and hydrogenstretching regions. IRMPD spectra previously reported for [dThd+H]+ and [Thd+H]+
are taken from reference [38].
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Figure 3.6 Comparison of the CID mass spectra of [Adom+H]+ to those of its
canonical DNA and RNA nucleoside analogues at rf excitation amplitudes (rfEA) that
result in ~50% dissociation.
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Figure 3.7 Comparison of the CID mass spectra of [Guom+H]+ to those of its
canonical DNA and RNA nucleoside analogues at rf excitation amplitudes (rfEA) that
result in ~50% dissociation.
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Figure 3.8 Comparison of the CID mass spectra of [Cydm+H]+ to those of its
canonical DNA and RNA nucleoside analogues at rf excitation amplitudes (rfEA) that
result in ~50% dissociation.
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Figure 3.9 Comparison of the CID mass spectra of [Urdm+H]+ to those of its 2′-deoxy
and canonical RNA nucleoside analogues at rf excitation amplitudes (rfEA) that result
in ~50% dissociation.
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Figure 3.10 Comparison of the CID mass spectra of [Thdm+H]+ to those of its
canonical DNA and 5-methylated RNA nucleoside analogues at rf excitation
amplitudes (rfEA) that result in ~50% dissociation.
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Figure 3.11 Comparison of the survival yield curves of [Adom+H]+ and [Guom+H]+ to
those of their canonical DNA and RNA nucleoside analogues. CID50% values (in V)
and estimated uncertainties in these values determined from survival yield analyses
are also given.
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Figure 3.12 Comparison of the survival yield curves of [Cydm+H]+, [Urdm+H]+,and
[Thdm+H]+ to those of their canonical and modified DNA and RNA nucleoside
analogues. CID50% values (in V) and estimated uncertainties in these values
determined from survival yield analyses are also given.
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N3A
syn, C2′-endo (2T1)
0.0 kJ/mol

N3B
syn, C3′-endo (3T4)
4.2 kJ/mol

N3E
anti, C4′-exo (4T3)
12.9 kJ/mol

N3F
anti, C2′-endo (2T3)
17.5 kJ/mol

N3H
syn, C2′-exo (2T3)
23.5 kJ/mol

N3K
syn, C1′-exo (1T2)
26.6 kJ/mol

N3R
anti, C3′-exo (3T4)
39.5 kJ/mol

N3S
anti, C3′-endo (3T2)
40.3 kJ/mol

[Adom+H]+

Figure 3.13 Select stable B3LYP/6-311+G(d,p) N3 protonated conformers of
[Adom+H]+ and their relative Gibbs energies at 298 K calculated at the
B3LYP/6-311+G(2d,2p) level of theory. The nucleobase orientation and sugar
puckering are also indicated for each conformer.
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N1A
anti, C2′-endo (2T3)
25.9 kJ/mol

N1B
N1D
anti, C3′-endo (3T2) syn, C2′-endo (2T1)
30.5 kJ/mol
39.9 kJ/mol

N1K
syn, C3′-endo (3T4)
46.8 kJ/mol

N1M
anti, C4′-exo (4T3)
47.1 kJ/mol

N1U
N1N
2
anti, O4′-endo (oT4) anti, C3′-exo (3T )
55.5 kJ/mol
47.1 kJ/mol

N1W
syn, C4′-exo (4T3)
59.5 kJ/mol

N1Z
anti, C1′-exo (1T2)
65.0 kJ/mol

N1AA
syn, O4′-endo (oT1)
72.8 kJ/mol

[Adom+H]+, N1

N7A
anti, C3′-endo (3T2)
33.2 kJ/mol

N7B
N7C
anti, C2′-endo (2T3) syn, C2′-endo (2T3)
39.1 kJ/mol
55.0 kJ/mol

N7U
syn, C3′-endo (3T4)
69.4 kJ/mol

[Adom+H]+, N7
Figure 3.14 Select stable B3LYP/6-311+G(d,p) N1 and N7 protonated conformers of
[Adom+H]+ and their relative Gibbs energies at 298 K calculated at the
B3LYP/6-311+G(2d,2p) level of theory. The site of protonation, nucleobase
orientation, and sugar puckering are also indicated for each conformer.
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N7A
N7B
anti, C3′-endo (3T2) anti, C2′-endo (2T3)
0.0 kJ/mol
2.0 kJ/mol

N7D
anti, C2′-endo (2T3)
10.5 kJ/mol

N7F
anti, C3′-exo (3T4)
21.7 kJ/mol

N7I
N7H
3
syn, C2′-endo (2T1) anti, C3′-endo ( T2)
24.2 kJ/mol
23.3 kJ/mol

N7M
anti, C2′-exo (2T1)
28.3 kJ/mol

N7O
syn, C2′-endo (2T1)
29.0 kJ/mol

N7V
anti, C4′-exo (4T3)
33.8 kJ/mol

[Guom+H]+

Figure 3.15 Select stable B3LYP/6-311+G(d,p) N7 protonated conformers of
[Guom+H]+ and their relative Gibbs energies at 298 K calculated at the
B3LYP/6-311+G(2d,2p) level of theory. The nucleobase orientation and sugar
puckering are also indicated for each conformer.
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O6A
anti, C2′-endo (2T3)
37.4 kJ/mol

O6B
anti, C3′-endo (3T2)
44.7 kJ/mol

O6D
syn, C2′-endo (2T1)
51.7 kJ/mol

O6J
syn, C3′-endo (3T4)
62.1 kJ/mol

O6L
anti, C2′-endo (2T3)
70.3 kJ/mol

[Guom+H]+, O6

N3A
syn, C2′-endo (2T1)
47.6 kJ/mol

N3B
syn, C3′-endo (3T4)
48.4 kJ/mol

N3C
syn, C2′-endo (2T3)
51.3 kJ/mol

N3N
anti, C2′-endo (2T1)
84.5 kJ/mol

[Guom+H]+, N3

Figure 3.16 Select stable B3LYP/6-311+G(d,p) O6 and N3 protonated conformers of
[Guom+H]+ and their relative Gibbs energies at 298 K calculated at the
B3LYP/6-311+G(2d,2p) level of theory. The site of protonation, nucleobase
orientation, and sugar puckering are also indicated for each conformer.
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N3A
N3B
3
anti, C3′-endo ( T2) anti, C2′-endo (2T3)
0.0, 0.5 kJ/mol
6.0, 6.0 kJ/mol

N3F
syn, C2′-endo (2T1)
22.6, 22.7 kJ/mol

N3C
N3D
2
anti, C2′-endo ( T3) anti, C2′-endo (2T3)
10.9, 11.7 kJ/mol
15.3, 15.5 kJ/mol

N3P
syn, C4′-exo (4T3)
35.4, 40.6 kJ/mol
[Cydm+H]+, N3

N3G
anti, C3′-exo (3T4)
24.3, 28.4 kJ/mol

O2A
O2B
2
anti, C2′-endo ( T3) anti, C3′-endo (3T2)
6.7, 0.0 kJ/mol
7.9, 1.4 kJ/mol

O2C
O2D
2
syn, C2′-endo ( T1) anti, C2′-endo (2T3)
9.9, 2.3 kJ/mol
13.4, 6.3 kJ/mol

O2E
anti, C3′-endo (3T2)
15.6, 11.3 kJ/mol

O2F
syn, C2′-endo (2T1)
17.9, 10.4 kJ/mol

O2G
anti, C3′-exo (3T2)
18.2, 11.2 kJ/mol

O2I
syn, C4′-exo (4T3)
23.5, 20.8 kJ/mol

O2V
syn, C2′-endo (2T1)
39.7, 42.2 kJ/mol

O2H
anti, C3′-endo (3T2)
19.5, 13.5 kJ/mol

[Cydm+H]+, O2

Figure 3.17 Select stable B3LYP/6-311+G(d,p) N3 and O2 protonated conformers of
[Cydm+H]+ and their relative Gibbs energies at 298 K calculated at the
B3LYP/6-311+G(2d,2p) (black) and MP2(full)/6-311+G(2d,2p) (red) levels of theory.
The site of protonation, nucleobase orientation, and sugar puckering are also given
for each conformer.
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O4A
O4B
3
anti, C3′-endo ( T2) anti, C2′-endo (2T3)
0.0, 5.3 kJ/mol
7.1, 12.0 kJ/mol

O4C
anti, C3′-endo (3T2)
11.3, 17.2 kJ/mol

O4E
O4F
3
anti, C3′-endo ( T2) anti, C2′-endo (2T3)
12.2, 18.0 kJ/mol
23.1, 29.4 kJ/mol

O4G
anti, C3′-exo (3T4)
23.6, 32.3 kJ/mol

O4N
anti, C1′-exo (1T2)
31.1, 40.7 kJ/mol

O4D
anti, C2′-endo (2T3)
11.7, 18.0 kJ/mol

O4I
syn, C2′-endo (2T1)
25.8, 30.8 kJ/mol

O4S
syn, C4′-exo (4E)
35.9, 45.9 kJ/mol

[Urdm+H]+

Figure 3.18 Select stable B3LYP/6-311+G(d,p) O4 protonated conformers of
[Urdm+H]+ and their relative Gibbs energies at 298 K calculated at the
B3LYP/6-311+G(2d,2p) (black) and MP2(full)/6-311+G(2d,2p) (red) levels of theory.
The nucleobase orientation and sugar puckering are also given for each conformer.
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TA
anti, C2′-endo (2T3)
3.2, 0.8 kJ/mol

TB
TC
syn, C2′-endo (2T1) anti, C2′-endo (2T3)
3.3, 0.0 kJ/mol
4.5, 0.5 kJ/mol

TD
anti, C3′-endo (3T2)
5.1, 1.9 kJ/mol

TE
anti, C2′-endo (2T3)
5.1, 3.1 kJ/mol

TF
syn, C4′-exo (4T3)
17.0, 19.1 kJ/mol

TG
anti, C2′-endo (2T3)
18.9, 17.0 kJ/mol

TH
anti, C3′-endo (3T2)
19.4, 17.7 kJ/mol

TI
anti, C3′-exo (3T2)
22.0, 20.4 kJ/mol

TT
anti, C4′-exo (4T3)
33.9, 38.5 kJ/mol

TAN
syn, C2′-exo (2T1)
51.5, 47.2 kJ/mol

TAO
syn, O4′-endo (oT1)
52.7, 62.2 kJ/mol

TAP
anti, O4′-endo (oT1)
54.2, 62.2 kJ/mol

TAU
syn, C3′-endo (3T2)
64.0, 69.2 kJ/mol

[Urdm+H]+

Figure 3.19 Select stable B3LYP/6-311+G(d,p) 2,4-dihyroxy tautomers of [Urdm+H]+
and their relative Gibbs energies at 298 K calculated at the
B3LYP/6-311+G(2d,2p) (black) and MP2(full)/6-311+G(2d,2p) (red) levels of theory.
The nucleobase orientation and sugar puckering are also given for each conformer.
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O2A
syn, C2′-endo (2T1)
1.8, 4.2 kJ/mol

O2B
anti, C2′-endo (2T3)
8.2, 10.2 kJ/mol

O2C
O2D
2
anti, C2′-endo ( T3) syn, C3′-endo (3T4)
9.2, 10.6 kJ/mol
12.6, 19.1 kJ/mol

O2E
anti, C3′-exo (3T2)
16.6, 18.5 kJ/mol

O2F
syn, C4′-exo (4T3)
18.3, 26.8 kJ/mol

O2G
O2J
anti, C2′-endo (2T1) anti, C2′-endo (2T1)
19.0, 26.7 kJ/mol
24.0, 30.9 kJ/mol

O2N
syn, C2′-endo (2T3)
26.8, 31.5 kJ/mol

O2P
syn, C2′-endo (2T1)
32.2, 39.2 kJ/mol

O2Q
O2R
syn, C2′-endo (2T3) syn, C2′-endo (2T1)
33.1, 40.3 kJ/mol
33.3, 40.5 kJ/mol

O2AB
anti, C3′-endo (3T2)
55.8, 59.4 kJ/mol

[Urdm+H]+

Figure 3.20 Select stable B3LYP/6-311+G(d,p) O2 protonated conformers of
[Urdm+H]+ and their relative Gibbs energies at 298 K calculated at the
B3LYP/6-311+G(2d,2p) (black) and MP2(full)/6-311+G(2d,2p) (red) levels of theory.
The nucleobase orientation and sugar puckering are also given for each conformer.
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TA
syn, C2′-endo (2T1)
0.0, 0.0 kJ/mol

TB
anti, C2′-endo (2T3)
2.4, 1.5 kJ/mol

TC
anti, C3′-endo (3T2)
3.3, 3.2 kJ/mol

TD
anti, C3′-endo (3T2)
10.6, 12.8 kJ/mol

TE
syn, C4′-exo (4T3)
12.9, 18.0 kJ/mol

TF
anti, C2′-endo (2T3)
18.1, 18.8 kJ/mol

TG
anti, C3′-endo (3T2)
19.0, 19.0 kJ/mol

TI
anti, C3′-exo (3T2)
21.6, 23.5 kJ/mol

TL
anti, C2′-endo (2T3)
23.7, 25.1 kJ/mol

TAL
anti, C4′-exo (4T3)
38.8, 39.5 kJ/mol

TBG
anti, O4′-endo (oT1)
47.5, 57.6 kJ/mol

TBR
syn, C1′-exo (1T2)
54.1, 60.5 kJ/mol

[Thdm+H]+

Figure 3.21 Select stable B3LYP/6-311+G(d,p) 2,4-dihyroxy tautomers of [Thdm+H]+
and their relative Gibbs energies at 298 K calculated at the
B3LYP/6-311+G(2d,2p) (black) and MP2(full)/6-311+G(2d,2p) (red) levels of theory.
The nucleobase orientation and sugar puckering are also given for each conformer.
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anti, C2′-endo (2T1)
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O2H
syn, C2′-endo (2T3)
19.9, 25.0 kJ/mol

O2N
syn, C2′-endo (2T3)
26.8, 31.5 kJ/mol

O2U
anti, O4′-endo (oT1)
40.4, 53.1 kJ/mol

O2W
anti, C3′-endo (3T2)
48.2, 51.1 kJ/mol
[Thdm+H]+, O2

O2AR
syn, O4′-endo (oT4)
79.5, 92.8 kJ/mol

O4A
anti, C3′-endo (3T2)
1.7, 10.0 kJ/mol

O4B
anti, C2′-endo (2T3)
9.2, 17.5 kJ/mol

O4F
syn, C2′-endo (2T1)
25.7, 34.4 kJ/mol

O4I
syn, C4′-exo (4T3)
39.5, 53.9 kJ/mol

O4C
anti, C2′-endo (2T3)
13.7, 22.9 kJ/mol

O4P
anti, C1′-exo (1T2)
59.5, 77.1 kJ/mol
[Thdm+H]+, O4

O4D
anti, C3′-endo (3T2)
14.1, 22.6 kJ/mol

O4T
syn, C3′-endo (2T1)
71.5, 82.8 kJ/mol

Figure 3.22 Select stable B3LYP/6-311+G(d,p) O2 and O4 protonated conformers of
[Thdm+H]+ and their relative Gibbs energies at 298 K calculated at the
B3LYP/6-311+G(2d,2p) (black) and MP2(full)/6-311+G(2d,2p) (red) levels of theory.
The site of protonation, nucleobase orientation, and sugar puckering are also given
for each conformer.
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Figure 3.23 Comparison of the experimental IRMPD spectrum of [Adom+H]+ with IR
spectra predicted at the B3LYP/6-311+G(d,p) level of theory for the N3A and N1A
conformers. The structures, nucleobase orientations, sugar-puckering modes, and
B3LYP/6-311+G(2d,2p) relative Gibbs energies at 298 K are also listed.
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Figure 3.24 Comparison of the experimental IRMPD spectrum of [Guom+H]+ with IR
spectra predicted at the B3LYP/6-311+G(d,p) level of theory for the N7A, N7B, and
N7H conformers. The structures, nucleobase orientations, sugar-puckering modes,
and B3LYP/6-311+G(2d,2p) relative Gibbs energies at 298 K are also listed.
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Figure 3.25 Comparison of the experimental IRMPD spectrum of [Guom+H]+ with
computed IR spectra of high-energy N7 conformers. The structures, nucleobase
orientations, sugar-puckering modes, and B3LYP/6-311+G(2d,2p) relative Gibbs
energies at 298 K are also listed.
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Figure 3.26 Comparison of the experimental IRMPD spectrum of [Cydm+H]+ with IR
spectra predicted at the B3LYP/6-311+G(d,p) level of theory for the N3A, O2A, and
N3D conformers. The structures, nucleobase orientations, sugar-puckering modes,
and B3LYP/6-311+G(2d,2p) (black) and MP2(full)/6-311+G(2d,2p) (red) relative Gibbs
energies at 298 K are also listed.
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Figure 3.27 Comparison of the experimental IRMPD spectrum of [Urdm+H]+ with IR
spectra predicted at the B3LYP/6-311+G(d,p) level of theory for the O4A, TA, and TB
conformers. The structures, nucleobase orientations, sugar-puckering modes, and
B3LYP/6-311+G(2d,2p) (black) and MP2(full)/6-311+G(2d,2p) (red) relative Gibbs
energies at 298 K are also listed.
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Figure 3.28 Comparison of the experimental IRMPD spectrum of [Urdm+H]+ with IR
spectra predicted at the B3LYP/6-311+G(d,p) level of theory for high-energy
conformers. The structures, nucleobase orientations, sugar-puckering modes, and
B3LYP/6-311+G(2d,2p) (black) and MP2(full)/6-311+G(2d,2p) (red) relative Gibbs
energies at 298 K are also listed.
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Figure 3.29 Comparison of the experimental IRMPD spectrum of [Urdm+H]+ with IR
spectra predicted at the B3LYP/6-311+G(d,p) level of theory for high-energy
conformers. The structures, nucleobase orientations, sugar-puckering modes, and
B3LYP/6-311+G(2d,2p) (black) and MP2(full)/6-311+G(2d,2p) (red) relative Gibbs
energies at 298 K are also listed.

112

800

Relative Intensity/ IRMPD Yield

400

[Thdm+H]+ IRMPD
TA
syn, C2'-endo (2T1)
0.0 kJ/mol
0.0 kJ/mol

240

120

0
800

400

0
[Thdm+H]+ IRMPD
240

O2A
2
syn, C2'-endo ( T1)
1.8 kJ/mol
4.2 kJ/mol

120

0
800

400

0
1000 1200
1400
[Thdm+H]+
IRMPD

1600

1800

3400

3600

Frequency (cm-1)

TC
anti, C3'-endo (3T2)
3.3 kJ/mol
3.2 kJ/mol

0

240

120

0
1000 1200 1400 1600 1800 3400 3600

Frequency (cm-1)
Figure 3.30 Comparison of the experimental IRMPD spectrum of [Thdm+H]+ with IR
spectra predicted at the B3LYP/6-311+G(d,p) level of theory for the TA, O2A, and TC
conformers. The structures, nucleobase orientations, sugar-puckering modes, and
B3LYP/6-311+G(2d,2p) (black) and MP2(full)/6-311+G(2d,2p) (red) relative Gibbs
energies at 298 K are also listed.
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Figure 3.31 Comparison of the experimental IRMPD spectrum of [Thdm+H]+ with IR
spectra predicted at the B3LYP/6-311+G(d,p) level of theory for high-energy
conformers. The structures, nucleobase orientations, sugar-puckering modes, and
B3LYP/6-311+G(2d,2p) (black) and MP2(full)/6-311+G(2d,2p) (red) relative Gibbs
energies at 298 K are also listed.
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[Adom+H]+, N3A
syn, C2′-endo

[Adom+H]+, N1A
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Figure 3.32 B3LYP/6-311+G(d,p) optimized geometries of the dominant low-energy
conformers of [Adom+H]+ populated in the experiments versus conformers populated
for [dAdo+H]+ and [Ado+H]+ from reference [34]. The site of protonation, nucleobase
orientation, and the sugar puckering are given for each conformer.

115

[Guom+H]+, N7A
anti, C3′-endo

[dGuo+H]+, N7A
anti, C3′-endo

[Guo+H]+, N7A
anti, C3′-endo
Figure 3.33 B3LYP/6-311+G(d,p) optimized geometries of the conformer of
[Guom+H]+ populated in the experiments versus conformers populated for [dGuo+H]+
and [Guo+H]+ from reference [35]. The site of protonation, nucleobase orientation,
and the sugar puckering are given for each conformer.
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Figure 3.34 B3LYP/6-311+G(d,p) optimized geometries of the conformers of
[Cydm+H]+ populated in the experiments versus conformers populated for [dCyd+H]+
and [Cyd+H]+ from reference [36]. The site of protonation, nucleobase orientation,
and the sugar puckering are given for each conformer.
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Figure 3.35 B3LYP/6-311+G(d,p) optimized geometries of the dominant low-energy
conformers of [Urdm+H]+ populated in the experiments versus conformers populated
for [dUrd+H]+ and [Urd+H]+ from reference [37]. The site of protonation, nucleobase
orientation, and the sugar puckering are given for each conformer.
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Figure 3.36 B3LYP/6-311+G(d,p) optimized geometries of the dominant low-energy
conformers of [Thdm+H]+ populated in the experiments versus conformers populated
for [dThd+H]+ and [Thd+H]+ from reference [38]. The site of protonation, nucleobase
orientation, and the sugar puckering are given for each conformer.
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CHAPTER 4 STRUCTURAL CHARACTERIZATION AND THEORETICAL APPROACH
EVALUATION FOR AMINO ACID-LINKED PLATINUM COMPLEXES: APPLICATION
TO GLYPLATIN
Portions of this chapter were reprinted with permission from the followed research
publication. C. C. He, B. Kimutai, X. Bao, L. Hamlow, Y. Zhu, S. F. Strobehn, J. Gao, G.
Berden, J. Oomens, C. S. Chow and M. T. Rodgers, J. Phys. Chem. A, 2015, 119,
10980-10987.
4.1

Introduction
The motivation for studying amino acid-linked platinum complexes was described

in Chapter 1. This chapter focuses on evaluation of various theoretical approaches for
the structural characterization of amino acid-linked platinum complexes using Glyplatin
as a simple model. IRMPD action spectroscopy experiments were performed on the
deprotonated form of Glyplatin, [(GlyH)PtCl2] to characterize its structure and guide the
selection of the most effective hybrid theoretical approach for determining its structure
and IR spectrum. Theoretical calculations were also performed to facilitate structural
elucidation from the IRMPD action spectroscopy results. A variety of hybrid theoretical
approaches are evaluated based on their ability to reproduce the measured IRMPD
spectrum of [(GlyH)PtCl2]. Relevant experimental and theoretical details were
described in Chapter 2. The simplicity of the Glyplatin system allows a wide variety of
density functionals, treatments of the Pt center including the use of all-electron basis sets
and valence basis sets combined with an effective core potential (ECP), and the basis
sets employed for all of the other atoms to be evaluated at a reasonable computational
cost. The results for Glyplatin provide the foundation for calculations of more complex
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amino acid-linked cisplatin derivatives such as Argplatin, Lysplatin, and Ornplatin
described in Chapter 5.
4.2

Results and Structural Elucidation of Glyplatin
When deprotonated Glyplatin ions, [(Gly‒H)PtCl2]‒, were irradiated with the FEL,

both HCl loss and sequential loss of CO2 from the initially formed product ion were
observed. However, when the ions were irradiated in the hydrogen-stretching region, only
HCl loss was observed as the power output of the OPO is lower and insufficient to
produce the sequential dissociation product. To first determine the ground structure of
Glyplatin, calculations were performed at the B3LYP/def2-TZVPPD level of theory using
the corresponding valence basis set and effective core potential (ECP) for Pt. Five local
minimum structures were found and their IR spectra were compared to the experimental
IRMPD spectrum of Glyplatin as shown in Figure 4.1. Scaling factors of 0.98 were
applied to all computed spectra in the fingerprint region of 7001850 cm-1 and 0.95 in the
hydrogen-stretching region of 28503700 cm-1, to compensate for known systematic
errors in the calculated frequencies [142]. The B3LYP/def2-TZVPPD method and basis
set were chosen based on previous studies, which found that this level of theory produces
a satisfactory description of the band positions and bond dissociation energies of
complexes involving metal cations [161-163]. The stable structures found for
[(GlyH)PtCl2] are designated by their modes of binding to the Pt center (Figure 4.1).
The nomenclature employed to describe these complexes is discussed in Section 1.2.3
and Figure 1.4. For example, OH binding indicates bidentate binding via interaction with
one of the carboxylate oxygen atoms and one of the -carbon hydrogen atoms. Different
proton orientations and positions on the carboxylic acid moiety were examined, and three
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additional local minimum structures were found (see Supporting Information of reference
[164]). However, these latter three structures are much higher (by >130 kJ/mol) in relative
Gibbs energy than the ground NO binding structure. Hence, deprotonation of the
backbone amino nitrogen is ruled out. Among the eight stable structures found, the IR
spectrum predicted for the NO binding structure of [(GlyH)PtCl2] is the only one that
provides a good match to the measured IRMPD spectrum, indicating that the NO ‒ binding
mode is the only structure populated in the experiments. This NO binding mode is also
consistent with the structures reported for Ornplatin and Lysplatin [109-111,113,114]. in
condensed phase and suggests that Glyplatin may serve as a reliable model for other
amino acid-linked cisplatin derivatives. Shifts in the positions of the predicted bands vs
those in the measured spectrum indicate that the B3LYP/def2-TZVPPD level of theory is
not able to reproduce the IRMPD spectrum with high fidelity.
Peak assignments based on the theoretical results indicate that the dominant peak
in the experimental spectrum arises from C=O stretching at a frequency of 1669 cm -1. The
second most intense peak is contributed by CO stretching and CH2 wagging at 1294
cm-1, with contributions from CH2 wagging and NH2 twisting at 1325 cm-1. The peak at
~1030 cm-1 arises from NH2 wagging. In the hydrogen-stretching region, the CH2
symmetric stretch is the strongest band and appears at 2939 cm -1, whereas the CH2
asymmetric stretch appears at 2972 cm -1. NH2 symmetric and asymmetric stretches
appear at 3302 and 3360 cm-1, respectively. Details regarding the vibrational band
assignments are listed in Table 4.1. Blue shifts of the bands at 1030 and 1577 cm-1 are
observed as well as red shifts of the features in the hydrogen-stretching region,
particularly for the band at 2939 cm-1. The lack of peak alignment throughout the IR region
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indicates the importance of choosing the density functional, treatment of the Pt center,
and basis set carefully to accurately describe the binding in amino acid-linked platinum
complexes. Based on this preliminary structural determination and peak assignments, all
further calculations were performed for the complex involving the NO ‒ mode of binding.
4.3

Evaluation of Hybrid Theoretical Approaches
Different treatments for the non-metal atoms were evaluated first. Pople basis sets

that increase in size from 6-31G to 6-311+(3df,3dp), Dunning basis sets that vary from
cc-pVDZ to aug-cc-pVQZ , as well as Ahlrichs basis sets that range from def2-SVP to
def2-QZVPPD were examined in conjunction with the B3LYP method and the LANL2DZ
valence basis set and ECP for Pt [136,145,146]. The IR spectral results are compared in
Figures 4.2 and 4.3. All theoretical spectra were aligned to the strong C=O stretch in the
fingerprint region (irradiated with the FEL) and the NH2 asymmetric stretch in the
hydrogen-stretching region (irradiated with the OPO laser system). Details regarding the
basis set and corresponding scaling factors used to achieve this alignment are listed in
Table 4.2. The interested reader is referred to the Supporting Information of reference
[164] for details regarding the computed frequencies, differences in the measured and
computed frequencies, and the mean absolute errors (MAEs, see Equation 2.4).
Theoretical results for the Pople basis sets in the fingerprint region are compared in
Figure 4.2 (a). The 6-31G basis set does not provide very satisfying results (MAE = 22.4
cm-1). An increase in the size of the basis set to 6-31G(d) significantly improves the
predicted spectrum (MAE = 11.4 cm-1), indicating that the extra polarization function is
essential for these calculations. Use of the 6-31+G(d) basis set improves the prediction of
the band at 1294 cm-1, however, this basis set exhibits poorer prediction of the feature at
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~1030 cm-1. Overall, the MAE values are similar for 6-31G(d) and 6-31+G(d), indicating
that the additional diffuse function does not necessarily lead to better results. Addition of a
polarization function on the hydrogen atoms, corresponding to the 6-31+G(d,p) basis set,
improves predictions in the fingerprint region significantly, however, the overall MAE
value is actually worse than the smaller 6-31G(d) and 6-31+G(d) basis sets. Increases in
the basis set beyond 6-31+G(d,p) such as 6-311+G(d,p), 6-311++G(d,p), and
6-311+G(3df,epd), produce only small differences, and even lead to slightly poorer
agreement for the 6-311+G(2d,2p) basis set in the fingerprint region. In the
hydrogen-stretching region, Figure 4.3 (a), each Pople basis set exhibits its own
limitations. Additional polarization functions on the hydrogen atoms improve the
prediction of the NH stretch but degrade that for the CH stretch. These results indicate
that adding additional polarization and diffuse functions to the non-metal atoms does not
improve the results beyond the 6-31+G(d) basis set in the hydrogen-stretching region.
Overall, none of the Pople basis set gives satisfactory results in both IR regions. 6-31G(d)
seems to be acceptable based on its low cost and relatively good performance, even
though the shift around 1294 cm -1 is quite significant (42 cm-1).
Among the Dunning basis sets, Figure 4.2 (b), correlation consistent results in the
fingerprint region improve with the increasing flexibility provided by the additional (ζ)
orbital exponents. In comparison, the performance of the augmented basis sets is slightly
worse in the fingerprint region. In the hydrogen-stretching region, Figure 4.3 (b), the
augmented basis sets improve the predictions for C-H stretching. Overall, cc-pVQZ
provides the most accurate prediction among the Dunning basis sets (MAE = 10.6 cm -1).
For the Ahlrichs basis sets, Figure 4.2 (c) and Figure 4.3 (c), results from consistent
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Ahlrichs treatments and the LANL2DZ basis set (with ECP) for Pt are compared because
previous work has indicated that the def2-TZVPPD basis set with the corresponding ECP
for Pt generally provides the best results for heavy metal systems [161-163]. It is clear
that the def2-TZVP basis set provides the best results when combined with the LANL2DZ
treatment for Pt among this series (MAE = 8.1 cm -1). Similar to the Pople basis sets, the
addition of polarization or diffuse functions does not significantly improve the accuracy of
the theoretical description. The def2-TZVP basis set provides better results than all of the
Pople basis sets examined, but provides a poor description of the CH stretching modes.
Because of its outstanding performance and low cost, the def2-TZVP basis was chosen
as the optimal basis set for the non-metal atoms. The very good performance of the
def2-TZVP basis set may result from the relatively balanced treatment of the metal center
and non-metal atoms. To further confirm this assumption, the four Ahlrichs basis sets
were used for all atoms and compared, Figure 4.2 (c) and Figure 4.3 (c). Among these
approaches, the def2-TZVP basis set provides the best prediction of the IR spectrum,
which is also better than results based on the LANL2DZ valence basis set and ECP
treatment for Pt. These results also indicate that the treatment of the Pt center must be
chosen very carefully.
The treatment of the Pt(II) metal center of cisplatin and its amino acid-linked
analogues is challenging due to the large number of electrons and the non-negligible
relativistic effects of the third transition row. To overcome this limit, calculations on Pt
complexes such as cisplatin and its derivatives are normally performed with a suitable
valence basis set combined with an effective core potential for the Pt(II) center. However,
basis sets have yet to be validated for amino acid-linked Pt(II)-based complexes. In this
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thesis, five valence basis sets and ECP treatments are compared with three all-electron
basis sets, with results summarized in Figure 4.4. Previous theoretical studies on
cisplatin indicated that the LANL2DZ basis set (with the Hay and Wadt ECP) is a
reasonable choice for cisplatin calculations [134]. The addition of a zeta set, from
LANL2DZ to LANL2TZ, or a polarization function, from LANL2TZ to LANL2TZ(f),
improves the overall computed frequencies (MAEs = 8.1, 7.6, and 7.0 cm -1, respectively),
consistent with previous work reported in the literature [149]. Although the
Stuttgart-Dresden ECP (SDD) treatment provides a better description than LANL2DZ for
many transition metal complexes, slightly poorer agreement is found here for Glyplatin
(MAE = 9.0 cm-1). The def2-TZVP treatment was again employed to achieve size
consistency with the non-metal atoms. The def2-TZVP treatment (MAE = 7.7 cm -1)
provides results similar to those from LANL2TZ, is slightly worse than LANL2TZ(f), but
better than all other ECP treatments. Among the all-electron basis sets examined, ADZP
and mDZP (modified DZP) provide similar and reliable results when combined with the
def2-TZVP basis set for the non-metal atoms (MAEs = 5.0 cm -1). These approaches also
provide an improved description of the NH2-wagging in the fingerprint region and the CH
stretches in the hydrogen-stretching region as compared to LANL2TZ(f) and def2-TZVP.
Because of its smaller size relative to ADZP, mDZP was selected for further study. For the
all-electron basis set treatments, the DZP and augmented DZP (ADZP) basis sets are
also available for all non-metal atoms. Thus, B3LYP calculations were also performed
using these basis sets for all atoms for the purpose of size consistency, but the results are
poor (MAEs = 26.7 and 15.1 cm-1, see reference [164]). In summary, the mDZP
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all-electron basis set for Pt combined with the def2-TZVP basis set for the non-metal
atoms yields the best results with the B3LYP functional.
DFT methods are widely applied due to their relatively low cost and acceptable
results for many systems. As our goal is to determine the most efficient method and basis
set for calculations of other amino acid-linked cisplatin analogues, only DFT methods
were examined and compared in this dissertation. B3LYP is often the method of choice
because of the benefit of its three-parameter hybridization [165,166]. B3PW91 and
mPW1PW91 have been reported to provide good agreement with experiment and thus
are also examined [134,147-150]. M06 was also included given its good performance in
studies of transition metal-ligand interactions [167]. PBE0 and LC-ωPBE are also
examined based on previous results for cisplatin [149]. CAM-B3LYP, as a further
optimized B3LYP method, was also included. Figure 4.5 indicates that even though
PBE0 and LC-ωPBE were recommended for computing vibrational spectra based on a
previous study of cisplatin, these methods do not provide results that are as satisfying as
the B3LYP method for Glyplatin (MAEs = 9.9 and 12.4 cm-1 vs 5.0 cm-1). CAM-B3LYP
gives results highly parallel to those of B3LYP. However, detailed comparisons of the
band positions find that CAM-B3LYP performs slightly worse (MAE = 8.4 cm -1) than
B3LYP. It is also clear that M06 provides the least reliable prediction for the geometry of
Glyplatin among the density functionals examined here (MAE = 14.9 cm -1). B3PW91 and
mPW1PW91 provide slightly poorer predictions (MAEs = 8.0 and 9.9 cm-1) than B3LYP,
besides their slightly higher computational cost. Hence, B3LYP is found to be the most
suitable DFT method for further calculations.
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Several anharmonic approaches were also performed and the predicted IR
spectra are compared to that of B3LYP/LANL2TZ(f)/def2-TZVP. Variations in the
predicted spectra, particularly in the hydrogen-stretching region, suggest that the
differences between the experimental and predicted spectra are primarily due to
anharmonic effects. Unfortunately, all three anharmonic approaches available in
Gaussian09 are unable to provide improved descriptions of the IR spectrum of Glyplatin
in the hydrogen-stretching region vs those based on the simpler harmonic approximation.
To achieve more accurate spectral predictions, more advanced and computationally
intensive approaches for the treatment of anharmonicity are being developed and
pursued by several theoretical research groups [168,169]. As the goal of the Glyplatin
work in this dissertation is to determine the most efficient hybrid theoretical approaches
for the characterization of Glyplatin and more complex amino acid-linked platinum
complexes, detailed time-consuming anharmonic calculations are left to the experts.
4.4

Conclusions
Balanced basis sets for platinum and the non-metal atoms of Glyplatin provide the

most reasonable results. The B3LYP/mDZP/def2-TZVP approach provides a robust
description of the vibrational spectrum of Glyplatin as shown in Figure 4.6. However, if
large platinum-biomolecular complexes are of interest, their ground structures may not be
easily identified, may require more comprehensive searching for stable structures, and
even mapping of the potential energy surface may be necessary. In such cases, use of
the 6-31G(d) basis set for the treatment of non-metal atoms is recommended due to its
ability to produce relatively good results at a low computational cost. If the fingerprint
region spectrum is more congested such as expected for more complex amino
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acid-linked cisplatin derivatives, the 6-31+G(d,p) basis set is recommended. To
summarize, results from this thesis work lead to the hybrid B3LYP/mDZP/def2-TZVP
method being recommended for future calculations of amino acid-linked platinum
complexes. It is important to note that this approach is chosen based on the accurate
prediction of geometric information for Glyplatin and may not represent the best choice for
energetic predictions.
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Table 4.1 Vibrational Band Assignments for [(Gly–H)PtCl2]–.a
B3LYP/def2-TZVPPD
Predicted Frequency (cm-1)c
1030 (4)
NH2 wagging
1056 (26)
–
1294 (2)
C–O stretching/CH2 wagging
1302 (8)
1325 (2)
CH2 wagging/NH2 twisting
1328 (3)
1577 (5)
NH2 bending
1611 (34)
1669 (6)
C=O stretching
1669 (0)
2939 (1)
CH2 symmetrical stretching
2906 (33)
2972 (1)
CH2 asymmetrical stretching
2952 (20)
3302 (2)
NH2 symmetrical stretching
3299 (3)
3360 (1)
NH2 asymmetrical stretching
3360 (0)
aScaling factors
of 0.9781 and 0.9502 were used in the fingerprint and
hydrogen-stretching regions, respectively.
bUncertainties are indicated in parentheses.
cShifts in the predicted frequencies vs the measured values are listed in parentheses.
Experimental (cm-1)b

Vibrational Mode
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Table 4.2 Scaling Factors Used for the Various Theoretical Approaches. a
B3LYP/LANL2DZ (with ECP)/Basis Set
B3LYP/LANL2DZ (with ECP)/Basis Set
Nonmetal Atoms
Nonmetal Atoms
Basis Set
FEL
OPO Basis Set
FEL
OPO
6-31G
0.9881
0.9473 def2-SVP
0.9283
0.9521
6-31G(d)
0.9367
0.9506 def2-TZVP
0.9705
0.9524
6-31+G(d)
0.9673
0.9495 def2-QZVP
0.9758
0.9485
6-31+G(d,p)
0.9676
0.9450 def2-TZVPPD
0.9775
0.9484
6-311+G(d,p)
0.9740
0.9486 def2-QZVPPD
0.9777
0.9495
6-311++G(d,p)
0.9740
0.9488
B3LYP/Basis Set All Atoms (with ECP for Pt
6-311+G(2d,2p)
0.9810
0.9473
when applicable)
6-311+G(3df,3dp)
0.9732
0.9492 Basis Sets
FEL
OPO
cc-pVDZ
0.9452
0.9571 def2-TZVP
0.9713
0.9539
cc-pVTZ
0.9634
0.9489 def2-QZVP
0.9767
0.9510
cc-pVQZ
0.9703
0.9504 def2-TZVPPD
0.9781
0.9502
aug-cc-pVDZ
0.9806
0.9516 def2-QZVPPD
0.9787
0.9512
aug-cc-pVTZ
0.9781
0.9513 DZP
0.9499
0.9823
aug-cc-pVQZ
0.9776
0.9519 ADZP
0.9728
0.9502
B3LYP/Pt Basis Set/def2-TZVP
DFT Method/mDZP/def2-TZVP
Pt Basis Set
FEL
OPO
DFT method
FEL
OPO
LANL2TZ
0.9704
0.9541
PBE0
0.9452
0.9454
LANL2TZ(f)
0.9701
0.9552
LC-ωPBE
0.9315
0.9321
SDD
0.9711
0.9526
CAM-B3LYP
0.9471
0.9457
DZP
0.9653
0.9654
B3PW91
0.9565
0.9509
ADZP
0.9705
0.9569
mPW1PW91
0.9465
0.9434
mDZP
0.9696
0.9568
M06
0.9394
0.9484
a All theoretical spectra were aligned to the experimental frequencies of the C=O stretch
observed at of 1669 cm-1 in the fingerprint region (indicated as FEL in the table), and the
NH2 asymmetric stretch observed at 3360 cm-1 in the hydrogen-stretching region
(indicated as OPO in the table).
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Figure 4.1 Comparison between the experimental IRMPD spectrum and calculated
IR spectra predicted for the five most stable binding modes of [(GlyH)PtCl2], i.e.,
NO, OO, N, OH, and O. The corresponding B3LYP/def2-TZVPPD optimized
structures and relative Gibbs energies at 298 K are also shown.
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Figure 4.2 Comparison between the experimental IRMPD spectrum and B3LYP IR
spectra predicted using various (a) Pople, (b) Dunning, and (c) Ahlrichs basis sets for
the non-metal atoms of [(Gly‒H)PtCl2]‒ in the fingerprint region. Pt was treated using
the LANL2DZ valence basis set with its corresponding ECP in all calculations, except
when the four Ahlrichs basis sets were used; in these cases all atoms were treated
using the same Ahlrichs basis set. MAE values are listed in parentheses.
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Figure 4.3 Comparison between the experimental IRMPD spectrum and B3LYP IR
spectra predicted using various (a) Pople, (b) Dunning, and (c) Ahlrichs basis sets for
the non-metal atoms of [(Gly‒H)PtCl2]‒ in the hydrogen-stretching region. Pt was
treated using the LANL2DZ valence basis set with its corresponding ECP in all
calculations, except when the four Ahlrichs basis sets were used; in these cases all
atoms were treated with the same Ahlrichs basis set. MAE values are listed in
parentheses.
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Figure 4.4 Comparison between the experimental IRMPD spectrum and
B3LYP/Pt treatment/def2-TZVP IR spectra predicted for [(GlyH)PtCl2] for various
treatments of the Pt center. MAE values are listed in parentheses.
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Figure 4.5 Comparison between the experimental IRMPD spectrum and the IR
spectra predicted for [(Gly‒H)PtCl2]‒ using various DFT methods along with the
mDZP basis set to describe Pt and the def2-TZVP basis set for all other atoms. MAE
values are listed in parentheses.
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Figure 4.6 The experimental IRMPD spectrum of [(Gly‒H)PtCl2]‒ (black) is best
reproduced by B3LYP/mDZP/def2-TZVP hybrid theoretical approach as shown. The
optimized structure of [(GlyH)PtCl2] is also shown.
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CHAPTER 5 STRUCTURAL CHARACTERIZATION OF ARGPLATIN, LYSPLATIN,
AND ORNPLATIN
5.1

Introduction
The motivation for studying amino acid-linked platinum complexes has been

discussed in Chapter 1. The theoretical approach used for the amino acid-linked
platinum complexes was established in Chapter 4. This chapter focuses on the structural
characterization of Argplatin, Lysplatin, and Ornplatin. IRMPD action spectroscopy
experiments were performed for the deprotonated and sodium cationized forms of these
amino acid-linked platinum complexes, and thus include examination of the
[(ArgH)PtCl2], [(Arg)PtCl2+Na]+, [(LysH)PtCl2], [(Lys)PtCl2+Na]+, [(OrnH)PtCl2], and
[(Orn)PtCl2+Na]+ complexes. Importantly, we seek to determine the mode of binding of
the amino acid (Arg, Lys, or Orn) to the Pt metal center and establish whether or not it is
influenced by changes in the local environment. Theoretical calculations were performed
to facilitate structural elucidation based on IRMPD action spectroscopy results. All
experimental and theoretical details were described in Chapter 2. The nomenclature
used to describe the mode of binding of the amino acid to Pt and of sodium to the amino
acid-linked platinum complexes was also described in Section 1.2.3 and Figure 1.4.
5.2

Experimental Results

5.2.1 IRMPD Action Spectroscopy of [(Arg‒H)PtCl2]‒ and [(Arg)PtCl2+Na]+
Photodissociation of [(Arg‒H)PtCl2]‒ and [(Arg)PtCl2+Na]+ produces many
different fragments, diversity partially afforded by the guanidino group of the Arg side
chain. A larger number of photon dissociation pathways were observed in the IR
fingerprint region than the hydrogen-stretching region, which likely arises from more
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extensive sequential fragmentation in the fingerprint region due to the enhanced power
provided by the free electron laser versus that provided by the OPO laser used in the
hydrogen-stretching region. In both spectral regions, the dominant fragmentation
pathway involves HCl loss. Sequential loss of a second HCl is also observed in both
regions. The HCl loss pathways are consistent with the proposed mechanism associated
with the reactivity of cisplatin, where the chlorido ligands are lost upon adduction to DNA
[105-107]. As an analogue of cisplatin, Argplatin is expected to exhibit a parallel
mechanism when reacting with a DNA or RNA chain. Hence, elucidating the intrinsic
fragmentation pathways of Argplatin in the gas phase may provide insight into its
reactivity in solution. A detailed listing of the fragments of [(Arg‒H)PtCl 2]‒ and
[(Arg)PtCl2+Na]+ observed in the experiments are listed in Table 5.1 and 5.2. Discussions
about the mechanism behind the intrinsic fragmentation pathways of [(Arg‒H)PtCl 2]‒ and
[(Arg)PtCl2+Na]+ are given in the discussion section in order to provide a better overview
after their conformations have been determined by IRMPD spectroscopy. The
experimental IRMPD spectra of [(Arg‒H)PtCl2]‒ (Figure 5.1) and [(Arg)PtCl2+Na]+
(Figure 5.2) are similar in the fingerprint region, especially for the dominant feature near
1650 cm-1. However, the feature observed at ~1300 cm -1 of [(Arg‒H)PtCl2]‒ is richer than
that of [(Arg)PtCl2+Na]+. The IR bands observed at ~1650 cm-1 and ~1300 cm-1 are also
consistent with the IR features observed for [(Gly–H)PtCl2]–, which are associated with
the CO stretches and CH2 wagging, and NH2 twisting modes (see Chapter 4). In the
hydrogen-stretching region, the deprotonated and sodium cationized species of Argplatin
exhibit significantly different IR signatures, which is likely the result of removal of one of
the hydrogen atoms in the deprotonated complex and different hydrogen-bonding
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interactions involving the guanidino side chain. The richness of the features of
[(Arg)PtCl2+Na]+ in the hydrogen-stretching region may also be associated with multiple
conformers present in the experiments. When compared the IR features in the
hydrogen-stretching region of [(Arg‒H)PtCl2]‒ and [(Gly–H)PtCl2]–, the split NH stretch
peaks of [(Gly–H)PtCl2]– merge into an extensive IR band in [(Arg‒H)PtCl2]‒, which is not
surprising due to the richness of NH stretches in the guanidino group.
5.2.2 IRMPD Action Spectroscopy of [(Lys‒H)PtCl 2]‒ and [(Lys)PtCl2+Na]+
Multiple photodissociation pathways were observed for [(Lys‒H)PtCl 2]‒ and
[(Lys)PtCl2+Na]+. All fragments are summarized in Table 5.3 and 5.4. The intrinsic
fragmentation pathways of Lysplatin in the gas phase can provide an insight to its
reactivity. Detailed discussion about fragmentation pathways is also provided in the
discussion section after the structures of Lysplatin are presented. IRMPD spectra of
[(Lys‒H)PtCl2]‒ and [(Lys)PtCl2+Na]+ are plotted in Figure 5.1 and 5.2. The experimental
spectra of deprotonated Glyplatin, Argplatin, and Lysplatin are highly parallel, especially
[(Gly‒H)PtCl2]‒ and [(Lys‒H)PtCl2]‒. [(Arg‒H)PtCl2]‒ has broadening around 1600 cm-1,
which is associated with the extra C‒N bond stretches. The IR band observed at ~3350
cm-1 for [(Lys‒H)PtCl2]‒ has low yield, which may relate to the mode of binding of Lys to
the Pt metal center. IRMPD spectra of [(Lys)PtCl2+Na]+ and [(Arg)PtCl2+Na]+ are
obviously different in both the IR fingerprint and hydrogen-stretching regions. An IR band
~1750 cm-1 arises in [(Lys)PtCl2+Na]+, indicating a free carbonyl stretch. The dominant IR
band of [(Lys)PtCl2+Na]+ ~1600 cm-1 is red shifted compared to that of [(Arg)PtCl2+Na]+,
and that is probably related to different hydrogen-bonding interactions involving the
carboxylate group. In the hydrogen-stretching region, [(Lys)PtCl 2+Na]+ exhibits fewer IR

140
bands compared to [(Arg)PtCl2+Na]+, which is related to the limited number of N‒H and
possible O‒H stretches in [(Lys)PtCl2+Na]+.
5.2.3 IRMPD Action Spectroscopy of [(Orn‒H)PtCl 2]‒ and [(Orn)PtCl2+Na]+
[(OrnH)PtCl2] and [(Orn)PtCl2+Na]+ exhibits unique fragmentation behavior. The
fragment ion m/z values along with proposed fragment ion compositions are summarized
in Table 5.5 and 5.6. To achieve maximum intensity during experiments, the highest
isotopic peak was mass isolated, which includes a combination of 194Pt37Cl35ClC5H11N2O2
and 196Pt35Cl35ClC5H11N2O2 for [(OrnH)PtCl2] as well as 194Pt37Cl35ClC5H12N2O2Na and
196Pt35Cl35ClC H N O Na
5 12 2 2

for [(Orn)PtCl2+Na]+. Hence, the loss of H35Cl and H37Cl yield

two isotopes in the mass spectra. Fragment peaks have been identified based on isotopic
envelope calculations. The intrinsic fragmentation pathways are discussed in detail in the
discussion section after the gas-phase conformation of Ornplatin is presented. The
overall experimental IRMPD spectra of the two Ornplatin complexes are compared in
Figure 5.1 and 5.2. The IRMPD results for [(Orn‒H)PtCl2]‒ is similar to the results for
[(Gly‒H)PtCl2]‒, [(Arg‒H)PtCl2]‒, and [(Lys‒H)PtCl2]‒. The IR bands observed in the
hydrogen-stretching region for [(Orn‒H)PtCl2]‒ have low yield, which may relate to the
mode of binding of Orn to the Pt metal center. The two major IR bands at ~330 cm -1 have
similar positions compared to those in [(Gly‒H)PtCl2]‒. In the spectrum of
[(Orn)PtCl2+Na]+, the peak observed near 1770 cm-1 is typically associated with the
carbonyl stretch of a free carboxyl group in the IR spectrum [89]. This feature is missing,
or significantly shifted to the red in the deprotonated spectrum. This very significant
spectral difference is probably due to the fact that the carboxyl group is deprotonated, and
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resonance stabilization of the carboxylate moiety results in a decrease in bond order that
causes the observed red shift of the carbonyl stretch.
5.3

Theoretical Results
The nomenclature employed for each conformer is based on the site of protonation,

followed by a letter that indicates the order of relative stability among all conformers
protonated at that site, where A is used for the most stable conformer protonated at a
given site, B for the next most stable, etc. Only selected structures are shown for each
nucleoside. To avoid confusion, the conformer names taken from the published work are
retained, but only a subset of those computed are discussed here, and thus the
designations are not continuous. The interested reader is referred to references [170-172]
for a more comprehensive discussion of the theoretical results.
5.3.1 Theoretical Results for [(Arg‒H)PtCl2]– and [(Arg)PtCl2+Na]+
To fully explore the potential energy surface of [(Arg‒H)PtCl2]‒, candidate
structures were constructed and subjected to simulated annealing to cover all possible
binding modes and allow relaxation of the Arg side chain. Selected low-energy
conformers with different binding modes are shown in Figure 5.35.4. Binding modes
investigated include NNs, NO–, NsO–, OO–, NN, NN′, NO–, N′O–. As a reminder, N, N,
and N′ represent three nitrogens on the side chain (see Figure 1.4). NNs is used to
describe N because it is the most likely sidechain binding site to Pt. Structures with N ′ or
N binding to Pt are definitely less favorable sites for Pt. Interestingly, the calculated
results for [(Arg‒H)PtCl2]‒ indicate that the NNs_A and NO‒_A (Figure 5.3) conformers
are equally stable and the lowest energy structures. Further, all structures exhibiting
either of these two binding modes are usually relatively low in energy. For NN s binding
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structures, the deprotonated carboxylate group has multiple hydrogen binding modes
with the backbone amino or sidechain guanidino group. If the side chain is stretched, the
guanidino group can even form a hydrogen bond with the chlorido ligand in some cases
(see for example, NNs_K conformer, Figure 5.3). The NO‒ binding mode provides more
sidechain flexibility to Arg and allows hydrogen-bonding interactions between the
guanidino group and the carboxylate group, Pt, or the chlorido ligand. In some cases,
multiple hydrogen bonds are formed between the guanidino and carboxylate moieties
(see for example conformer NO‒_K, Figure 5.3). The relative Gibbs free energy of
conformer NsO‒_A (Figure 5.4) is ~25 kJ/mol higher than that of the lowest-energy
conformers, even though the delocalized  bond is maintained. The OO‒ binding mode
was also investigated (Figure 5.4). Conformers with this binding mode lie much higher in
Gibbs free energy than the ground conformers even after relaxation via simulated
annealing, this destabilization arises from the unfavorable angle formed between oxygen
atoms and Pt. Conformers involving interaction with the less favorable sidechain nitrogen
atoms NN′_A and NN_A are less stable by ~25 kJ/mol than NNs_A, which is probably
due to the disruption of the delocalized  bond of the guanidino group. The N′O‒_A and
NO‒_A conformers also exhibit high relative Gibbs free energies, indicating that binding
via N′ or N is probably not favored. Overall, the NNs and NO‒ binding modes are
energetically favored over all other binding modes (including N sO‒, OO‒, NN′, NN, N′O‒,
and NO‒).
For the [(Arg)PtCl2+Na]+ complex, the binding modes of both the Pt and Na cations
is of interest. The candidate structures were constructed and subjected to simulated
annealing to allow relaxation of the Arg side chain. The select optimized structures are
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shown in Figure 5.5 and 5.6. In general, bidentate interaction of the sodium cation with
the chlorido ligands is favored over other sodium cation binding modes. Parallel to the
results for [(Arg‒H)PtCl2]‒, the NNs_ClbCls and NO‒_ClbClO binding conformers of
[(Arg)PtCl2+Na]+ exhibit relatively low Gibbs free energies. Many conformers involving
these two binding modes are found within 20 kJ/mol of the ground NNs_ClbCls_A
conformer. For the NNs binding conformers, OClbCls and OCls sodium binding modes are
also much less favorable than the ClbCls mode (at least 36 kJ/mol less stable). When Arg
binds to Pt via NO‒ and the Na+ binds via OClb instead of ClbClO, the energy of the most
stable conformer (NO‒_OClb_A) is almost 20 kJ/mol higher than NO‒_ClbClO_A
conformer. NsO_ClsClO, NsO‒_ClsClO, and OO‒_ClOClO conformers all adopt at least 49
kJ/mol higher energies than NNs_ClbCls and NO‒_ClbClO conformers, even though the
sodium cation remains on the chlorido ligands. One interesting observation is that the
relative Gibbs free energies computed for conformer NsO‒_ClsClO_A is higher than that
of conformer NsO_ClsClO_A (65.8 vs 49.8 kJ/mol), suggesting the relative proton affinity
of the carboxylate versus amino moieties is altered upon binding to Pt. All other binding
modes cause significant energy increase compared to NNs_ClbCls and NO‒_ClbClO
binding modes. When Arg binds to Pt via NN and NN′ modes, the cost to disrupt the
delocalized πbonding interaction of the guanidinium group is very high.
5.3.2 Theoretical Results for [(Lys‒H)PtCl2]‒ and [(Lys)PtCl2+Na]+
Figure 5.7 and 5.8 show the select stable conformers in the electronic structure
calculations of [(Lys‒H)PtCl2]‒, with their corresponding name and relative Gibbs free
energies calculated at B3LYP/mDZP/def2-TZVP level of theory. Further calculations
using

polarizable

continuum

model

corresponding

to

water

[141]

at

the
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B3LYP/mDZP/def2-TZVP level of theory were performed, and the relative Gibbs free
energies of these conformers are listed in red. Conformers NO‒_E and NO‒_I (Figure 5.7)
lose hydrogen-bonding interaction when polarizable continuum is applied, thus their
energies with polarizable continuum have been marked with stars to indicate the
reasonable structural change. No stable conformation with polarizable continuum has
been found for conformer NO‒_AX. NNs binding conformers exhibit low relative energy in
gas phase and solution phase. NNs binding conformers have less flexibility compared to
NO‒ binding conformers. The deprotonated carboxylate group of NN s binding conformers
are inclined to form hydrogen bonds with hydrogen on the backbone or sidechain nitrogen.
A noncanonical hydrogen-bonding interaction between the oxygen and hydrogen on
carbon can also be formed (NNs_C). The relative energies of NO‒ binding conformers are
at least 30 kJ/mol higher than NNs conformers, but the energy difference significantly
drops to ~10 kJ/mol or less in solution phase, indicating that NO ‒ binding conformers are
energetically competing with NNs binding conformers in solution. Multiple types of
hydrogen-bonding interactions were observed in the computed NO ‒ binding conformers.
Interactions of the sidechain amino group with carboxylate group (NO‒_E), chlorido group
(NO‒_I), backbone amino group and Cl (NO‒_Q), even with Pt (NO‒_AC) were found
within 10 kJ/mol energy difference. The neutral sidechain NH2 group in NO‒ binding
conformers does not favor hydrogen-bonding interactions with the deprotonated
carboxylate group in the gas phase, and conformers NO‒_E and NO‒_G exhibit
within 3 kJ/mol higher energy than conformer NO‒_A, while the trend is reversed in
solution. NsO‒ binding conformers are at least 40 kJ/mol higher than the most stable NN s
binding conformer, even though the energy difference decreases to ~30 kJ/mol in solution
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(Figure 5.8). NsO‒ binding conformer also exhibit various hydrogen-bonding interactions
between the backbone amino group and the carboxylate group or chlorido group, dual
hydrogen-bonding interactions are formed with oxygen dual hydrogen-bonding to NH 2
group and CH2 group (NsO‒_L). OO‒ binding conformer exhibits high relative Gibbs free
energy in both gas phase and solution phase compared to the most stable conformer
(Figure

5.8).

Conformer

OO‒_A

exhibits

a

stretched

side

chain

with

no

hydrogen-bonding interaction. Pt prefers a square planner shape of chelation, while the
bond angle between the two oxygen atoms and Pt is clearly less than 90 degree. This
non-ideal binding angle may contribute to the high relative energy of OO ‒ conformer
compared to conformers with other binding modes.
Select stable low-energy conformers of [(Lys)PtCl2+Na]+ with their corresponding
relative Gibbs free energies calculated at B3LYP/mDZP/def2-TZVP level of theory are
shown in Figure 5.9‒5.11. Further calculations using a polarizable continuum model
corresponding to water [141] at B3LYP/mDZP/def2-TZVP level of theory were performed,
and the relative Gibbs free energies of these conformers are listed in red. Conformers
NNs_ClbCls_O, NO‒_ClbClO_F, and NsO‒_ClsClO_J lose hydrogen-bonding interactions
when the polarizable continuum is applied, and they are indicated with stars to represent
the structural change. The chelation mode of the Na cation changes from bidentate to
monodentate in conformers NNs_OO_A and NO_NsO_A. In general, conformers with
sodium cationized between two chlorido groups are more stable than other sodium
binding modes. Similar to the results of [(Lys‒H)PtCl2]‒, NNs_ClbCls conformers are more
stable than other binding modes of lysine to the Pt or Na cation. The relative energy of
conformer NNs_OClbCls_A (Figure 5.11) sits between NNs_ClbCls and NO‒_ClbClO
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conformers, which is not surprising that the flexible side chain of lysine enables the
interaction between the backbone oxygen and sodium cation. Relative Gibbs free
energies of NO‒_ClbClO conformers are ~30 kJ/mol higher in the gas phase but are
competitive in the solution phase than that of NNs_ClbCls conformers. It is worth
mentioning

that

the

relative

energy

of

conformer

NO‒_ClbClO_X

changes

from ~140 kJ/mol to ~4 kJ/mol, indicating the addition of solvent significantly stabilizes
this stretched-out conformer. Conformers NO‒_ClbClO_A and NO_ClbClO_A represent
the zwitterionic and nonzwitterionic structures of lysine, while their energy difference is
almost 30 kJ/mol (32.6 and 59.5 kJ/mol, respectively). However, the other zwitterionic
and nonzwitterionic structure pair, conformer NsO_ClsClO_A and NsO‒_ClsClO_A, only
differs within 4 kJ/mol in energy (50.4 vs 54.5 kJ/mol). Other sodium cation chelation
modes, including NNs_OCls, NNs_OO, NNs_O, NO_NsClbCls, NO‒_OClb, NO_Ns,
NO_NsO, NsO‒_OOCls, and NsO‒_OCls, were also investigated, and relative Gibbs
energies of the corresponding conformers are much higher than those adopting binding
modes mentioned before. The relative energy of conformer OO‒_ClOClO_A is 113.9
kJ/mol (in the gas phase) and 94.8 kJ/mol (in solution phase) higher than the most stable
conformer, suggesting this binding mode is less likely to be present.
5.3.3 Theoretical Results for [(Orn‒H)PtCl2]‒ and [(Orn)PtCl2+Na]+
Figure 5.12 shows the stable conformers in the electronic structure calculations of
[(Orn‒H)PtCl2]‒ with their corresponding relative Gibbs free energies calculated at
B3LYP/mDZP/def2-TZVP level of theory, and Figure 5.13 and 5.14 show the equivalent
results of [(Orn)PtCl2+Na]+. It has been demonstrated previously that conformers with
OO‒ binding mode for [(Orn‒H)PtCl2]‒ (or OO‒_ClOClO for [(Orn)PtCl2+Na]+) usually adopt
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significantly high relative Gibbs free energy and always have misalignment found in later
spectral comparison (Section 5.3.1 and 5.3.2). Hence, only conformers found with NNs,
NO‒, and NsO‒ binding modes were investigated in this work. Parallel results have been
found for [(Orn‒H)PtCl2]‒ and [(Orn)PtCl2+Na]+ compared to [(Lys‒H)PtCl2]‒ and
[(Lys)PtCl2+Na]+, respectively. NNs binding conformers exhibit low relative energy in gas
phase. The relative energies of NO‒ binding conformers in [(Orn‒H)PtCl2]– are at least 37
kJ/mol higher than NNs conformers; while the relative energies of NO‒_ClbClO binding
conformers are more than 50 kJ/mol higher than NNs_ClbCls conformers in
[(Orn)PtCl2+Na]+. The energy difference of NNs and NO‒ binding structures is getting
larger than the results found for [(Lys‒H)PtCl2]‒ and [(Lys)PtCl2+Na]+. NsO‒ binding
conformers exhibit even higher relative energy. The relative energy of NsO‒_A is 50.4
kJ/mol higher than NNs_A conformer in [(Orn‒H)PtCl2]‒, and NsO‒_ClsClO_A adopts 75.8
kJ/mol relative energy compared to the most stable conformer NNs_ClbCls_A in
[(Orn)PtCl2+Na]+. Different protonation sites have also been investigated for
[(Orn)PtCl2+Na]+. For instance, conformers NO‒_ClbClO_A and NO_ClbClO_A represent
the zwitterionic and nonzwitterionic structures of Orn. Surprisingly, their energy difference
is only ~15 kJ/mol, while the energies of their counterpart structures in [(Lys)PtCl 2+Na]+
differ by ~30 kJ/mol. Conformer NsO‒_ClsClO_A is less stable than NsO_ClsClO_A by ~5
kJ/mol (75.8 vs 70.3 kJ/mol), which is quite different from the proton affinity in the solution
phase of Orn but consistent with the equivalent structures found in [(Lys)PtCl 2+Na]+. A
structural search has also been performed on [(Orn)PtCl2+Na]+ with different Na binding
modes for each Orn binding mode (NNs, NO‒, and NsO‒), including NNs_OClbCls,
NNs_OCls, NNs_OOCls, NNs_OO, NNs_O, NO‒_OClb, NsClbCls, NO_NsO, NO_Ns,
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NsO‒_OOCls, NsO_NbClsClO, NsO‒_OCls, NsO_NbCls. All of them exhibit at least 60 kJ/mol
higher

relative

energies

compared

to

the

lowest-energy

conformer,

except

NNs_OClbCls_A (Figure 5.14).
5.4

Binding Mode of Arginine to Platinum Populated in the Gas Phase

5.4.1 Conformational Elucidation of [(Arg–H)PtCl 2]–
Figure 5.15 compares the experimental IRMPD spectrum of [(Arg‒H)PtCl2]‒ and
the convoluted IR spectra of the stable conformers found that provide the best match.
Green highlighting is used to identify IR features that involve strong hydrogen-bonding
interactions. For instance, the IR band at ~3200 cm -1 of NO‒_A is associated with the
N′H2 symmetric stretch, and the peak at ~3460 cm-1 is the corresponding asymmetric
stretch. Using harmonic computational modeling may cause significant misalignments
between

the

experimental

and

the

computed

IR

features

involving

strong

hydrogen-bonding interactions in the IR hydrogen-stretching region [157-160]. Theory
tends to overestimate the intensity of the IR frequencies of such hydrogen bonds,
whereas features in the experimental data are usually broadened and much flatter, and
red shifted versus the harmonic approximation. Unfortunately, current protocols such as
the second-order vibrational perturbation theory (VPT2) approach for making anharmonic
corrections generally do not improve spectra alignment without heroic efforts and thus not
pursued here (see Chapter 4).
The computed IR spectrum of the most stable conformer, NO‒_A, represents the
experimental data very well. Conformers NO‒_K and NO‒_T cannot be ruled out based
on their computed IR spectra. However, their relative Gibbs free energies suggest that
their populations in the experiment are probably insignificant. Hence peak assignments of
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[(Arg‒H)PtCl2]‒ are based on the NO‒_A conformer and listed in Table 5.7. Other NO‒
binding conformers exhibiting different hydrogen-bonding interactions all have small
shifts in the IR bands compared with the experimental data. For instance, an intense IR
feature is predicted for NO‒_B at ~1550 cm-1 (see reference [170]). However, the IRMPD
spectrum does not have an intense peak at this frequency. Even though NN s conformers
are stable energetically, their predicted IR spectra exhibit several spectral misalignments
compared to the experimental data, especially the peaks between ~900 and 1050 cm -1
(see reference [170]). Absence of these features in the measured spectrum suggests that
if present, they are present in low abundance in the experiments. NN and NN′
conformers are less stable than NNs conformers. Further, they also have predicted IR
features in the region from ~900‒1050 cm -1 where the experimental spectrum is flat. Thus,
they cannot significantly populate in the experiments. The spectrum predicted for NsO‒_A
exhibits IR features at ~1500 cm-1 corresponding to sidechain C‒N bond stretching,
which are blue shifted versus the experimental spectrum (see reference [170]). The lack
of spectral agreement combined with their relative Gibbs free energies indicate that NsO‒
conformers do not contribute significantly to the experiments. The N O‒ and N′O‒
conformers are also ruled out for similar reasons. Several intense IR features near ~1000
cm-1 are predicted for OO‒ conformers (see reference [170]) suggesting they are also
either not populated or present in negligible abundance in the experiments.
5.4.2 Conformational Elucidation of [(Arg)PtCl 2+Na]+
Figure 5.16 compares the experimental IRMPD spectrum of [(Arg)PtCl2+Na]+ to
the IR spectra of NO‒_ClbClO conformers that exhibit the best match to the experimental
spectrum. As mentioned above, green highlighting is used to identify IR features that
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involve strong hydrogen-bonding interactions. These conformers well represent the
experimental spectrum in the IR fingerprint and hydrogen-stretching regions. The intense
feature at ~1600 cm-1 and the small features below 1500 cm-1 match the experimental
ratio relatively well. Conformers NO‒_ClbClO_A and NO‒_ClbClO_B differ only in the
orientation of N′H2, which is hard to distinguish from their predicted IR spectra. Their
Gibbs free energies also differ by only 1 kJ/mol. However, the peak at ~3500 cm -1 is not
well represented by these two conformers. Conformers NO‒_ClbClO_C, NO‒_ClbClO_D,
and NO‒_ClbClO_F provide better agreement with the experimental IRMPD spectrum in
the hydrogen-stretching region because of the different hydrogen-bonding interactions
between the guanidinium and carboxylate group present in these conformers. The
predicted IR spectrum of the NO‒_ClbClO_H conformer matches the experimental data in
the fingerprint region even better although it is computed to be ~10 kJ/mol less stable
than the NO‒_ClbClO_A conformer. The IR spectrum predicted for NO‒_ClbClO_W
matches the small experimental feature at ~3380 cm -1 in the hydrogen-stretching region.
Hence, it may be accessed in the experiment in small abundance. Considering the
desolvation process that occurs during electrospray ionization (ESI), it is easy to imagine
that all these hydrogen-bonding interactions could possibly be formed when the side
chain folds back seeking stabilization as solvent molecules are removed in the gas phase.
The experimental peak assignments in Table 5.8 are based on the NO‒_ClbClO_A
conformer. The spectra predicted for other NO‒ conformers exhibit some misalignment
with the experimental data, and therefore can be eliminated as important conformers in
the experiments.
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NNs_ClbCls conformers of [(Arg)PtCl2+Na]+ lie low in Gibbs free energy. All
NNs_ClbCls conformers exhibit an intense IR feature at ~1750 cm -1, corresponding to the
C=O stretch of the carboxylic acid moiety, whereas the corresponding feature is barely
above noise in the measured IRMPD spectrum, which suggests none of those
conformers are significantly populated in the experiments. In the cases of the
NNs_OClbCls and NNs_OCls conformers (Figure 5.11), the C=O stretch shifts to the red
due to coordination with the sodium cation, but still does not match the experimental data
(see reference [170]). Hence, the abundance of any NNs binding conformers accessed in
the experiments is very low. The comparison of the experimental and computed IR
spectra for NsO‒ conformers involving different protonation sites and sodium binding
modes predict an IR band at ~1500 cm-1 associated with C‒N′ stretching of the guanidino
group, which is an obvious mismatch compared to the experimental spectrum.
OO‒_ClOClO conformers are disfavored both energetically and spectroscopically due to
the misalignment at ~1500 cm-1. The disagreements found for conformers with other
binding modes also indicate the unlikelihood of their presence in the experiments.
5.4.3 Structural Comparison of [(Arg‒H)PtCl2]‒ and [(Arg)PtCl2+Na]+
IRMPD spectroscopy data and theoretical results indicate that in the
[(Arg‒H)PtCl2]‒ and [(Arg)PtCl2+Na]+ complexes, Arg binds to Pt via backbone amine and
carboxylate moieties. These results are consistent with its previously reported crystal
structure [110]. The IR features observed for [(Arg‒H)PtCl2]‒ are also consistent with
condensed-phase IR results. However, the hydrogen-bonding interactions between the
side chain and the carboxylate group of Pt in the gas phase are not observed in the
condensed phase. In the case of [(Arg‒H)PtCl2]‒, the guanidino group folds back to bind
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with Pt, the carboxylate moiety, and a chlorido ligand. When a sodium cation is present
and binds to the chlorido ligands, this hydrogen-bonding interaction is less likely to form.
The positively charged guanidinium group cannot get close to the positively charged Pt
metal center. Hence, conformers with a hydrogen bond between the guanidinium and
carboxylate groups are more stable than conformers with a hydrogen bond between
guanidinium and Pt or Cl as in the case of [(Arg)PtCl2+Na]+. Argplatin is more likely to be
neutral in solution, thus the hydrogen-bonding modes of [(Arg)PtCl 2+Na]+ better parallel
the condensed phase results.
Calculations for [(Arg‒H)PtCl2]‒ and [(Arg)PtCl2+Na]+ both suggest that the NNs
and NO‒ conformers (with Na+ binds to the chlorido ligands if present) exhibit lower Gibbs
free energies compared with all other conformers calculated. When Argplatin is
deprotonated, it is hard to distinguish NNs and NO‒ conformers from the data in the IR
fingerprint region. On the other hand, if NNs conformers are present in [(Arg)PtCl2+Na]+,
the signature C=O peak at ~1700 cm-1 produces strong evidence for its presence in the
ESI process. The NNs_A and NO‒_A are conformers computed to be isoenergetic and
the ground conformers of [(Arg‒H)PtCl2]‒, and NNs_ClbCls_A has even lower energy
than NO‒_ClbClO_A conformer. NNs conformers were not observed in the experiments,
probably due to the high energy barrier for converting between NO ‒ and NNs conformers.
As a soft activation technique, ESI usually maintains the major features of solution phase
structure of biomolecules. In the case of [(Arg‒H)PtCl2]‒ and [(Arg)PtCl2+Na]+, this
appears to be true as well.
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5.5

Binding Mode of Lysine to Platinum Populated in the Gas Phase

5.5.1 Conformational Elucidation of [(Lys‒H)PtCl 2]‒
Figure 5.17 shows the comparison between the experimental IRMPD spectrum of
[(Lys‒H)PtCl2]‒ and theoretical IR spectra computed for several stable low-energy
conformers. All predicted IR spectra of these NNs and NO‒ binding conformers represent
the experimental data very well. It is also interesting to see that NNs and NO‒ binding
conformers exhibit highly parallel IR spectra in the IR fingerprint region. The predicted IR
spectra of both NNs and NO– binding conformers exhibit some misalignment compared to
the experimental spectrum in the hydrogen-stretching region. These predicted IR bands
have low intensities suggesting the IRMPD yield for these bands are low if they can be
observed. However, with the anharmonic effect and limited laser power, it is not surprising
to see these features missing from the experimental data. NNs_E adopts the lowest
energy when polarizable continuum model corresponding to water was applied. The
predicted IR spectrum of NNs_E matches the experimental IR spectrum better than the
most stable conformer NNs_A, even though there is a tiny bump in the experimental data
that matches the NH2 scissoring ~1520 cm-1. Other NNs binding conformers exhibit high
relative energies than conformers NNs_A, and the predicted IR spectra of these
structures also have small misalignments compared to the experimental spectrum. The
predicted IR spectrum of conformer NNs_E in the hydrogen-stretching region has a
dominant peak arising from the Ns–HO hydrogen-bonding interaction, which is caused
by the anharmonic effect of this strong hydrogen bond. The predicted spectra of NO‒
binding conformers in Figure 5.17 are highly parallel, and all of them have a free C=O
stretch. When the non-bonding oxygen is involved in hydrogen-bonding interaction, the
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C=O stretch is influenced, and the predicted IR spectrum cannot match the experimental
IR band (NO‒_G and NO‒_L in Figure 5.7). Other NO‒ binding conformers do not provide
unique IR band compared to the low energy NO‒ binding structures, and they also adopt
higher energy compared to conformer NO‒_A. All IR features predicted for conformer
NO–_A at ~3350 cm-1 have low predicted intensity, suggesting these IR bands are not
easy to be observed in the experiment. Thus, they cannot be the dominant conformation
populated in the experiment. The predicted IR spectra of NsO‒ and OO‒ binding
conformers are compared to the experimental IRMPD spectra (see reference [171]).
Misalignments were observed in each comparison, suggesting these conformers cannot
populate in the ESI process with significant amount. Overall, the stable low-energy NN s
and NO‒ binding conformers shown in Figure 5.17 best represent the experimental
spectrum, and these conformers were accessed in the IRMPD experiment. Detailed peak
assignment is listed in Table 5.9 based on conformers NNs_E and NO‒_A. Although
multiple features predicted by conformer NNs_E and NO–_A at ~3350 cm-1 were not
observed in the experimental data in the hydrogen-stretching region, those features may
not be able to be detected due to the low IRMPD yield.
5.5.2 Conformational Elucidation of [(Lys)PtCl2+Na]+
The predicted IR spectra of select stable low-energy NNs and NO‒ binding
conformers are compared to the experimental IRMPD spectrum of [(Lys)PtCl 2+Na]+ in
Figure 5.18 and 5.19. NNs_ClbCls binding conformers contribute to the IR band
~1750 cm-1, while NO‒_ClbClO binding conformers contribute to the intense and broad IR
band ~1600 cm-1 in the IR fingerprint region. Conformer NNs_ClbCls_D has slightly higher
energy than the most stable conformer NNs_ClbCls_A (4.1 kJ/mol in gas phase and
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1.6 kJ/mol in solution). The predicted spectrum of conformer NNs_ClbCls_D reproduces
the IR band ~1750 cm-1 better than conformer NNs_ClbCls_A, hence these two
conformers are probably competing in solution. The small IR features ~1700 and 1720
cm-1 (note that the peak split is real) are well represented by the computed IR spectra of
NNs_ClbCls_B and NO‒_ClbClO_X conformers, suggesting their presence but low
abundance in the IRMPD experiment of [(Lys)PtCl2+Na]+. Although the relative energy of
NO‒_ClbClO_X is extremely high compared to the most stable conformer in the gas
phase, the energy difference is significantly reduced after the addition of water solvation.
Conformer NO‒_ClbClO_H explains the shoulder left to the most intense peak near ~1550
cm-1, and it is also the most stable NO‒_ClbClO binding conformer in solution. The
predicted IR spectrum of conformer NO‒_ClbClO_G represents the IR feature at ~1500
cm-1 very well. In hydrogen-stretching region, only NNs binding conformers exhibit strong
O‒H stretch near 3550 cm-1, and they also represent the left IR feature of the broad peak
at ~3350 cm-1. NO‒_ClbClO binding conformers all have N‒H asymmetric stretches
resulting in an IR band that matches the right IR feature of the broad peak at ~3350 cm -1.
Other stable low-energy NNs_ClbCls conformers are compared to the experimental
IRMPD spectrum, and misalignments indicate the low possibility for their presence in the
ESI experiment. The computed IR spectra of other NO ‒_ClbClO conformers besides the
ones shown in Figure 5.19 exhibit several IR features that do not match the experimental
IR spectrum. These NO‒ conformers also have high relative Gibbs free energies both in
gas phase and in solution (i.e. with polarizable continuum model corresponding to water).
Hence, these NO‒_ClbClO conformers cannot populate in the experiment with a significant
amount. Theoretical IR spectra for NsO_ClsClO and NsO‒_ClsClO species exhibit some IR
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features that were not observed in the experimental IRMPD spectrum, and their high
relative energies also indicate their absence in the ESI process. Conformer
NNs_OClbCls_A (Figure 5.11) does not exhibit obvious misalignment with the measured
spectrum, but it provides no unique IR features compared to the conformers shown in
Figure 5.17 and 5.18. Thus, this conformer is less likely to be present with a large amount.
OO‒_ClOClO binding conformers again adopt high relative Gibbs free energies and exhibit
intense IR features that were not observed in the experimental data. The predicted IR
spectra of conformers with other binding modes (Figure 5.11) all exhibit some
misalignments compared to the experimental spectrum. In summary, multiple stable
low-energy NNs_ClbCls and NO‒_ClbCls conformers were populated in the ESI process.
The solution is likely to be a mixture of conformers with these two binding modes.
Experimental peak assignment is listed in Table 5.10.
5.5.3 Structural Comparison of [(Lys‒H)PtCl2]‒ and [(Lys)PtCl2+Na]+
Lysine binds to Pt metal center via NNs and NO‒ binding mode in both
[(Lys‒H)PtCl2]‒ and [(Lys)PtCl2+Na]+. Some NNs conformers have almost identical
structures,

for

instance,

NNs_E

for

[(Arg‒H)PtCl2]‒

and

NNs_ClbCls_D

for

[(Lys)PtCl2+Na]+, and NNs_A for [(Lys‒H)PtCl2]‒ and NNs_ClbCls_B for [(Lys)PtCl2+Na]+.
On the other hand, the conformations of NO‒ binding conformers in these two
quasimolecular forms of Lysplatin are quite different. Hydrogen-bonding interaction
between the non-bound oxygen and the sidechain amino group is strongly favored in
[(Lys)PtCl2+Na]+ but not in [(Lys‒H)PtCl2]‒. Conformer NO‒_A in [(Lys‒H)PtCl2]‒ with the
sidechain stretched out exhibits comparable or even lower energy than other NO ‒
conformers with hydrogen bonds, while its counterpart conformer NO‒_ClbClO_X in
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[(Lys)PtCl2+Na]+ exhibits extremely high energy in the gas phase. Despite the subtle
difference in hydrogen-bonding interactions, NNs and NO‒ conformers coexist in
[(Lys‒H)PtCl2]‒ and [(Lys)PtCl2+Na]+. Even though the intensity of the experimental
IRMPD spectrum cannot be compared to the intensity of the single photon model used in
calculations (see Section 2.8.3), a simple fit is still provided to best replicate the
measured spectrum. Figure 5.20 shows the comparison of the experimental IRMPD
spectrum of [(Lys‒H)PtCl2]– with summed theoretical IR spectra predicted for NNs_E and
NO–_A conformers (top). The computed IR spectra of NNs_E and NO‒_A were added
together using a 1:1 ratio (shown in grey) and compared against the measured IRMPD
spectrum of [(Lys‒H)PtCl2]‒; however, the predicted spectrum does not reproduce the
experimental IR spectrum in the hydrogen-stretching region well. The most dominant
peak is from the Ns–HO hydrogen-bonding interaction in conformer NNs_E, which is
caused by the anharmonic effect of the strong hydrogen-bonding interaction. Multiple
features predicted at ~3350 cm-1 were not observed in the experiment. Due to the low
IRMPD yield in this region, those features may not be able to be detected. Comparison of
the experimental IRMPD spectrum of [(Lys)PtCl2+Na]+ with summed theoretical IR
–

spectra predicted for NNs_ClbCls_A and NO _ClbClO_A conformers (bottom). The sum
spectrum of NNs_ClbCls_A and NO‒_ClbClO_A using 1:1 ratio (shown in grey) is
compared with the experimental IRMPD spectrum of [(Lys)PtCl2+Na]+. The IR spectrum
–

predicted for NO _ClbClO_G conformer is further added to the summed spectrum
–

NNs_ClbCls_A and NO _ClbClO_A conformers (NNs_ClbCls_A : NO‒_ClbClO_A :
NO‒_ClbClO_A = 1:0.5:0.5, shown in dashed black) to achieve a better reproduction of
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the experimental spectrum of [(Lys)PtCl2+Na] . This combination better reproduces the
features in the fingerprint region of [(Lys)PtCl2+Na]+. The ratio of NNs and NO‒
conformers present in the experiment is probably near 1:1.
5.6

Binding Mode of Ornithine to Platinum Populated in the Gas Phase

5.6.1 Conformational Elucidation of [(Orn–H)PtCl2]–
The computed IR spectra of the low-energy NNs structures and the measured
IRMPD spectrum of [(Orn‒H)PtCl2]‒ are compared in Figure 5.21. The NNs binding
structures represent the experimental peaks reasonably well. The peak at ~1650 cm -1
arises from the carboxyl stretch, whereas sidechain and backbone N‒H bending occur at
~1570 and ~1515 cm-1, respectively, and are red shifted versus the predicted band
positions, likely the result of anharmonicity of the complex ion. All select NO ‒ binding
conformers (see reference [172]) exhibit a carbonyl stretch at ~1650 cm -1 and no obvious
mismatch in the hydrogen-stretching region, such that none can be definitively ruled out
based on spectroscopic evidence even though their computed stabilities suggest that
they should not be present in measurable abundance. The NsO‒ binding structures,
however, can be easily eliminated by the red shifts of their carbonyl stretch. The intensity
of the broad bands at ~1570 and ~1515 cm-1 can only be contributed by the intense IR
features of the NNs binding structure, which indicates that the NNs structure exists in a
reasonably large population. Interestingly, conformer NNs_E is reproducing the band
feature ~1050 cm-1 very well, which is related to C‒N bond stretching for both backbone
and sidechain amino groups. The calculations indicate that conformer NNs_A is the
lowest in Gibbs free energy among the structures computed and is present in significant
abundance in a 298K Boltzmann distribution, and conformer NNs_E represents the
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experimental spectrum the best. Conformers NNs_C and NNs_E also exhibit better
alignment in the hydrogen-stretching region. Detailed peak assignments are listed in
Table 5.11.
5.6.2 Conformational Elucidation of [(Orn)PtCl2+Na]+
Various binding modes and sodium cation chelating positions of [(Orn)PtCl 2+Na]+
were investigated. Figure 5.22 compares the measured IRMPD spectrum and computed
IR spectra of four NNs_ClbCls binding conformers, which differ only slightly in the
orientations of the Orn side chain and carboxyl moiety. Conformer NNs_ClbCls_A adopts
the lowest relative energy structure and reproduces most of the band features with minor
shifts. Conformers NNs_ClbCls_B, NNs_ClbCls_C, and NNs_ClbCls_D are only slightly
higher in energy (by 1.8 to 4.2 kJ/mol) and show similar or even improved representation
of the experimental IR spectrum. Based on the similarities of these structures and the size
of the chelating ring, interconversion is likely facile at 298K. Among all other calculated
binding modes shown in Figure 5.13 and 5.14, only conformers with NNs_ClbCls binding
mode possesses a free C=O stretch consistent with the band at ~1760 cm -1 (see
reference [172]). Three major peaks with contributions from backbone and side-chain
NH2 wagging and C–O stretching nicely reproduce the broad feature around 1180 cm -1.
The predicted spectra of low-energy conformers with NO ‒_ClbClO, NsO_ClsClO, or
NsO‒_ClsClO binding mode (Figure 5.13) were also compared to the measured IR
spectrum and the results suggest that at least one significant misalignment of the strong
IR bands was observed for each conformer. Conformers NO‒_ClbClO_A and
NsO‒_ClsClO_A are also much less stable (by > 50 kJ/mol) than the lowest-energy
conformer NNs_ClbCls_A. Different sodium chelating positions were also investigated for
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NNs binding mode (Figure 5.14). None of the computed IR spectra of NNs binding
structures with other sodium chelating positions (OClbCls, OCls, OOCls, OO, and O)
reproduce the measured IRMPD spectrum well. These structures are also much less
stable, and thus would not be expected to be measurably populated in the experiments.
In summary, comparison between the measured IRMPD spectrum and computed IR
spectra of [(Orn)PtCl2+Na]+ clearly indicates the existence of the NNs_ClbCls binding
structures. Multiple NNs binding structures within 5 kJ/mol are likely contributing to the
experimental spectrum. Peak assignments listed in Table 5.12 are based on conformer
NNs_ClbCls_A.
5.6.3 Structural Comparison of [(Orn‒H)PtCl2]‒ and [(Orn)PtCl2+Na]+
Orn binds to Pt via NNs binding mode in both [(Orn‒H)PtCl2]‒ and [(Orn)PtCl2+Na]+.
The conformation of NNs binding conformers are relatively rigid, thus no significant
conformation difference is found between populated conformers in [(Orn‒H)PtCl 2]‒ and
[(Orn)PtCl2+Na]+. In comparison, conformer NNs_E of [(Orn‒H)PtCl2]‒ and conformer
NNs_ClbCls_A of [(Orn)PtCl2+Na]+ maintained the same carboxylate group position and
adopt a similar sidechain orientation. This is also the conformer that can reproduce the
spectrum the best. This conformation is likely to be reserved in solution. Conformer
NNs_C of [(Orn‒H)PtCl2]‒ and conformer NNs_ClbCls_B of [(Orn)PtCl2+Na]+ adopt
consistent structures and are managed to have low relatively Gibbs free energies.
However, the counterpart conformer for NNs_A of [(Orn‒H)PtCl2]‒ is conformer
NNs_ClbCls_L of [(Orn)PtCl2+Na]+ (Figure 5.13), however this conformer is less stable
than the lowest-energy conformer NNs_ClbCls_A by 12.4 kJ/mol. The discrimination in
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conformations is easy to be explained based on the electronegativity of the deprotonated
carboxylate group in [(Orn‒H)PtCl2]‒.
5.7

Comparisons between Glyplatin, Argplatin, Lysplatin and Ornplatin
Glycine binds to Pt via NO‒ binding mode, and arginine binds to Pt via NO‒ binding

mode as well. Lysine binds to Pt via both NNs and NO‒ binding modes, and ornithine only
binds to Pt via NNs binding mode. IRMPD spectroscopy data of Glyplatin, Argplatin,
Lysplatin, and Ornplatin are compared in Figure 5.1 and 5.2. The experimental IRMPD
spectra of [(Arg‒H)PtCl2]‒, [(Lys‒H)PtCl2]‒, [(Orn‒H)PtCl2]‒, and [(Gly‒H)PtCl2]‒ in the IR
fingerprint region are very parallel, especially the peak position of the C=O stretch. The IR
band of [(Arg‒H)PtCl2]‒ is quite asymmetric compared to that of all other three spectra.
According to the peak assignment in Table 5.7, the asymmetry is a result of the backbone
and sidechain C‒N stretches. C‒N and C‒N′ stretches provide the shoulder peaks near
1550 cm-1. The NNs binding mode of [(Arg‒H)PtCl2]‒ yields in changes on the position of
C‒N stretches. Thus, the NNs binding conformers for [(Arg‒H)PtCl2]‒ have been ruled out.
However, based on our previous interpretation, the predicted IR spectra of NN s and NO‒
conformers for [(Lys‒H)PtCl2]‒ are hard to distinguish as long as they have free carbonyl
stretch. This IR feature of [(Orn‒H)PtCl2]‒ is highly parallel to that of [(Lys‒H)PtCl2]‒. The
broader IR band in the range of 1255‒1400 cm-1 of [(Arg‒H)PtCl2]‒ is related to the extra
methylene groups along the side chain of arginine compared to glycine. The same
argument is also true for [(Lys‒H)PtCl2]‒ and [(Orn‒H)PtCl2]‒. The IR feature of
[(Gly‒H)PtCl2]‒ associated with backbone NH2 wagging is blue shifted in the case of
[(Arg‒H)PtCl2]‒, and the contribution of this IR feature to the overall IRMPD spectrum is
lower in [(Arg‒H)PtCl2]‒. This feature is also blue shifted in [(Lys‒H)PtCl2]‒ and
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[(Orn‒H)PtCl2]‒, but the relative intensity is higher than that of [(Arg‒H)PtCl 2]‒. A unique
IR feature ~800 cm-1 was observed only in [(Arg‒H)PtCl2]‒, and that is associated with the
NH2 wagging on the side chain and CH2 rocking, which are lack in the case of
[(Gly‒H)PtCl2]‒. A similar IR band was observed in [(Lys‒H)PtCl2]‒ and [(Orn‒H)PtCl2]‒,
but it is also blue shifted. The clearly separated backbone NH2 stretches in
[(Gly‒H)PtCl2]‒ becomes one large peak in [(Arg‒H)PtCl2]‒, which is the only IR feature in
the IR range of 3000‒3700 cm-1. In the deprotonated form of Argplatin, the carboxylate
group is deprotonated thus no O‒H stretch is available, and only N‒H stretches
contribute significantly to the peak intensity. With the flexible side chain of Arg, a variety of
hydrogen-bonding interactions are formed between the positively charged side chain and
the negatively charged moieties or the Pt metal center, which reduces the IR band
visibility. [(Lys‒H)PtCl2]‒ and [(Orn‒H)PtCl2]‒ do not have available O‒H stretch, and the
only N‒H stretches are also limited by binding to Pt center especially in the case of NN s
binding structures. Hence, it is understandable that data with good quality have not been
collected for [(Lys‒H)PtCl2]‒ and [(Orn‒H)PtCl2]‒.
The IRMPD spectra of [(Arg)PtCl2+Na]+, [(Lys)PtCl2+Na]+, and [(Orn)PtCl2+Na]+
exhibit notable differences in both the IR fingerprint and hydrogen-stretching regions
(Figure 5.2). [(Lys)PtCl2+Na]+ and [(Orn)PtCl2+Na]+ have parallel band positions, but the
relative intensities between different features are quite different. The dominant IR band
on the spectrum of [(Arg)PtCl2+Na]+ in IR fingerprint region is associated with the C=O,
C‒N stretches, and NH2 scissoring vibrational modes. The bands of C‒N stretches and
NH2 scissoring locate on the blue side, while the C=O stretch locates on the red side. The
asymmetric peak shape ~1650 cm-1 is the combination of the vibrational modes coming
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from the side chain and the backbone carboxylate group. On the other hand, NO ‒ binding
conformers of [(Lys)PtCl2+Na]+ only have intense C=O stretch that overlays with the red
side of the intense IR feature in [(Arg)PtCl2+Na]+. In [(Orn)PtCl2+Na]+, the peak is much
smaller and further red shifted, which is hard to tell where it comes from. NN s binding
conformers of [(Lys)PtCl2+Na]+ yields a distinguishable IR band at ~1750 cm-1. So does
the equivalent conformers of [(Orn)PtCl2+Na]+. The relative intensity of this feature
compared to other features in the same spectrum becomes more significant in
[(Orn)PtCl2+Na]+, suggesting the ratio of NNs conformers is at least higher than that in
[(Lys)PtCl2+Na]+. The lack of this feature in [(Arg)PtCl2+Na]+ support the lack of NNs
binding conformers in this species. In the hydrogen-stretching region, [(Lys)PtCl 2+Na]+
exhibits an intense IR feature at ~3550 cm-1, corresponding to O‒H stretch in NNs binding
conformers. Similar feature in [(Orn)PtCl2+Na]+ has also been assigned to O‒H stretch in
NNs binding conformers, and this feature is dominant enough that all other features in
[(Orn)PtCl2+Na]+ seems negligible. Although a similar IR feature was observed in the
spectrum of [(Arg)PtCl2+Na]+, this small feature is related to the N‒H asymmetric stretch
on the side chain of arginine, along with several other intense N‒H stretching features
(3450‒
3600 cm-1) that cannot be observed in [(Lys)PtCl2+Na]+ or [(Orn)PtCl2+Na]+.
5.8

Comparisons of Gas-Phase Conformers to Previous Experimental Results
In Chapter 1, I introduced previous studies indicating that Dap and Dab bind to Pt

via NN or NO modes under different reaction conditions, whereas Orn and Lys were only
observed to bind Pt via the NO mode due to the lack of a strong C=O stretch in the IR
fingerprint region [113]. While spectroscopic measurements made by our work were
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carried out in the gas phase via IRMPD action spectroscopy techniques, the IRMPD
spectrum measured for [(Arg‒H)PtCl2]‒, [(Lys‒H)PtCl2]‒, and [(Orn‒H)PtCl2]‒ parallels
that observed in the condensed-phase IR experiments (Figure 5.25‒5.27). If the amino
acid binds to Pt via NO‒ binding mode, we can elucidate its structure via IRMPD action
spectroscopy easily, like Glyplatin and Argplatin. However, if the proton affinity of the
carboxylate group is not high enough to be protonated in solution, it is hard to distinguish
NNs and NO‒ binding structures just based on the deprotonated species without detailed
calculations, such as Lysplatin and Ornplatin. Thus, the condensed-phase IR
experimental data are not strong enough to rule out the NNs binding conformers. It is also
worth pointing out that the NO‒ binding mode of (Dap)PtCl2 is stable under mild reaction
conditions, and that its crystal structure has been reported [114]. But previous studies
have shown that NNs binding mode is the most stable conformation of (Dap)PtCl2 [112].
Hence, the existence of a crystal structure with the NO‒ binding mode does not mean that
Dap prefers to bind to Pt via NO‒ binding mode. Orn and Lys were found to bind to Pt via
the NO‒ binding mode in crystal structures and condensed-phase IR experiments but no
NNs structures were reported [109,111,113,114]. Comparison of the experimental results
with theoretical predictions performed here suggest that the deprotonated form of Orn
and Lys bind to Pt via the NNs binding mode, which was neglected rather than ruled out in
previous work [109,111].
Another comparison that can be made is to diaminocarboxylate-linked palladium(II)
complexes. In the circular dichroism studies of these palladium(II) complexes, the results
suggested that Dap and Dab chelate to Pd(II) via NNs, Orn binding to Pd(II) yields a
mixture of NNs and NO binding complexes, and Lys forms NO binding structures
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[173,174]. NNs binding mode has also been reported for ornithine-linked palladium
complex, suggesting the existence of NNs binding Ornplatin is not quite surprising.
5.9

Intrinsic Pathways of Argplatin, Lysplatin and Ornplatin

5.9.1 Intrinsic Pathways of [(Arg‒H)PtCl2]– and [(Arg)PtCl2+Na]+
IRMPD

spectroscopy

results

suggest

that

both

[(Arg‒H)PtCl 2]‒

and

[(Arg)PtCl2+Na]+ adopt the NO‒ binding mode of Arg to the Pt metal center. Based on
previous studies of protonated and cationized arginine, the intrinsic fragmentation
pathways of [(Arg‒H)PtCl2]‒ and [(Arg)PtCl2+Na]+ have been proposed (Scheme 5.1 and
5.2) [175-181]. Major intrinsic pathways are highlighted. Most pathways observed in the
IRMPD experiments are parallel to the previous findings in the cases of protonated and
cationized arginine or 18-crown-6 capture arginine, except for the unique HCl loss in
Argplatin [175-178,180,182-185]. In particular, one and two HCl loss are both major
pathways in [(Arg‒H)PtCl2]‒ and [(Arg)PtCl2+Na]+, which involves proton transfer from
Arg to chlorido ligands. It is probably related to the mechanism for the reactivity of
cisplatin [105-107]. HCl loss has also been observed in previous Glyplatin work [164].
Loss of the guanidino group is one of the major pathways [(Arg‒H)PtCl 2]‒ as well as one
of the minor pathways in [(Arg)PtCl2+Na]+. This neutral loss is commonly observed in the
study of protonated and cationized arginine, and the formation of a 5-membered ring has
been proposed and examined [178-180]. Water loss and HN=C=NH loss were observed
as dominant fragments in [(Arg)PtCl2+Na]+ but not in [(Arg‒H)PtCl2]‒. The mechanism of
water loss involves tautomerization forming zwitterions, which is impossible in
[(Arg‒H)PtCl2]‒. Water loss is the most common fragmentation pathway that has been
seen in protonated arginine and several metal cationized arginine species with different
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kinds of tandem mass spectrometry [175,177,180,183,184]. Sequential HCl loss was
observed after water loss. However, no further HCl loss was observed after water and the
first HCl loss. The loss of HN=C=NH in combination of water loss was also observed
before for protonated arginine, giving a loss of 60 m/z [176]. Among all major pathways,
guanidino group loss is competing with HCl loss in [(Arg‒H)PtCl2]‒, while water loss is in
competition with HCl loss. Those are the intrinsic pathways that may also happen in the
solution phase to influence the dissociation of the chlorido ligands. The NH3 loss was
observed in both [(Arg‒H)PtCl2]‒ and [(Arg)PtCl2+Na]+, but it is always a sequential minor
pathway after one or two HCl loss. The NH3 loss has been seen in many protonated and
cationized studies, sometimes as the only fragment from arginine (when binding to Rb or
Cs) [175,177,180,183,184]. Isotopic labeling experiments suggest that NH 3 comes from
the guanidino side chain, and the mechanism has been proposed and supported by
theoretical calculations [176,177,180]. Due to the enhanced power provided by the free
electron laser, several interesting fragments have been observed in [(Arg‒H)PtCl 2]‒. CO2
loss was observed in [(Arg‒H)PtCl2]‒ as a sequential loss after HCl or guanidino group
loss. CO2 loss was also observed in the fragmentation of [(Gly‒H)PtCl2]‒ [164]. On the
other hand, CO loss is much more common in previous studies of arginine interacting with
metal or 18-crown-6, usually with combination of water loss [175,180,182]. CO 2 loss in
[(Arg‒H)PtCl2]‒ is probably due to the lack of transferable proton to initiate a water loss
from the free oxygen, while the other oxygen binds to the Pt metal center. H 2 loss, CO2H2
loss, and CH3CH=CH2 loss are sequential losses after HCl or guanidino group loss in the
experiment of [(Arg‒H)PtCl2]‒ with excessive laser power. These high energy intrinsic
pathways are less likely to happen in solution phase.

167
5.9.2 Intrinsic Pathways of [(Lys‒H)PtCl2]‒ and [(Lys)PtCl2+Na]+
In previous studies of protonated, alkali metal cationized, and 18-crown-6 chelated
lysine, NH3 loss was usually the major fragmentation pathway yielding in a protonated
pipecolic acid (contains a 6-membered ring); H2O loss was sometimes observed as a
minor fragmentation pathway [175,178,182,186-188]. The NH3 loss has been confirmed
coming from the sidechain amino group by

15N

labeling experiments [175,186]. CO2H2

loss was observed in the fragmentation of protonated lysine or more commonly seen as
sequential loss after losing NH3, and CO2H2 was proposed as a combined elimination of
CO and H2O to give an immonium ion [175,178,182,186,187]. The intrinsic fragmentation
pathways of [(Lys‒H)PtCl2]‒ (Scheme 5.3) and [(Lys)PtCl2+Na]+ (Scheme 5.4) were
proposed based on previous study of lysine and chemical intuition. The dominant
fragmentation pathway of [(Lys‒H)PtCl2]‒ is HCl loss, which is associated with the
mechanism of reactivity for cisplatin [105-107]. Same pathway has been seen in the
fragmentation of [(Gly‒H)PtCl2]‒ and [(Arg‒H)PtCl2]‒. It is also interesting to see the
entire Lys coming off the Pt metal center. All other fragments observed in the fingerprint
region are sequential loss after the first HCl loss, which is probably due to the substantial
power provided by the free electron laser. Minor NH3 loss is only observed in the
hydrogen-stretching region, and it may come from the NO– binding conformers that have
a free amino group. When Lysplatin reacts with DNA or RNA strands in solution, these
sequential pathways are less likely to occur. The photofragments of [(Lys)PtCl 2+Na]+
indicate a competition of HCl and NH3 loss. Sequential losses after HCl or NH3 loss were
also observed, especially the second HCl loss. In the case of [(Arg)PtCl2+Na]+, one and
two HCl loss were also observed. However, HCl loss is competing with H 2O loss instead
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of NH3. Direct NH3 loss was only observed in [(Lys)PtCl2+Na]+ but not in [(Lys‒H)PtCl2]‒.
Only one and two HCl loss and NH3 loss were observed in the experiment of
[(Lys)PtCl2+Na]+ in the IR hydrogen-stretching region, suggesting that excessive power
of the free electron laser yields many sequential fragments that are less likely to occur
when Lysplatin reacts with DNA or RNA in solution. Several H 2 loss pathways were
observed in the fragmentation of [(Lys‒H)PtCl2]‒ and [(Lys)PtCl2+Na]+, which is unique
compared to Glyplatin and other lysine complexes [175,178,182,186-188]. The H 2 loss
was also observed in [(Arg‒H)PtCl2]‒ as a minor fragmentation pathway, but it was not
observed in [(Arg)PtCl2+Na]+. The loss of H2 have been reported in the previous IRMPD
and tandem mass spectrometry studies of platinum with methane and other alkanes
[189-197].
5.9.3 Intrinsic Pathways of [(Orn‒H)PtCl2]‒ and [(Orn)PtCl2+Na]+
The intrinsic pathways of [(Orn‒H)PtCl2]‒ and [(Orn)PtCl2+Na]+ undergoing
photodissociation are proposed in Scheme 5.5 and 5.6. Ornplatin shares many pathways
with Lysplatin, and many fragmentation pathways have also been reported previously
[186,198]. The NH3 loss and HCl losses are the major pathways of [(Orn‒H)PtCl2]‒ in the
fingerprint region, and CO2 loss was also observed as an important pathway. HCl loss is
the only pathway observed in the hydrogen-stretching region. NH3 loss probably comes
from the side chain based on the previous studies of lysine [175,186]. The HCl loss is
associated with the mechanism of reactivity for cisplatin [105-107]. The CO 2 loss is not a
common fragmentation pathway for amino acids, and was only reported in amino
acid-linked platinum complexes that have been studied [164,170,171]. Direct water loss
was not observed in either forms of Ornplatin, which is different from that found for
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ornithine in peptides [199,200]. In peptides, the side chain of Orn is free, hence a
six-membered ring is proposed after a water loss (if Orn is the C-terminal residue). In
Ornplatin, Orn binds to Pt via NNs binding mode, which probably increase the energy
barrier to form this 6-membered ring. Orn comes off entirely in the case of [(Orn‒H)PtCl 2]‒
but not [(Orn)PtCl2+Na]+. The H2 loss was observed as sequential pathways with high
energy in [(Orn‒H)PtCl2]‒, which has also been observed previously with Lysplatin. It is
interesting that HCl loss was not directly observed in the photodissociation of
[(Orn)PtCl2+Na]+, and 2HCl loss was also a minor fragmentation pathway. This
phenomenon can be easily explained by that the tridentate structure formed after HCl is
not favored because the side chain of Orn is not long enough to fold back. When NH 3
dissociates first, Orn adopts a NO‒ binding conformation to bind to Pt, and the sidechain
length is no longer a barrier for further dissociation. Hence, HCl and 2HCl were observed
as important fragmentation pathways in combination with NH3 loss. Another explanation
is that the sodium cation may have stabilized the structures, making the loss of HCl
harder to observe. The second NH3 loss has only been found for Orn, and this pathway
was also previously observed for chemical ionized Orn [186]. It is also worth well to point
out that the second NH3 loss yields in a Pt=C bond, changing the oxidation state of Pt
from II to IV to satisfy the electron configuration. The water loss and CO loss were only
observed in [(Orn)PtCl2+Na]+ but not[(Orn‒H)PtCl2]‒, which may due to the excess proton
of the carboxylate group in sodium cationized Ornplatin. H2O and CO losses are
commonly found for the fragmentation of amino acids, even though they are not common
pathways for lysine [175,178].

170
Energy-resolved sustained off-resonance irradiation collision-induced dissociation
(ER-SORI-CID) experiments were further performed on parallel forms of cisplatin and
Ornplatin to compare the similarity of their intrinsic pathways in collision-induced
dissociation (CID). The comparison of energy-resolved intrinsic pathways of
deprotonated and sodium cationized cisplatin and Ornplatin are shown in Figure 5.23
and 5.24. Deprotonated cisplatin, [(NH3)(NH2)PtCl2]‒, only has three pathways, which are
NH3 loss, sequential loss of the second amino group, and NH3 loss in combination of HCl
loss (Figure 5.23). Only pathways with normalized intensity more than 1% were plotted
for [(Orn‒H)PtCl2]‒ in Figure 5.23. Further MS3 experiments have confirmed that many
low intensity fragments are sequential dissociation from the dominant losses of NH 3 and
HCl in [(Orn‒H)PtCl2]‒. The dominant pathways of [(Orn‒H)PtCl2]‒ are consistent with
those of [(Arg‒H)PtCl2]‒ and [(Lys‒H)PtCl2]‒. Many intrinsic pathways observed in
photodissociation of [(Orn‒H)PtCl2]‒ were observed in the ER-SORI-CID experiments.
Two new pathways are revealed, including the complete (Orn‒H) loss and
2HCl+(Orn‒CN‒3H) loss. The latter fragmentation corresponds to PtCN ‒ as the fragment
ion. These high energy pathways are less likely to be accessed when Ornplatin reacts
with nucleic acids in the solution phase. The ER-SORI-CID experiments of sodium
cationized cisplatin, [(NH3)PtCl2+Na]+, yields only NH3 loss as the fragmentation pathway,
which suggests that sodium cation stabilizes the chlorido ligands thus limits the loss of
HCl. NH3 loss and in combination of HCl or 2HCl losses were observed for
[(Orn)PtCl2+Na]+. The NH3 loss is the dominant pathway as observed in cisplatin. The
fragmentation pathways of [(Orn)PtCl2+Na]+ are also consistent with the results of
photodissociation. No higher energy pathways were observed in this experiment.
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5.10

Conclusions
IRMPD action spectra for deprotonated and sodium cationized Argplatin, Lysplatin,

and Ornplatin were acquired in the IR fingerprint and hydrogen-stretching regions.
Candidate structures for all possible Pt and Na binding modes were calculated at the
B3LYP/mDZP/def2-TZVP level of theory. The experimental and the predicted IR spectra
are compared and deconvoluted. Arginine binds to Pt via NO‒ binding mode. Lysine binds
to Pt via both NNs and NO‒ binding modes, and ornithine only binds to Pt via NNs binding
mode. The advantage of charge manipulation in the gas phase provides evidence of the
existence of the NNs binding conformers for Lysplatin and Ornplatin. The most stable
chelation mode of the sodium cation in all three platinum complexes is a bidentate
interaction with the chlorido ligands roughly in the plane of the Pt center. IRMPD action
spectroscopy is robust to detect the NO‒ binding mode of Glyplatin and Argplatin, and it
also detects the variation of binding modes of amino acid to Pt metal center in Lysplatin
and Ornplatin. When these amino acid-linked platinum complexes chelate with
nucleosides, Glyplatin may have the opportunity to bind multiple sites due to its small size,
and Argplatin may have the opportunity to form various hydrogen bonds with the
nucleobase or sugar moieties of the nucleosides. Lysplatin and Ornplatin are more likely
to benefit from the NNs binding conformers to exhibit outstanding reactivity as discovered
previously [108,109].
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Table 5.1 Fragment Ions and Neutral Losses Observed upon IRMPD of [(Arg–H)PtCl 2]– in
the Fingerprint and Hydrogen-Stretching Regions. a
Ionic Product
m/z (FEL) m/z (OPO)
Neutral Losses
C6H12N4O2ClPt
401.8
401.9
HCl
C6H9N3O2ClPt
384.8
HCl + NH3
C5H8NO2Cl2Pt
378.7
378.9
CN3H5
C6H11N4O2Pt
365.8
365.9
2HCl
C6H9N4O2Pt
363.8
2HCl + H2
C5H12N4ClPt
355.8
355.9
HCl + CO2H2
C6H8N3O2Pt
348.8
2HCl + NH3
C5H7NO2ClPt
342.7
342.9
HCl + CN3H5
C5H11N4Pt
319.8
2HCl + CO2
C5H9N4Pt
317.8
2HCl + CO2H2
C4H7NClPt
296.6
HCl + CO2 + N3H5
CHNClPt
256.5
HCl + CO2 + N3H5 + C3H6
a Precursor ions of m/z 437.8 in the fingerprint region (FEL) and m/z 437.9 in the
hydrogen-stretching region (OPO) were isolated and fragmented.

Table 5.2 Fragment Ions and Neutral Losses Observed upon IRMPD of [(Arg)PtCl 2+Na]+
in the Fingerprint and Hydrogen-Stretching Regions.a
Ionic Product
m/z (FEL) m/z (OPO)
Neutral Losses
C6H12N4OCl2PtNa
443.8
443.9
H2O
C6H13N4O2ClPtNa
425.9
426.0
HCl
C6H10N3O2ClPtNa
408.9
HCl + NH3
C6H11N4OClPtNa
407.9
407.9
H2O + HCl
C5H9NO2Cl2PtNa
402.8
CN3H5
C5H8NO2Cl2PtNa
401.8
401.9
H2O + HN=C=NH
C6H12N4O2PtNa
389.9
390.0
2HCl
C6H9N3O2PtNa
372.9
2HCl + NH3
a Precursor ions of m/z 461.8 in the fingerprint region (FEL) and m/z 461.9 in the
hydrogen-stretching region (OPO) were isolated and fragmented.
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Table 5.3 Fragment Ions and Neutral Losses Observed upon IRMPD of [(Lys–H)PtCl 2]– in
the Fingerprint Region.a
Ionic Product
m/z (FEL)
m/z (OPO)
Neutral Losses
C6H10NO2PtCl2
–
392.973
NH3
C6H12N2O2PtCl
373.8
374.024
HCl
C6H10N2O2PtCl
371.7
HCl + H2
C6H9NO2PtCl
356.7
HCl + NH3
C6H7NO2PtCl
354.8
HCl + H2 + NH3
C6H11N2O2Pt
337.8
2HCl
C6H9N2O2Pt
335.8
2HCl + H2
C5H12N2PtCl
329.8
HCl + CO2
C5H10N2PtCl
327.7
HCl + CO2 + H2
C5H8N2PtCl
325.7
HCl + CO2 + 2H2
C5H9NPtCl
312.7
HCl +NH3 + CO2
C5H7NPtCl
310.7
HCl + NH3 + CO2 + H2
C5H5NPtCl
308.7
HCl + NH3 + CO2 + 2H2
C5H9N2Pt
291.7
2HCl + CO2H2
HPtCl2
265.5
Lys‒2H
HCNPtCl
256.5
HCl + NH3 + CO2 + 2H2 + C4H4
H2PtCl
231.4
HCl+(Lys4H)
a Precursor ions of m/z 409.7 in the fingerprint region (FEL) and m/z 410.001 in the
hydrogen-stretching region (OPO) were isolated and fragmented.

Table 5.4 Fragment Ions and Neutral Losses Observed upon IRMPD of [(Lys)PtCl 2+Na]+
in the Fingerprint and Hydrogen-Stretching Regions.a
Ionic Product
m/z (FEL) m/z (OPO)
Neutral Losses
C6H11NO2PtCl2Na
416.8
416.9
NH3
C6H13N2O2PtClNa
397.8
397.9
HCl
C6H10NO2PtClNa
380.8
381.0
HCl + NH3
C6H12N2O2PtNa
361.9
362.0
2HCl
C6H10N2O2PtNa
359.9
2HCl + H2
C6H8N2O2PtNa
357.8
2HCl + 2H2
C6H9NO2PtNa
344.8
345.0
2HCl + NH3
C5H10N2PtNa
315.8
2HCl + CO2H2
a Precursor ions of m/z 433.8 in the fingerprint region (FEL) and m/z 433.9 in the
hydrogen-stretching region (OPO) were isolated and fragmented.
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Table 5.5 Fragment Ions and Neutral Losses Observed upon IRMPD of [(Orn–H)PtCl2]–
in the Fingerprint Region.a
Ionic Product
m/z (FEL)
m/z (OPO)
Neutral Losses
C5H8NO2PtCl2
379.9
378.957
NH3
C5H10N2O2PtCl
361.0/359.0
HCl
C5H8N2O2PtCl
359.0/357.0
HCl + H2
C5H7NO2PtCl
344.0/342.0
HCl + NH3
C4H10N2PtCl
317.0/315.0
HCl + CO2
C4H8N2PtCl
315.0/313.0
HCl + CO2 + H2
C4H6N2PtCl
313.0/311.0
HCl + CO2 + 2H2
C4H7NPtCl
300.0/297.9
HCl + CO2 + NH3
C4H5NPtCl
297.9/295.9
HCl + CO2 + NH3 + H2
C4H9N2Pt
281.0b/279.0
2HCl + CO2
C4H7N2Pt
279.0/277.0
2HCl + CO2 + H2
C4H5N2Pt
277.0/274.9
2HCl + CO2 + 2H2
HPtCl2
266.9
Orn‒2H
HCNPtCl
257.9/255.9
HCl + CO2 + NH3 + 2H2 + C3H6
H2PtCl
232.8/230.8
HCl + (Orn4H)
a To achieve maximum intensity during experiments, the most intense peak of the isotopic
envelope (m/z 397.0) was mass isolated in the fingerprint region (FEL), which includes a
combination of 194Pt35Cl and 196Pt37Cl isotopic distribution. Hence, multiple isotopic peaks
were observed for fragments that involve HCl loss. Precursor ions of m/z 395.985 in the
hydrogen-stretching region (OPO) were isolated and fragmented.
b m/z 281.0 was not included in the calculation of IRMPD yield due to its low abundance.

Table 5.6 Fragment Ions and Neutral Losses Observed upon IRMPD of [(Orn)PtCl 2+Na]+
in the Fingerprint and Hydrogen-Stretching Regions.a
Ionic Product
m/z (FEL)a
m/z (OPO)
Neutral Losses
C5H9NO2PtCl2Na
404.0
402.9
NH3
C5H7NOPtCl2Na
386.0
384.9
NH3 + H2O
C5H8NO2PtClNa
368.0/366.0 366.9
NH3 + HCl
C4H7NPtCl2Na
358.0
NH3 + H2O + CO
C5H5O2PtClNa
351.0/349.1 349.9
2NH3 + HCl
C5H11N2O2PtNa
347.1/345.1
2HCl
C4H8NOPtClNa
340.1/338.0
HCl + NH3 + CO
C5H8NO2PtNa
332.0/330.1 330.9
NH3 + 2HCl
C4H8NPtClNa
324.1/322.1 322.9
NH3 + HCl + CO2
a To achieve maximum intensity during experiments, the most intense peak of the isotopic
envelope (m/z 421.0) was mass isolated in the fingerprint region (FEL), which includes a
combination of 194Pt35Cl and 196Pt37Cl isotopic distribution. Hence, multiple isotopic peaks
were observed for fragments that involve HCl loss. In the hydrogen-stretching region
(OPO), precursor ions of m/z 422.0 were isolated and fragmented.

175
Table 5.7 Vibrational Band Assignments for [(Arg‒H)PtCl2]‒.a,b
Experimental Band (cm-1)
Vibrational Mode
771
N′H2/NsH wagging
839
CH2 rocking
1072 ̶ 1132
NH2 wagging/ guanidino group rocking
1255 ̶ 1400
CH2 twisting/CH2 wagging/C‒O– stretch
1436
CH2 scissoring
1526
C‒N stretch
1569
C‒N stretch
1597
C‒N′ stretch
1672
C‒Ns stretch/C=O stretch
3356
NH2 asymmetric stretch
3381
NH stretch
3446
NH2 asymmetric stretch
a Vibrational assignments are based on conformer NO‒_A. Scaling factors of 0.970 and
0.957 were used in the fingerprint (FEL) and hydrogen-stretching (OPO) regions,
respectively.
b Please see Section 1.2.3 and Figure 1.4 for nomenclature.

Table 5.8 Vibrational Band Assignments for [(Arg)PtCl2+Na]+.a,b
Experimental Band (cm-1)
Vibrational Mode
1108
NH2 wagging
1276
CH2 twisting
1320 ̶ 1380
CH2 wagging/C‒C stretch
1435
CH2 scissoring
1560 ̶ 1718
NH2 scissoring/C‒N stretch/C=O stretch
3300
NH2 symmetric stretch
3352
NH2 asymmetric stretch
3412
N′H2 symmetric stretch
3464
N′′H2 symmetric stretch
3516
N′H2 asymmetric stretch
3560
N′H2 asymmetric stretch
a Vibrational assignments are based on conformer NO‒_Cl Cl _A. Scaling factors of
b s
0.970 and 0.960 were used in the fingerprint (FEL) and hydrogen-stretching (OPO)
regions, respectively.
b Please see Section 1.2.3 and Figure 1.4 for nomenclature.
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Table 5.9 Vibrational Band Assignments for [(Lys‒H)PtCl2]‒.a,b
Experimental Band (cm-1)
NNs_E
NO‒_A
1046
‒
NH2 wagging
1157
NH2 wagging
‒
1242–1383
C‒H wagging/twisting
C‒H wagging/twisting
1581
NsH2 scissoring
NH2 scissoring
1608
NH2 scissoring
NsH2 scissoring
1675
C=O stretch
C=O stretch
CH2 symmetric stretching
CH2 symmetric stretching
2862
CH2 asymmetric stretching CH2 asymmetric stretching
2934
3354
NsH2 asymmetric stretching NsH2 asymmetric stretching
a Vibrational assignments are based on conformers NN _E and NO‒_A. A scaling factor
s
of 0.970 and 0.957 were used in the fingerprint (FEL) and hydrogen-stretching (OPO)
regions, respectively.
b Please see Section 1.2.3 and Figure 1.4 for nomenclature.
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Table 5.10 Vibrational Band Assignments for [(Lys)PtCl2+Na]+.a,b
Experimental Band (cm-1)
NNs_ClbCls_A
NO‒_ClbClO_A
1113
‒
NH2/NsH2 wagging/twisting
1134
CH2 twisting/C‒O(H) stretch
‒
1200
NH2/NsH2 wagging/twisting
‒
1382
CH2 wagging
CH2 wagging
1436
CH2 scissoring
CH2 scissoring
1500
‒
NsH2 scissoringd
1515
‒
NsH2 scissoring
1579
NH2/NsH2 scissoring
C=O stretch
1612
‒
NH2/NsH2 scissoring
1709
‒
C=O stretche
1727
C=O stretchc
‒
1761
C=O stretch
‒
3296
NH2/NsH2 symmetric stretch
NH2/NsH2 symmetric stretch
3324
‒
NsH2 asymmetric stretchc
3344
NH2/NsH2 asymmetric stretch
‒
3360
‒
NH2/NsH2 asymmetric stretch
3564
O‒H stretch
‒
a Vibrational assignments are mainly based on conformers NN _Cl Cl _A and
s
b s
NO‒_ClbClO_A. Scaling factors of 0.970 and 0.960 were used in the fingerprint (FEL) and
hydrogen-stretching (OPO) regions, respectively.
b Please see Section 1.2.3 and Figure 1.4 for nomenclature.
c Assigned based on NN _Cl Cl _B conformer.
s
b s
d Assigned based on NO‒_Cl Cl _G conformer.
b O
e Assigned based on NO‒_Cl Cl _X conformer.
b O
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Table 5.11 Vibrational Band Assignments for [(Orn‒H)PtCl2]‒.a,b
Assigned Experimental Band (cm-1)
Assigned Vibrational Mode
834
CH2 rocking/NH2 rocking
1039
NH2 wagging/C–C stretching
1129
NH2 wagging/CH2 wagging
1310
CH2 twisting/CO2 stretching
1430
CβH2 bending
1520
NH2 bending
1598
NsH2 bending
1655
C=O stretching
2870
CH2 symmetric stretching
2937
CH2 asymmetric stretching
3290
NsH2 symmetric/NH2 asymmetric stretching
3349
NsH2 asymmetric stretching
a Vibrational assignments are based on conformer NN _E. A scaling factor of 0.970 and
s
0.957 were used in the fingerprint region (FEL) and hydrogen-stretching (OPO) regions,
respectively.
b Please see Section 1.2.3 and Figure 1.4 for nomenclature.

Table 5.12 Vibrational Band Assignments for [(Orn)PtCl2+Na]+.a,b
Assigned Experimental Band (cm-1)
Assigned Vibrational Mode
1068
C–C stretching/C–N stretching
1131
C–O stretching/NH2 wagging
1184
NH2 wagging
1315
NH2 twisting
1400
NH2 twisting/CH2 wagging
1470
CH2 bending
1585
NH2 bending
1765
C=O stretching
3270
NsH2 symmetric stretch
3290
NH2 symmetric stretch
3320
NsH2 asymmetric stretch
3360
NH2 asymmetric stretch
3560
O‒H stretch
a Vibrational assignments are mainly based on conformers NN _Cl Cl _A. Scaling
s
b s
factors of 0.970 and 0.960 were used in the fingerprint (FEL) and hydrogen-stretching
(OPO) regions, respectively.
b Please see Section 1.2.3 and Figure 1.4 for nomenclature.
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Figure 5.1 Comparison between the experimental IRMPD spectra of the
deprotonated forms of Glyplatin, Argplatin, Lysplatin, and Ornplatin.
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Figure 5.2 Comparison between the experimental IRMPD spectra of the sodium
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Figure 5.3 Select stable NNs and NO binding conformers of [(ArgH)PtCl2] and
their relative Gibbs energies at 298 K calculated at the B3LYP/mDZP/def2-TZVP
level of theory.
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Figure 5.4 Select stable NsO, NN, NN, NO, NO, and OO binding conformers
of [(ArgH)PtCl2] and their relative Gibbs energies at 298 K calculated at the
B3LYP/mDZP/def2-TZVP level of theory.

183

NNs_ClbCls_A
0.0 kJ/mol

NNs_ClbCls_E
7.2 kJ/mol

NO‒_ClbClO_A
1.8 kJ/mol

NO‒_ClbClO_B
2.8 kJ/mol

NO‒_ClbClO_C
7.7 kJ/mol

NO‒_ClbClO_D
7.8 kJ/mol

NO‒_ClbClO_F
11.1 kJ/mol

NO‒_ClbClO_H
12.1 kJ/mol

NO‒_ClbClO_V
25.4 kJ/mol

NO‒_ClbClO_W
25.8 kJ/mol

NO‒_ClbClO_Y
30.7 kJ/mol

NO‒_ClbClO_AF
60.7 kJ/mol

[(Arg)PtCl2+Na]+
Figure 5.5 Select stable NNs_ClbCls and NO_ClbClO binding conformers of
[(Arg)PtCl2+Na]+ and their relative Gibbs energies at 298 K calculated at the
B3LYP/mDZP/def2-TZVP level of theory.
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Figure 5.6 Select stable conformers of [(Arg)PtCl2+Na]+ exhibiting other modes of
binding and their relative Gibbs energies at 298 K calculated at the
B3LYP/mDZP/def2-TZVP level of theory.
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Figure 5.7 Select stable NNs and NO binding conformers of [(Lys‒H)PtCl2] and
their relative Gibbs energies in the gas phase (black) and in a polarizable continuum
corresponding to water (red) at 298 K calculated at the B3LYP/mDZP/def2-TZVP
level of theory. No stable conformer was found for NO‒_AX in water.
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Figure 5.8 Select stable NsO‒ and OO binding conformers of [(Lys‒H)PtCl2] and
their relative Gibbs energies in the gas phase (black) and in a polarizable continuum
corresponding to water (red) at 298 K calculated at the B3LYP/mDZP/def2-TZVP
level of theory.
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Figure 5.9 Select stable NNs_ClbCls and NO_ClbClO binding conformers of
[(Lys)PtCl2+Na]+ and their relative Gibbs energies in the gas phase (black) and in a
polarizable continuum corresponding to water (red) at 298 K calculated at the
B3LYP/mDZP/def2-TZVP level of theory.
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Figure 5.10 Select stable NsO_ClsClO and NsO_ClsClO binding conformers of
[(Lys)PtCl2+Na]+ and their relative Gibbs energies in the gas phase (black) and in a
polarizable continuum corresponding to water (red) at 298 K calculated at the
B3LYP/mDZP/def2-TZVP level of theory.
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Figure 5.11 Select stable conformers of [(Lys)PtCl2+Na]+ exhibiting other modes of
binding and their relative Gibbs energies in the gas phase (black) and in a polarizable
continuum corresponding to water (red) at 298 K calculated at the
B3LYP/mDZP/def2-TZVP level of theory.
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Figure 5.12 Select stable conformers of [(OrnH)PtCl2] and their relative Gibbs
energies at 298 K calculated at the B3LYP/mDZP/def2-TZVP level of theory.
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Figure 5.13 Select stable NNs_ClbCls, NO‒_ClbClO, NsO‒_ClsClO, and NsO_ClsClO
conformers of [(Orn)PtCl2+Na]+ and their relative Gibbs energies at 298 K calculated
at the B3LYP/mDZP/def2-TZVP level of theory.
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Figure 5.14 Select stable conformers of [(Orn)PtCl2+Na]+ exhibiting other modes of
binding and their relative Gibbs energies at 298 K calculated at the
B3LYP/mDZP/def2-TZVP level of theory.
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Figure 5.15 Comparison of the experimental IRMPD spectrum of [(Arg‒H)PtCl2]‒ with
predicted IR spectra for conformers populated along with their optimized structures
and relative 298 K Gibbs energies computed at B3LYP/mDZP/def2-TZVP level of
theory. Strong hydrogen-bonding interactions are highlighted in green.
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Figure 5.16 Comparison of the experimental IRMPD spectrum of [(Arg)PtCl2+Na]+
with predicted IR spectra for conformers populated along with their optimized
structures and relative 298 K Gibbs energies computed at B3LYP/mDZP/def2-TZVP
level of theory. Strong hydrogen-bonding interactions are highlighted in green.
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Figure 5.17 Comparison of the experimental IRMPD spectrum of [(Lys‒H)PtCl2]‒ with
predicted IR spectra for conformers populated along with their optimized structures
and relative 298 K Gibbs energies (black) and in a polarizable continuum
corresponding to water (red) computed at B3LYP/mDZP/def2-TZVP level of theory.
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Figure 5.18 Comparison of the experimental IRMPD spectrum of [(Lys)PtCl2+Na]+
with predicted IR spectra for select NNs_ClbCls conformers along with their optimized
structures and relative 298 K Gibbs energies (black) and in a polarizable continuum
corresponding to water (red) computed at B3LYP/mDZP/def2-TZVP level of theory.
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Figure 5.19 Comparison of the experimental IRMPD spectrum of [(Lys)PtCl2+Na]+
with predicted IR spectra for select NO‒_ClbClO conformers along with their optimized
structures and relative 298 K Gibbs energies (black) and in a polarizable continuum
corresponding to water (red) computed at B3LYP/mDZP/def2-TZVP level of theory.
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Figure 5.20 Comparison of the experimental IRMPD spectrum of [(Lys‒H)PtCl2]‒ with
summed theoretical IR spectra predicted for NNs_E and NO‒_A conformers (top) and
comparison of the experimental IRMPD spectrum of [(Lys)PtCl2+Na]+ with summed
theoretical IR spectra predicted for NNs_ClbCls_A and NO–_ClbClO_A conformers
(bottom). The IR spectrum predicted for NO–_ClbClO_G conformer is further added to
the summed spectrum NNs_ClbCls_A and NO–_ClbClO_A conformers to achieve a
better reproduction of the experimental spectrum of [(Lys)PtCl2+Na]+.
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Figure 5.21 Comparison of the experimental IRMPD spectrum of [(Orn‒H)PtCl2]‒
with predicted IR spectra for conformers populated along with their optimized
structures and relative 298 K Gibbs energies computed at B3LYP/mDZP/def2-TZVP
level of theory.
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Figure 5.22 Comparison of the experimental IRMPD spectrum of [(Orn)PtCl2+Na]+
with predicted IR spectra for conformers populated along with their optimized
structures and relative 298 K Gibbs energies computed at B3LYP/mDZP/def2-TZVP
level of theory.
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Figure 5.23 Comparison of the ER-SORI-CID results for [(NH3)(NH2)PtCl2] and
[(OrnH)PtCl2] Fragmentation pathways observed in the experiment were plotted
against the excitation power, and the corresponding neutral losses are indicated.
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[(Orn)PtCl2+Na] Fragmentation pathways observed in the experiment were plotted
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Figure 5.25 Comparison of the solid-phase IR spectrum of Argplatin and the IRMPD
spectrum of deprotonated Argplatin, [(Arg‒H)PtCl2]‒, and parallel results have been
found in these two spectra. Similar IR features have been aligned by dotted lines for
visual comparison.
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Figure 5.26 Comparison of the solid-phase IR spectrum of Lysplatin and the IRMPD
spectrum of deprotonated Lysplatin, [(Lys‒H)PtCl2]‒, and parallel results have been
found in these two spectra. Similar IR features have been aligned by dotted lines for
visual comparison.
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Figure 5.27 Comparison of the solid-phase IR spectrum of Ornplatin and the IRMPD
spectrum of deprotonated Ornplatin, [(Orn‒H)PtCl2]‒, and parallel results have been
found in these two spectra. Similar IR features have been aligned by dotted lines for
visual comparison.
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CHAPTER 6 CONCLUSIONS AND FUTURE WORK
6.1

Conclusions for 2-O-Methylated Nucleosides
In this dissertation work, the influence of 2′-O-methylation on the ribose has been

characterized and compared to canonical DNA and RNA nucleosides. Infrared multiple
photon dissociation (IRMPD) action spectroscopy was applied to obtain the structural
information for five 2′-O-methylated nucleosides. Theoretical calculations were employed
to facilitate structural determination from the IRMPD experiments. Energy-resolved
collision-induced dissociation (ER-CID) experiments were performed to characterize the
fragmentation behavior of these 2′-O-methylated nucleosides as well as the canonical
DNA and RNA nucleosides to elucidate their relative glycosidic bond stability.
In Chapter 3, five protonated 2′-O-methylated nucleosides, including protonated
2′-O-methyladenosine, [Adom+H]+, protonated 2′-O-methylguanosine, [Guom+H]+,
protonated 2′-O-methylcytodine, [Cydm+H]+, protonated 2′-O-methyluridine, [Urdm+H]+,
and protonated 5,2′-O-dimethyluridine, [Thdm+H]+, were investigated experimentally by
IRMPD action spectroscopy and theoretically via electronic structure calculations. The
calculations find that the stable low-energy conformations of the protonated
2′-O-methylated nucleosides are highly parallel to those found for the protonated forms of
the canonical nucleosides. The preferred site of protonation (N3 for Adom and N7 for
Guom), nucleobase orientation (syn for [Adom+H]+ and anti for [Guom+H]+), and sugar
puckering (C2′-endo for [Adom+H]+ and C3′-endo for [Guom+H]+), are preserved among
the DNA, RNA and 2′-O-methylated variants of the protonated purine nucleosides.
[Cydm+H]+ adopts anti, C3′-endo (3T2) for N3 protonation or anti, C2′-endo (2T3) for O2
protonation conformers. Minor contribution may come from an anti, C2′-endo (2T3)

213
conformer. The major conformers populated in the experiment of [Urdm+H]+ are O4
protonated, anti, C3′-endo (3T2) conformer, 2,4-dihydroxy tautomerized anti, C2′-endo
(2T3) and syn, C2′-endo (2T1) conformers. For [Thdm+H]+, O2 protonated, syn, C2′-endo
(2T1) conformer, 2,4-dihydroxy tautomerized syn, C2′-endo (2T1) and anti, C2′-endo (2T3)
conformers contribute to the experimental spectrum. The conformations found for
protonated 2′-O-methylated pyrimidine nucleosides are slightly different from those found
for protonated canonical pyrimidine nucleosides.
ER-CID experiments were employed on 2′-O-methylated and canonical DNA and
RNA nucleosides. According to previous and current studies of our group, RNA
nucleosides stabilize the glycosidic bond compared to DNA nucleosides, and
2′-O-methylation further strengthen the glycosidic bond slightly except for [Guom+H] +.
The glycosidic bond stabilities of all protonated nucleosides follow the order: [dNuo+H] + <
[Nuo+H]+ < [Nuom+H]+ except for guanine nucleosides.
6.2

Conclusions for Amino Acid-Linked Platinum Complexes
In this dissertation, experimental and theoretical studies were performed on four

different amino acid-linked platinum complexes to elucidate the binding mode of amino
acid to the Pt metal center. Many hybrid approaches of density functional theory (DFT)
have been examined to evaluate their performance of predicting the IRMPD spectra of
Glyplatin. Theoretical work for Glyplatin reduces the possibility of misinterpretation from
the IRMPD experiments, especially from different binding mode of the amino acid to the
Pt metal center. With the guidance from Glyplatin work, further structural determination of
Argplatin, Lysplatin, and Ornplatin were performed. An interesting binding mode trend
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was observed from Gly and Arg bind to Pt via NO‒ binding mode, to Lys binds to Pt via
both NO‒ and NNs binding mode, to Orn binds to Pt only via NNs binding mode.
In Chapter 3, the structure of deprotonated Glyplatin, [(Gly‒H)PtCl 2]‒, has been
determined

via

IRMPD

action

spectroscopy

and

theoretical

calculations

at

B3LYP/def2-TZVPPD level of theory. Glycine has been confirmed to bind Pt via
backbone NO‒ binding mode, and small band shifts between the predicted and
experimental IR spectra were observed. Further calculations involving different DFT
methods, Pt treatments, and various basis sets for non-metal atoms suggest balanced
basis sets for platinum and the non-metal atoms of Glyplatin provide the most reasonable
results. The B3LYP/mDZP/def2-TZVP approach provides a robust description of the
vibrational spectrum of Glyplatin, and this hybrid approach has been applied to other
amino acid-linked platinum complexes in Chapter 5. If large platinum-biomolecular
complexes are of interest, for instance, the adducts of platinum complexes with
nucleosides or even mononucleotides. In such cases, use of the 6-31G(d) basis set for
the treatment of non-metal atoms is recommended due to its ability to produce relatively
good results at a low computational cost to achieve comprehensive searching for stable
structures. If the fingerprint region spectrum is more congested such as expected for
more complex amino acid-linked cisplatin derivatives, the 6-31+G(d,p) basis set is
recommended. It is important to note that this approach is chosen based on the accurate
prediction of geometric information for Glyplatin and may not represent the best choice for
energetic predictions.
Based on the results in Chapter 4, Chapter 5 further discussed IRMPD action
spectra for deprotonated and sodium cationized Argplatin, Lysplatin, and Ornplatin
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acquired in the IR fingerprint and hydrogen-stretching regions. Candidate structures for
all possible Pt and Na binding modes were calculated at the B3LYP/mDZP/def2-TZVP
level of theory. The experimental and the predicted IR spectra are compared and
deconvoluted. Arginine binds to Pt via NO‒ binding mode. Lysine binds to Pt via both NNs
and NO‒ binding modes, and ornithine only binds to Pt via NNs binding mode. The
advantage of charge manipulation in the gas phase provides us undiscoverable NNs
binding mode of Lysplatin and Ornplatin. The most stable chelation mode of sodium
cation in all three platinum complexes is bidentate interaction with the chlorido ligands
roughly in the plane of the Pt center. IRMPD action spectroscopy is robust to detect the
NO‒ binding mode of Glyplatin and Argplatin, and it also detects the variation of binding
modes of amino acid to Pt metal center in Lysplatin and Ornplatin.
6.3

Future Work
This thesis aims to examine the influence of 2′-O-methylation on the ribose

structurally via infrared multiple photon dissociation (IRMPD) action spectroscopy,
theoretically via electronic structure calculations, and energetically via energy-resolved
collision-induced dissociation (ER-CID) experiments. This research could be expanded
upon in at least two different ways, which are discussed below:
1) The glycosidic bond stabilities of all protonated nucleosides follow the order:
[dNuo+H]+ < [Nuo+H]+ < [Nuom+H]+ except for guanine nucleosides. However, only the
stability trend of guanine nucleosides is consistent with the trend of the glycosidic bond
length computed. With the conformations determined in this thesis, further transition state
calculations and accurate thermochemical measurements are needed to reveal the
mechanistic and energetic effects of 2′-O-methylation on protonated nucleosides.
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2) Studies of other modifications besides 2′-O-methylated nucleosides are also
worth investigating. Various sugar modifications, such as 2′-halogenated nucleosides, as
well as nucleobase methylation should be investigated via the same techniques to better
understanding the effects of the modifications on structures and glycosidic bond
stabilities. Structural determination is the basic step for further interpretation of the
stability, and IRMPD action spectroscopy is a powerful technique to elucidate the gas
phase structures of protonated nucleosides, especially the subtle changes of
hydrogen-bonding interactions between different modifications.
For the amino acid-linked platinum complexes work, the structural determinations
of Glyplatin, Argplatin, Lysplatin, and Ornplatin are based on interpretation of the IRMPD
action spectroscopy and theoretical calculations. The foundations for the amino
acid-linked platinum complexes have been set up. Further work can be expanded upon in
a variety of ways. Several potential projects are described below:
1) In Chapter 1, I mentioned that the study of Lysplatin with HeLa cells indicated
that it suffers from low uptake by cells, which may relate to inefficient penetration
[109,118]. It is now easily explained that Lys also binds to Pt via NN s binding mode. Other
studies also suggest that and the ethyl ester derivatives of (Dap)PtCl 2 and (Dab)PtCl2,
(Dap‒H+Et)PtCl2 and (Dab‒H+Et)PtCl2 exhibited higher antitumor activity than the parent
complexes, (Dap)PtCl2 and (Dab)PtCl2 [115]. (Dap)PtCl2 and (Dab)PtCl2 should both
adopt NNs binding mode according to the reactions conditions found previously [112-114].
The increased antitumor activity of these ester derivatives was explained based on the
negative charge on [(Dap‒H)PtCl2]‒ and [(Dab‒H)PtCl2]‒ could inhibit their penetration of
cell membranes relative to that of the ethyl esters. The study also suggests that
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(Dab‒H+Et)PtCl2 has a better antitumor performance than (Dap‒H+Et)PtCl2, and the only
difference of these two complexes is Dab is one methylene group longer than Dap. As
ligands, Orn and Lys have even longer side chains than Dap and Dab. If we derivatize
Ornplatin or Lysplatin with ethyl ester or other functional groups to prevent the negative
charge formed in solution, the antitumor activity of these complexes may be improved.
However, Lysplatin is a mixture of NNs and NO‒ binding conformers. If the mechanism of
the antitumor reactivity is only related to NNs binding structures, derivatized Lysplatin is
not necessary to have a better reactivity than Ornplatin even the side chain of Lys is
longer than Orn.
2) As mentioned in the first potential project, the mechanism behind the antitumor
reactivity of the platinum complexes is unclear. If the outstanding performance of
Lysplatin in amino acid screening experiment is related to its NNs binding conformation,
investigations of other amino acid-linked platinum complexes is less meaningful. On the
other hand, if the mechanism behind the reactivity also involves NO ‒ binding conformers,
Glyplatin and Argplatin, as well as several other amino acid-linked platinum complexes all
have potentials of antitumor reactivity. To further reveal the mechanism of the reactivity of
platinum complexes, structural studies of the adducts of platinum complexes with
nucleosides (particularly adenosine and guanosine) are needed. Structural and energetic
information of these adducts will provide a better view of further modifications of amino
acid-linked platinum complexes.
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ABSTRACT
CHARACTERIZATION OF PROTONATED MODIFIED NUCLEOSIDES AND AMINO
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The chemical difference between DNA and RNA nucleosides is their 2′-hydrogen
versus 2′-hydroxyl substituents. The 2′-O-methylation is common among natural
posttranscriptional modifications of RNA. The structures and relative glycosidic bond
stabilities

of

the

2′-O-methyladenosine

protonated

forms

of

the

2′-O-methylated

nucleosides,

(Adom), 2′-O-methylguanosine (Guom), 2′-O-methycytidine

(Cydm), 2′-O-methyluridine (Urdm), and 5,2′-O-dimethyluridine (Thdm) are examined
using two complementary tandem mass spectrometry approaches, infrared multiple
photon dissociation (IRMPD) action spectroscopy and energy-resolved collision-induced
dissociation (ER-CID). Theoretical calculations are also performed to predict the
structures and relative stabilities of stable low-energy conformations of the protonated
forms of the 2′-O-methylated nucleosides and their infrared spectra in the gas phase.
Low-energy conformations of protonated 2′-O-methylated nucleosides highly
parallel to those found for the protonated forms of the canonical DNA and RNA
nucleosides. Importantly, the preferred site of protonation, nucleobase orientation, and
sugar puckering are preserved among the DNA, RNA and 2′-O-methylated variants of the
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protonated nucleosides. The 2′-substituent does however influence hydrogen-bond
stabilization as the 2′-O-methyl and 2′-hydroxyl substituents enable a hydrogen-bonding
interaction between the 2′- and 3′-substituents, whereas a 2′-hydrogen atom does not.
Furthermore,

2′-O-methylation

reduces

the

number

of

stable

low-energy

hydrogen-bonded conformations possible, and importantly inverts the preferred polarity
of this interaction versus that of the RNA analogues. Trends in the CID50% values
extracted from survival yield analyses of the 2′-O-methylated and canonical DNA and
RNA forms of the protonated nucleosides are employed to elucidate their relative
glycosidic bond stabilities. Overall, the glycosidic bond stabilities of all protonated
nucleosides follow the order: [dNuo+H]+ < [Nuo+H]+ < [Nuom+H]+, except for guanine
nucleosides.
Cisplatin is one of the most successful metal-based anticancer agents. This
compound is also used to target RNA for exploration of new binding sites for future drugs.
Seeking to discover alternative reactivity, amino acid-linked platinum complexes are
being investigated and used as potential anticancer drug and for targeting and probing
RNA. To gain a better understanding of the binding mechanism and assist in the
optimization of chemical probing and drug design applications, experimental and
theoretical studies of a series of amino acid-linked platinum complexes are being pursued.
Glyplatin (glycine-linked cisplatin analogue) is examined first for its structural simplicity
and to enable backbone effects to be separated from sidechain effects on the structure
and reactivity. Infrared multiple photon dissociation (IRMPD) action spectroscopy
experiments are performed on Glyplatin to characterize its structure and guide the
selection of the most effective hybrid theoretical approach for determining its structure
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and IR spectrum. The simplicity of the Glyplatin system allows a wide variety of density
functionals, treatments of the Pt center including the use of all-electron basis sets vs
valence basis sets combined with an effective core potential (ECP), and basis sets for all
other atoms to be evaluated at a reasonable computational cost. Present results suggest
that the B3LYP/mDZP/def2-TZVP hybrid method can be effectively employed for
structural and IR characterization of more complex amino acid-linked cisplatin complexes
and their nucleic acid derivatives.
Based on theoretical guidance obtained from the Glyplatin work, deprotonated and
sodium cationized arginine-, lysine-, and ornithine- linked cisplatin complexes are
investigated both experimentally and theoretically. Quasimolecular forms of platinum
complexes

examined

are

[(ArgH)PtCl2],

[(Arg)PtCl2+Na]+,

[(LysH)PtCl2],

[(Lys)PtCl2+Na]+, [(OrnH)PtCl2], [(Orn)PtCl2+Na]+. IRMPD action spectroscopy
experiments and complementary electronic structure calculations are performed for these
platinum complexes to elucidate the binding mode of the amino acid to the Pt center and
determine how that binding is influenced by the local environment when pH or ionic
strength change. By comparing the predicted IR spectra for various stable conformations
of each form of platinum complex to the corresponding measured IRMPD spectra, trends
of the binding mode of amino acids to the Pt metal center can be determined. Binding of
Arg to the Pt center is found to involve backbone amino group and carboxylate moiety
(NO binding mode), whereas Lys binds to Pt via two binding modes: backbone amino
and carboxylate moieties (NO binding mode) and backbone and sidechain amino groups
(NNs binding mode). The NNs binding mode is the only dominant binding mode of Orn
binding to Pt that has been accessed in the IRMPD experiment.
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